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2Sum m ary
1. This dissertation addresses both the physical requirements (in terms of the minimal 
mass of tissue needed) for the generation and propagation of epileptiform activity, 
and the purinergic modulation of this epileptiform activity in the cerebral cortex. 
Studies on the minimal mass were performed in rat somatosensory cortex in vivo, 
using subpial transsections based on a recently developed neurosurgical approach to 
the treatment of drug-resistant epilepsy (Morrell et al., 1989: "Multiple subpial 
transection: a new approach to the surgical treatment of focal epilepsy"), in 
conjunction with the iontophoretic application of the convulsant penicillin. For a 
detailed analysis of the structural requirements for epileptiform activity and the rapid 
application and wash-out of drugs of known concentration, a novel in vitro model of 
the isolated neocortical column was developed which allowed the manipulation of 
radial intracortical pathways via pressure ejection of drugs at various cortical depths, 
and the isolation of specific layers by subsectioning the tissue. It therefore provided a 
unique way of studying the intrinsic pathways of individual cortical layers. The 
epileptiform potentials in rat and mouse neocortical cylinders were recorded with 
standard extracellular recording techniques in an attempt to elucidate some of the 
aspects of the ongoing debate on whether the so-called 'cortical columns' are hard­
wired information processing units, or functional groups of co-active neurones whose 
configuration varies with the task performed.
2. After preliminary findings in rat neocortex in vivo had indicated that the minimal 
mass, i.e. the smallest block of cortical brain tissue able to generate epileptiform 
spiking, was small enough to be investigated in vitro, work on the subsequently 
developed in vitro model of the cortical column clearly showed that the minimal 
diameter was below that of the postulated columns defined by the so-called 'barrel' 
structures found in layer IV of the rat somatosensory cortex. Furthermore, blocks of 
brain tissue (containing an estimated 1500 neurones) which excluded layer IV 
displayed epileptiform activity which was indistinguishable from that observed in 
preparations containing all neocortical layers, or indeed from records obtained by 
other groups in chronically isolated neocortex in situ. It is concluded that the minimal
3mass problem is, to a certain extent, merely a question of the degree of connectivity; 
from the results of the present study, no horizontal boundaries corresponding to the 
postulated 'cortical modules' were found to exist with respect to the generation of 
paroxysmal discharges. Similarly, the importance of layer IV in the generation of 
epileptiform discharges appears to pertain only to the specialised case of discharges 
induced by GABA receptor blockade, as exclusion of this layer did not affect the 
ability of the tissue to display the spikes/afterdischarges commonly observed in intact 
cortical slices in vitro, and in cortical subpial isolations in vivo.
3. In Part Two, the purinergic modulation of this epileptiform activity was studied in 
mouse neocortical cylinders and in rat hippocampal slices. The inhibitory effects of 
adenosine (a metabolite of nucleotide hydrolysis which may act as an 'endogenous 
anticonvulsant') on low-magnesium ACSF-induced epileptiform activity are 
described, followed by an analysis of the factors contributing to the proconvulsant 
effects caused by selective adenosine A1 receptor blockade in vitro. The main 
compound used was 1,3-dipropyl-8-cyclopentyl-xanthine (DPCPX), a highly 
selective A1 antagonist which in previous in vitro studies had been reported to induce 
persistent epileptiform activity by an unknown mechanism after transient application 
(Alzheimer et al., 1989: "Transient and selective blockade of adenosine A1 receptors 
by DPCPX causes sustained epileptiform activity in hippocampal CA3 neurons of 
guinea pigs"); these prolonged epileptogenic effects are not usually observed after the 
application of less selective adenosine antagonists. 1
4. Despite the marked proconvulsant effects reported for DPCPX in vitro, the drug does 
not induce seizures when administered in vivo. A similar effect was observed in the 
present study in vitro', on the basis of these findings, it is suggested that the main 
physiological role of adenosine in the brain is to exert an activity-dependent negative 
feedback control which limits the effects of calcium influx through voltage-activated 
Ca++ channels, rather than the 'inhibitory purinergic tone' proposed by some authors.
45. Based on the physico-chemical properties of DPCPX, and on a comparison with the
effects of less lipophilic alkylxanthine adenosine antagonists, it is proposed that the
affinity of these compounds for the adenosine A1 receptor is governed to a large 
extent by the degree to which they accumulate in the lipid bilayer of cell membranes. 
Theoretical considerations, and the fact that DPCPX could be displaced by 
theophylline, indicate that an accumulation within the lipid bilayer, and subsequent 
binding to the A1 receptor via the plasma membrane is the most likely route of 
access. The model also provides an explanation for the previously reported unusually 
rapid recovery of adenosine-mediated inhibition during DPCPX-mediated A1 
blockade.
6. HPLC analysis of the superfusate of incubated hippocampal slices indicated a
substantial release of endogenous adenosine. During prolonged periods of
epileptiform activity in the presence of the highly selective DPCPX-mediated 
blockade of A1 receptors, the endogenously released adenosine may cause excitatory 
effects through the activation of A2 receptors. The recently described function of 
adenylyl cyclase as a coincidence detector which can integrate information from 
multiple signalling pathways suggests that A2-mediated activation of adenylyl 
cyclase is likely to be maximal under these conditions. Recent results obtained with 
genetic 'knockout' mutants or the i.c.v. administration of irreversible Gs protein 
activators suggest that the gene transcription and protein synthesis induced by 
increased cAMP levels may be involved in the pathophysiological changes which 
occur in the epileptic brain. This hypothesis is supported by clinical observations 
indicating that some methylxanthine-induced toxic effects (seizures) may not respond 
to anticonvulsant treatment, while at the same time showing a poor correlation with 
xanthine serum levels.
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1 In t r o d u c t io n  t o  P a r t  O n e
Although the mechanisms by which specific manipulations of cellular excitability 
can lead to a control of seizures are well understood, the origin of spontaneous 
seizures and therefore the aetiology of epilepsy in man is still unclear, regardless of 
the fact that a number of predisposing factors have been found which include central 
nervous system (CNS) infections in early childhood, head trauma, and genetic factors 
(Annegers et al., 1980; Annegers, 1994). The long list of potential causative factors 
currently under discussion is mirrored by the large number of animal models of 
epilepsy. Experimental seizures may for example be induced by the application of 
chemoconvulsants like GABA-antagonists or excitatory amino acids, acute or 
chronic electric stimulation, or the creation of chronic foci induced by alumina 
cream, iron compounds or cold lesions (Loscher and Schmidt, 1988). In fact, it is 
probably the ease with which seizures can be evoked experimentally which has been 
partly responsible for the popularity of epilepsy research, as evidenced by the steadily 
growing number of citations on epilepsy or seizures available in the computerised 
Medline database (Fisher, 1991).
However, the precise changes that lead to a human brain suffering from repeated 
epileptic seizures, i.e. the cellular and molecular basis of the development and lasting 
predisposition for seizures, are unknown. There has been discussion (e.g., Ayala et 
al., 1973) as to whether the tendency of the vertebrate brain to suffer seizures can be 
explained in terms of changes in cellular properties (decrease in GABAergic 
transmission, abnormal channel properties or ionic buffering) or changes in the 
connections of otherwise healthy cells (the network theory). Arguments in favour of 
both models have been found, and the aetiologies of the various epileptic syndromes 
in Man are probably a mixture of both: a change in the cellular properties initiating 
seizures, and a network of neurones with a certain degree of connectivity to allow the 
expression of seizures. The principle that - independently of pathological changes at 
the cellular level - a network of given size and connectivity is needed to express a 
seizure has been linked to the idea of functional units (the cortical columns defined
14
below), leading to the concept that a certain 'minimal mass' is needed for the 
generation of seizure activity.
1.1 The m odular organisation of the neocortex
The mammalian cerebral cortex contains about 109 nerve cells in a relatively 
amorphous sheet covering the phylogenetically more ancient regions of the brain. 
Based on variations in the relative thickness of the various layers and on detailed 
mapping studies, the cortex has been subdivided into more than 40 functionally 
distinct areas in the horizontal plane. Along the vertical axis, a six-layered pattern 
first introduced by the anatomist Brodmann (1909) has come to be accepted as the 
standard. The layers differ in their composition, functional properties and sets of 
connections. On Nissl-stained sections, they can be defined as follows (from pia to 
white matter):
- Layer I (the plexiform or molecular layer) contains very few cell bodies (mainly
neuroglial cells, and some - mostly GABAergic - neurones), and the apical 
dendritic tufts of layer n , ID and V pyramidal cells. It is the site of synaptic 
terminations from cortico-cortical projections, and occupies about 5% of the 
distance between pia and white matter
- Layer II (the external granular layer), which consists of small, tightly packed cell
bodies, and Layer IQ (the external pyramidal layer), a thick layer containing 
large pyramidal cells. Layers Q and IQ are not separated by a clear border on 
Nissl-stained sections; they occupy about 20% of the distance between pia and 
white matter
- Layer IV (the internal granular layer) is densely packed with the somata of small
pyramidal and non-pyramidal cells. It receives most of the thalamocortical 
afferent input, and occupies about 10% of the cortical depth
- Layer V (the internal pyramidal layer) consists primarily of large, loosely dispersed
pyramidal cell somata, and is often subdivided into superficial (Va) and deep 
(Vb) zones. Its thickness is about 20% of cortical depth.
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- Layer VI (the polymorph layer) is composed of relatively tightly packed, small 
round cell somata that belong mostly to a modified form of pyramidal cells 
(thickness approximately 40%).
With the exception of laminae I and VI, the cortical layers contain predominantly 
projection neurones (such as pyramidal cells) with axons leaving the cortex and 
projecting to different parts of the brain including other areas of the neocortex. In 
addition to these principal neurones, intrinsic intemeurones of variable morphology 
are found in all cortical layers. The granular layer (IV) represents the input relay 
station of the neocortex and is therefore most prominently developed in primary 
sensory areas. It consists mainly of intrinsic cortical intemeurones (Miller, 1988).
Besides the horizontal structure characterised by a specific pattern of afferent and 
efferent fibre connections, vertical organisational features have been proposed: in 
sensory and other areas of the cerebral neocortex, afferent information from the 
thalamus is thought to be processed by vertically oriented neuronal assemblies, or 
columns (Mountcastle, 1979). These stmctural or functional modules, which are 
connected to each other by horizontal fibres (Gilbert, 1985), are considered to be the 
functional units of the neocortex, and the synaptic networks within a column have 
been assumed to provide the basis for the higher integrative and cognitive functions 
of the mammalian brain. The concept of a columnar organisation of the cortex is 
based on evidence obtained from developmental, electrophysiological and 
morphological studies.
1.1.1 Ontogenesis
Newly generated neurones in the developing cerebral cortex migrate outward from a 
proliferative zone near the cerebral ventricle (which is divided by glial septa into 
columns of precursor or stem cells termed proliferative units by Rakic [1974]), 
through a cell-sparse intermediate zone, and into the cortical plate below the pial 
surface of the brain (Luskin and Shatz, 1985). The postmitotic neurones migrate to
16
their prespecified areal and laminar position by following shafts of radial glial cells 
through the cellular lattice of the intermediate and subplate zones. These elongated 
non-neuronal cells stretch across the (oc tal cerebral wall from the beginning of 
corticogenesis and are the main reason for the radial organisation of the cortex. All 
postmitotic neurones generated in a single proliferative unit have been claimed to 
form a morphologically identifiable stack of neurones in the cortex variously called 
an "ontogenetic" or "embryonic" column (Rakic, 1978), in which earlier generated 
neurones occupy deeper positions and therefore those arriving later have to pass them 
to become situated more superficially (the 'inside out' gradient of neurogenesis). 
Recombinant retrovirus studies demonstrated that a single progenitor cell can 
produce more than one cell phenotype, most of which end up within the same radial 
ontogenetic column (Wetts and Fraser, 1988). This suggests that the evidence for a 
common origin of a group of neurones within a cortical columnar module is fairly 
strong, although there are exceptions to this point-to-point mapping between the 
ventricular zone and cortical plate, which suggests that areal specification occurs 
after neurogenesis: Walsh and Cepko (1992) reported that clonally related neurones 
in the cerebral cortex of the rat can become widely dispersed across functional areas 
of the neocortex. Further indications that radially oriented groups of neurones form a 
functional unit come from dye coupling experiments. Dye coupling, an indicator of 
electrotonic coupling via gap junctions, is extensive in immature rat neocortex and 
declines rapidly between birth and 10 days of age (Connors et a l, 1983); this 
corresponds to the critical period of development of the primary somatosensory 
cortex in rats.
Fluorescent calcium indicator labelling studies by Yuste et al. (1992) have revealed 
distinct domains of spontaneously co-active neurones in tangential slices of 
developing rat neocortex; the authors suggest that "this nonsynaptic cellular 
communication via gap junctions may influence subsequent synaptic rearrangements: 
if synapses are formed, retained or modified by activity-dependent mechanisms, 
selective synapse formation could occur among members of a domain, resulting in an 
adult column".
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1.1.2 Electrophysiology and morphology
The first experimental evidence for columnar domains in mature neocortex came 
from electrophysiological data from primary sensory cortex (Mountcastle, 1957), 
where vertical microelectrode penetrations encountered neurones with similar 
receptive fields, whereas tangential penetrations revealed cells whose orientation 
preference shifted systematically. The findings confirmed the hypothesis advanced by 
Lorente de No (1938) that the elementary pattern of organisation in the cerebral 
cortex is a vertically oriented column of neurones. Vertically oriented functional 
columns have since been demonstrated in other cortical areas of various species 
(Mountcastle, 1979); in the visual cortex, neurones that respond preferentially to 
stimuli presented to one eye or stimuli having a particular orientation, wavelength, or 
direction of movement are grouped together in independently organised, vertically 
oriented multicellular arrays (Berman et a l, 1987, Hubei and Wiesel, 1962, LeVay et 
al., 1987, Michael, 1978). Other studies have shown that, in the cat and monkey 
primary somatosensory cortices, rapidly adapting neurones which respond only at the 
onset and offset of skin indentation, and slowly adapting neurones which respond 
throughout the stimulus, are situated within separate slablike columns of cortex 
(Dykes et a l, 1980; Sur et a l, 1984). Columns of cells with similar receptive field 
properties have also been identified in the primary (Favorov et a l, 1987) and 
secondary (Alloway and Burton, 1985) somatosensory cortices of the cat. In the 
primary auditory cortex of the cat are columns of cells that respond to the same or to 
similar frequencies or to auditory stimuli from one or both ears (Abeles and 
Goldstein, 1970). Neurones within a single efferent column in motor cortex receive 
proprioceptive input from the same joints or muscles that are activated by cells in 
that column, as well as from skin that is superficial to the target muscles (Asanuma, 
1975); the diameter of these cortical motor columns is about 1 mm in cross section. 
Columns for visual features of objects in monkey inferotemporal cortex having an 
average diameter of 400 pm were described by Fujita et a l  (1992). Iterated modular 
units have also been demonstrated by histological means, leading to the definition of 
ocular dominance stripes in layer IV of the primary visual cortex, alternating bands of 
cortico-cortical connections related to monaural or binaural responses in the auditory
18
system of monkeys (Imig and Brugge, 1978), and so-called 'barrels' in the rodent 
primary somatosensory cortex.
1.2 Barrels
In the rat, the somatosensory cortex (the region most frequently used in studies on the 
mechanisms of neocortical epileptogenesis) comprises the rostro-medial part of the 
parietotemporal cortex. It can be subdivided cytoarchitecturally into a primary region, 
thought to be the principal termination site of receptotopically organised specific 
thalamocortical afferent projections, and areas of secondary sensory cortex whose 
receptive fields are less specific, are usually not lateralised, and which receive 
projections from associated primary sensory cortex, commissural input from 
contralateral cortex, and parallel afferent input from the thalamus as well (Kolb, 
1990). Primary somatosensory cortex (SI - referred to as sensorimotor cortex SmI by 
Woolsey) may be readily identified in Nissl-stained (Chapin and Lin, 1990) or 
cytochrome oxidase-stained (Land and Simons, 1985) tangential sections through 
layer IV by clearly defined aggregates of granule cells (see Fig. 1). These 
aggregations of layer IV neurones - called "barrels" - are related one-to-one to 
individual vibrissae on the contralateral mystacial pad (Woolsey and van der Loos, 
1970; vibrissae are tactile organs consisting of a central hair in a mechanically 
isolated hair follicle receiving a segregated and substantial sensory innervation which 
are moved back and forth at frequencies of 7 Hz in rats and 15 Hz in mice during 
exploratory behaviour, and are arranged in species-specific, stereotyped, grid-like 
patterns in which each vibrissa has a unique position).
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Figure 1: Thionine-stained tangential section through layer IV of the postero-medial barrel field. The 
tissue was flattened between glass slides according to the method described by Strominger and 
Woolsey (1987), fixed and stained in a 10 % neutral formalin / thionine solution for one week and cut 
at 20 p m , A  ^cix^uuutJko cu o tlu .(e s & sClou^  c
This spatial organisation of the vibrissal pad is mirrored in the primary 
somatosensory cortex, where each barrel has a unique position corresponding to the 
vibrissa projecting to it; the barrel field as a whole is homeomorphic to the whisker 
pattern of the face. Numerous studies using a variety of approaches have supported 
the hypothesis first advanced by Woolsey and van der Loos (1970) that a barrel is a 
morphologically identifiable component of a functional cortical column that extends 
throughout the thickness of the cortical sheet (Armstrong-James, 1975; Land and 
Simons, 1985). In single unit studies this is evidenced by one whisker evoking the 
sole or maximally excitatory response from all drivable cells encountered within a 
vertical penetration (Simons, 1978). Further evidence for the central role played by 
the barrels in sensory information processing comes from the finding that markers for 
intense metabolic activity (mitochondrial enzyme staining, blood vessel density, and 
Na+/K+ ATPase activity) are all greatest in the barrels (Riddle et a l, 1993).
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1.2.1 Innervation
Barrels receive their afferent sensory inputs via a trisynaptic pathway (Armstrong- 
James and Fox, 1987) reaching the cortex via the principal trigeminal nucleus and the 
thalamic ventral posteromedial nucleus; these projections constitute the barrel's 
predominant source of extrinsic inputs (Land et al., 1986). The terminal arbours of 
thalamocortical axons in layer IV are confined almost exclusively to barrel centres 
(Bernardo and Woolsey, 1987). However, the pathway does not correlate whiskers 
and barrels in a simple one-to-one fashion, as more recent studies have revealed that 
most neurones projecting from the thalamus to the barrel cortex respond to inputs 
form a large number of whiskers (Simons and Carvell, 1989); this indirectly implies 
that the one-to-one response of individual barrels is based on an active integrative 
process rather than a restricted afferent input. The barrels contain two major cell 
classes corresponding to spiny stellate cells and smooth nonpyramidal cells that have 
been described in different cortical areas in a variety of species (Woolsey et al., 
1975); the total cell number of large barrels in the rat averages 2500 neurones. The 
dendritic fields of intrinsic barrel neurones are confined to the barrel, and their axons 
ramify extensively within it, where they come in close apposition to barrel neurones 
of both classes (Harris and Woolsey, 1983). Since thalamic contacts account for only 
20 percent of all barrel synapses (White, 1989) and since locally projecting axons of 
non-barrel neurones largely avoid barrel centres, it appears that a majority of synaptic 
connections in a barrel arise from neurones within it. Thus, available evidence 
strongly indicates that a barrel is a densely interconnected network of layer IV 
neurones that receives its predominant afferent drive from a single external source 
(Kyriazi and Simons, 1993).
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Figure 2: Location of the barrel field on the left hemisphere of a rat brain. The posteromedial barrel 
subfield (PMBSF; filled black circles) corresponds to the major whiskers on the mystacial pad. The 
drawing of the barrel field was taken from Woolsey and van der Loos (1970); the position was 
determined according to the definition of area SI by Schober (1986) and relative to prominent 
anatomical landmarks such as the middle cerebral artery
1.2.2 Receptive fields
The receptive fields in the SI barrel cortex are small in the layer IV barrels and 
distinctly larger outside of them (Swadlow, 1989); the functional data are consistent 
with anatomical descriptions of segregated afferent inputs from barreloids (the 
homeomorphic representation of the barrel field at the second relay station of the 
trigeminal pathway, at the level of the ventrobasal complex of the thalamus [Van der 
Loos, 1976]) to homologous cortical barrels (Land et a l, 1986) and of 
interconnections among neighbouring barrel columns by way of supra- and 
infragranular routes that largely avoid barrel centres (Bernardo et a l, 1990).
Specifically, the idea that progressively larger receptive fields are elaborated as 
intracortical processing of information proceeds from layer IV and deep layer ID to 
more superficial layers and then to deep layers is supported by a comparative
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electrophysiological and histochemical study (Ito, 1992) which showed that the mean 
dendritic field size of layer Vb pyramidal neurones in terms of the number of barrels 
involved averaged 2.2 , and -&4 Wu, / o /
^ rec^ v c^ ^ jev en  reached a telue. of 5.8. Therefore, the extent of the columns in 
lower layers of the cortex are somewhat larger and more ill-defined than in the layer 
of principal somatosensory input.
1.2.3 What shapes barrels?
Both intrinsic and extrinsic factors have been implied in cortical parcellation. 
Developmental studies show that the first trigeminal ganglion cell axons are present 
within the brain stem on the eleventh day of gestation (El l )  in the rat, whereas 
peripheral axons do not reach the mesenchyme of the developing whisker pad until 
day E l3 (Scarisbrick and Jones, 1993); however, the subsequent superimposition of 
the pattern of whisker follicles on neural networks at successive relay stations of the 
CNS is generated in an activity-dependent manner, as injury of the whisker follicles 
in rat pups disrupts the formation of characteristic cytoarchitectonic and 
histochemical patterns within the vibrissal representation found in the ventrobasal 
complex of the thalamus and in the somatosensory cortex (Belford and Killackey, 
1980). The sensory input relayed through the thalamic afferents appears to be a 
critical factor in determining later cytoarchitecture (Erzurumlu and Jhaveri, 1990; 
Schlaggar and O'Leary, 1991). That the barrel field formation is defined mainly by 
sensory input rather than glia is supported by an electrophysiological study 
(McCandlish et al., 1993) of the development of the SI cortical barrel field map; 
although the development of the physiological map of the representation of the body 
surface follows the same lateral-to-medial gradient as morphological studies, the 
morphological map lagged behind the physiological map by about 48 hours. Evoked 
responses could be detected as early as 12 hr after birth in the rat, suggesting that 
thalamocortical afferents have reached the developing cortical plate and are 
functional before glial cells are first detected: this can be seen as further evidence for 
a purely functional origin of cortical pattern formation. Final evidence that barrels are 
not simply an extrapolation of predetermining ontogenetic columns as proposed by
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Rakic comes from an analysis of virally tagged cortical clones which revealed no 
coincidence with barrel structures (Walsh and Cepko, 1992). In summary, the sharp 
boundaries observed in mature neocortex are likely to be due to activity-dependent 
mechanisms, being shaped both by spatial cues in the early phases of cortical 
development, and by extensive axonal remodelling and pruning which is thought to 
require neuronal activity.
1.2.4 What is their function?
As mentioned earlier, it is a widely held belief that information is processed within 
columns in the cortex (Mountcastle, 1957), but experimental evidence on how this 
might occur, or how information might be associated between columns, is sparse. 
However, the sequence of connections between layers has been found to be relatively 
uniform, and may provide an insight into how the cortex 'works'. Studies on the flow 
of excitation within the barrel cortex upon striking a single vibrissa (Armstrong- 
James et a l, 1992) reveal the following picture: layer IV is activated before any other 
layer but is closely followed by cells in layer Vb. The next group of cells to fire were 
found to lie directly above the barrel (layer ID). Next, layer Va cells fired 
simultaneously below the main barrel and neighbouring barrels; at the same time, 
layer II cells became active. Therefore, information is first relayed within a column 
before relay to cells in adjacent columns takes place. (The septal regions above, 
below and between barrels are innervated via a different pathway relayed by the 
rostral zone of the thalamic posterior complex [Diamond et al., 1992], which itself 
receives corticofugal inputs from the barrels [cortico-thalamo-cortical loop]). Why 
these cortical columns should be apparent at the macroscopic level is beyond the 
scope of this introduction. Woolsey and van der Loos (1970) speculated that "the size 
of the mouse cerebral cortex may approach a minimum; [..] neurones in layer IV in 
the mouse cerebral cortex are perhaps just barely enough for the cortical 
manipulation of sensory data" (p. 238), while Krubitzer et al. (1993) advanced the 
hypothesis that modules within a cortical field may represent the initial stage of the 
evolution of a new cortical field by a gradual aggregation and eventual segregation of 
functionally distinct neuronal groups.
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1.2.5 Are barrels identical with cortical columns?
Cortical columns have been defined in various ways. It has been suggested recently 
(White and Peters, 1993) that barrels actually comprise a large number of cortical 
modules consisting of clusters of layer V apical dendrites with a centre-to-centre 
spacing of about 25 pm; the authors drew the conclusion that the pyramidal cell 
modules (which have been found throughout the cerebral cortex) are fundamental 
neuronal units, and that the various functional areas of the cortex in different species 
are organised according to a common, basic plan. However, evidence for a clear 
functional segregation of computational tasks into cell subgroups within the barrel 
hollow is sparse. Therefore, barrels are still regarded as functional units subserving a 
single computational task; reference to the idea that barrels correspond to columns is 
frequently found in recent publications. For example, Welker et al. (1993) state that 
"a barrel is regarded as layer IV's morphological substrate of a cortical column, i.e. 
the barrel column" (and see Ito, 1992).
1.3 The 'M inimal mass' problem  in epilepsy research
Related to the question of whether there are defined cortical processing units shaped 
by a stringent (pre-existing) organisational principle forming the whole of the 
neocortical sheet, and which by definition should be able to perform a defined 
computational task, is whether these columns coincide with the minimal amount of 
cortical tissue involved in the generation and maintenance of epileptiform activity, 
the so-called 'minimal mass'.
1.3.1 Historical background
The first indication that epileptiform spiking could be evoked in a subregion of the 
neocortex came from an in vivo study by Kristiansen and Courtois (1949) who 
demonstrated that paroxysmal discharges could be evoked in a completely isolated 
portion of the suprasylvian gyrus in the cat in which the pial circulation was left
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essentially intact. Echlin (1959) isolated "an area of cortex approximately 2 to 2.5 cm 
square and 1 cm in thickness by extensive subpial section along four sides and wide 
undercutting" in the frontal or parietal lobes of 90 Rhesus monkeys and was able to 
demonstrate an enhanced epileptiform response to topical eserine solution up to three 
and a half years later. Similar results were obtained by Sanders and Pinski (1967) in 
cortical isolations in the suprasylvian gyrus in the cat measuring 18-25 mm long, 3 
mm wide and 4 mm deep.
The findings were extended to the human CNS with the observation that epileptiform 
activity could still be seen in isolated cerebral cortex in patients who had undergone 
functional hemispherectomy, suggesting that "intracortical connections allow 
sufficient neuronal synchrony to produce epileptiform discharges" (Pierre-Louis and 
Morrell, 1992).
1.3.2 Multiple subpial transections
The concept of a minimal mass needed for the generation of epileptic activity saw its 
first clinical application with the development of a novel surgical technique for the 
inactivation of foci in refractory partial epilepsy by Morrell and Hanbery (1969; see 
Fig. 3). It was based on a number of observations which indicated that whereas the 
columnar organisation of the cerebral cortex discussed above results in a vertical 
processing of information, the spread of epileptic activity to previously uninvolved 
brain regions occurs in a horizontal fashion; and furthermore, that the amount of 
cortical tissue needed to generate the seizure activity has a critical lower limit: Sperry 
et al. (1955) had demonstrated that surgical cross-hatching of the visual cortex did 
not impair visual perception in the cat, which suggested that most of the functionally 
important connections of a cortical territory were arranged in vertical columns and 
that, if this columnar organisation was preserved, the horizontal fibres could be 
sectioned without causing serious disability.
Other studies on the minimal mass in vivo indicated that a minimal contiguous 
volume of cortical tissue was necessary to sustain synchronous spiking. Duysens and
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a 2 mm2 area by four subpial vertical cuts abolished its epileptic activity. In 1977, 
Reichenthal and Hochermann had showed that after the topical application of 
penicillin to the exposed rat cortex in vivo, the division of the active epileptic focus 
by a subpial cut only resulted in active subfoci if the surface area exceeded 0.5 mm2. 
Lueders et al. (1981) showed that stable penicillin foci generated by weak penicillin 
solutions had a minimal area of distribution of 12.5 mm2 in the cat, as two foci 
separated by four millimetres on the same gyrus were consistently dependent and 
simultaneous, whereas foci separated by 6 mm were almost always independent. 
Cortical islands greater than 5 mm in width, or horizontal connections of greater than 
5 mm, were known to be able to support paroxysmal discharges (Tharp, 1971). More 
recently, Silva-Barrat et al. (1992) showed that the neurones in rat somatosensory 
cortex responding to the discontinuation of GABA infusion with epileptiform 
bursting (the so-called "GABA withdrawal syndrome") were located within 0.7 to 1.2 
mm from the infusion site. Morrell's own preliminary studies on small alumina cream 
foci in monkeys indicated that epileptiform potentials disappeared when the focus 
was transsected, and he therefore assumed that "the spontaneous generation of 
epileptiform potentials in intact [human] brain appears to require several millimetres 
of contiguous tissue" (Morrell and Hanbery, 1969).
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Figure 3: Multiple subpial transections, a method devised by F. Morrell et al. for the treatment of 
focal epilepsy: a small, right-angled hook is inserted underneath the pia and drawn through the gray 
matter (middle, and right inset). Further transections are performed at 5 mm intervals to include the 
entire area of electrical abnormality (adapted from Morrell et al., 1989)
The surgical technique, which requires the severing of tangential intracortical fibres 
while preserving the vertical fibre connections of both incoming and outgoing nerve 
pathways and of the penetrating blood vessels (which also have a vertical 
orientation), was intended particularly to be used in those cases where the 
epileptogenic lesion lies in "unresectable" cortex; that is, those cerebral regions 
subserving speech, memory, and primary motor and sensory function. It consisted of 
a number of parallel incisions spanning the depth of the cortex which were performed 
by introducing a heavy steel wire with a right-angled hook through a small, pin-sized 
pial opening, pushing it through the grey matter and then gently drawing it back 
across the sulcus to sever all horizontal connections.
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The results with respect to seizures and cortical function were highly encouraging: 
over a follow-up period of up to 22 years, eleven out of twenty patients with foci in 
unresectable brain regions treated with this technique became seizure-free; in no case 
did the treatment result in major dysfunctions of the affected brain area. Furthermore, 
in those cases where the relief of seizures was only transient, spanning a period of 
several months to years, the electrical abnormalities and clinical seizures which 
eventually recurred were noted to arise from spike foci outside from the transected 
region; also, the seizures had behavioural features different from those of the original 
attacks, indicating that the new focus had developed independently from the original 
site.
1.4 Purpose of this study
Based on the results published by Morrell et al., we asked ourselves whether it was 
possible to demonstrate a minimal mass for the induction of epileptic activity in the 
rat, and if so, whether it coincides with suspected organisational units of cortical 
function like the barrels found in the primary somatosensory cortex of the rat. That 
this may be so was based on theoretical considerations, and on reports in the 
literature that small penicillin foci evoked in vivo resulted in a zone of columnar 
activation in sensory cortex (Collins, 1978) as measured by the [14C]-deoxyglucose 
method in the rat, and that the propagation of epileptiform discharges in rat 
neocortical slices was spatially periodical in the somatosensory (but not the 
secondary visual) cortex, with the dominant spatial frequency averaging one 
millimetre (Chervin et al., 1988). Also, Gabor et al. (1979) had reported that in cat 
visual cortex, the margin of a penicillin focus coincided with a shift in the preferred 
axis of movement of individual neurones, and stated that "the minimal epileptogenic 
aggregate is probably no smaller than the number of cells with the same preferred 
axis of movement and ocular dominance [...] physiologically defined neuronal 
populations (columns) may be the subunits of epileptogenesis".
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In its original form, the aim of the research project was stated as follows (O. Holmes, 
1990): "Several laboratories have shown that, both in vivo and in the tissue slice, 
epileptiform manifestations cannot be induced in a partially isolated island of 
neocortical tissue of less than a certain critical size. In this laboratory it has further 
been shown that the enhancement of somatosensory evoked potentials which heralds 
the onset of overt spontaneous spiking also requires a critical mass of neural tissue of 
the same dimensions. These observations indicate that the neuronal circuitry 
subserving epileptiform manifestations is much more spatially extensive than that 
subserving normal electrical activity such as the electroencephalogram and normal 
somatosensory evoked potentials. [The] objective is to specify the anatomical layout 
of the cortical circuitry necessary for epilepsy to occur. In the anaesthetised rodent, 
using acute focal epileptogenesis induced with agents such as penicillin, [it will be 
investigated] whether the minimal cortical mass subserving epilepsy is the cortical 
barrel, whether several barrels are needed or whether epilepsy depends on some other 
modular cortical organisation which is out of register with the barrel fields."
These questions are also relevant to the ongoing discussion as to whether epilepsy is 
due to changes in individual neurones (the "epileptic neurone" hypothesis) or whether 
the behaviour of an entire population has been altered (the "circuit" hypothesis). The 
approach chosen for the present study involved the induction of epileptiform 
(interictal) spiking in isolated rat somatosensory (SI) cortex both in vivo and in vitro 
with the help of chemical convulsants.
1.4.1 Evoked potentials and interictal spikes
Evoked potentials, which can be monitored in non-invasive surface 
electroencephalographic (EEG) recordings, are the sum of many thousands of 
synchronised postsynaptic potentials produced by parallel cortical dendritic processes 
extending normal to the pial surface in response to physiological stimuli, and reflect 
mainly the activity of pyramidal cells. They play an important role in CNS diagnostic 
routines in the clinical setting, and are the main tool for the mapping of
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representational regions in the vertebrate cortex. In this study, they were used to 
locate the forepaw region within the primary somatosensory cortex, and to gauge the 
physiological health of the cortex. The field potentials recorded at depth reflect the 
sum of dipole activity in the surrounding cortex. In the anaesthetised rat these field 
potentials show slow, random oscillations due to remaining cortical activity, and also 
a certain degree of noise due to the mechanical movement imposed on the electrode 
tip by blood flow and respiration. When convulsant drugs are applied to the cortex, a 
general increase in activity can be observed which is then followed by the 
development of epileptic discharges; these represent the synchronous activity of a 
large number of neurones. The most regular in form and the most easily identifiable 
discharge is the spontaneous interictal spike.
Interictal spikes are abrupt, spontaneous changes in potential lasting about 70 ms 
which are frequently found between seizures in EEG recordings in human patients; 
they are electrically similar to seizures, but are self-limiting and brief enough not to 
interfere with normal behaviour, and often represent the most reliable indicator for an 
epileptic syndrome; furthermore, they are often localised in the brain region in which 
seizures originate in a given patient. They are, however, clearly pathological, as the 
mismatch between information content (which is inversely correlated to synchrony) 
and energy cost is similar to that of an epileptic fit. The events leading to an interictal 
EEG spike have been elucidated in studies combining in vitro electrophysiology and 
computer modelling of neuronal networks. Pyramidal neurones, which rarely fire 
action potentials in response to a single excitatory postsynaptic potential (EPSP), 
may recruit additional neurones through sequential activation under circumstances 
where GABAergic inhibition is reduced or excitatory transmission is facilitated. An 
increasing number of pyramidal cells then fire bursts of action potentials in response 
to a single synaptic input, until a critical fraction of cells in the population becomes 
simultaneously active; and then virtually all the remaining neurones become recruited 
simultaneously, leading to the interictal spike which can be detected in the EEG. This 
kind of paroxysmal activity requires recurrent innervation and is therefore not 
observed in structures lacking such connections, like the cerebellar cortex. In human 
epileptic foci, seizures have been speculated to be triggered by spontaneously spiking
31
'epileptic neurones' at the centre of the focus which occasionally recruit a critical 
mass of surrounding neurones (Shaw and Chadwick, 1987).
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Figure 4: Discharge patterns observed during the transition from normal to ictal EEG in a quisqualate 
(30 pg i.c.v.)-treated, freely moving rat (modified from Kanai et al., 1992)
The role played by interictal spikes within the epileptic syndrome is not yet fully 
understood: they could be either abortive seizures, or represent a necessary build-up 
to the seizure proper, or be a completely independent phenomenon associated with 
epileptic activity. Interictal spikes may be entirely lacking between clinical seizures, 
or only be present in significant numbers in the wake of a seizure; other patients have 
frequent interictal spikes, but few seizures (Fisher, 1991). However, most researchers 
assume that interictal spikes represent a minor form of epileptic seizure; this is 
supported by results from experimentally induced seizures in intact animals, where 
the transition to generalised tonic-clonic seizures after the administration of chemical 
convulsants is graded, leading from periodic single spikes over polyspike bursts 
(preictal EEG) to irregular polyspike patterns (ictal EEG; see Fig. 4). It can therefore
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be assumed that interictal spikes provide a valid if simple system for investigating the 
basic mechanisms of epilepsy.
1.4.2 Convulsants
Experimentally, acute paroxysmal activity can be evoked by either reducing the 
inhibitory activity of neural systems, or by increasing excitatory influences. The 
conceptually simplest method involves the pharmacological blockade of GABAa 
receptors. Within the higher central nervous system, the GABAa receptor with its 
integral chloride channel is the major inhibitory neurotransmitter receptor. GABA- 
mediated inhibition shapes sensory input, motor output, and maintains a basal level 
of excitability in the mammalian cortex; any diminution of GABAergic inhibition 
can lead to excessive excitability, which often manifests itself as seizure activity. In 
this study, epileptiform activity was evoked in vivo by the iontophoretic application 
of a sodium penicillin G solution to specific layers of the neocortex.
In common with several other clinically used antibiotics (Grondahl and Langmoen, 
1993), penicillin G is convulsant when applied to the central nervous system; it acts 
mainly by blocking GABAergic postsynaptic inhibition (Schwartzkroin and Prince, 
1980), and the epileptogenic effect appears to be linked to the beta-lactam ring, as 
enzymatic cleavage of this ring results in loss of epileptogenic activity (Gutnick and 
Prince, 1971). It has been shown to reduce the mean open time of GABA-activated 
channels (Chow and Mathers, 1986) and is extensively used in models of absence 
seizures (the feline generalised penicillin epilepsy - Quesney and Gloor, 1978), and 
for evoking local epileptiform activity in the cortex. The focal intracortical 
application of convulsants has been routinely used in this laboratory and has led to 
the discovery that layer IV is the most sensitive to the convulsant action of penicillin 
(Holmes and Lockton, 1982), of other GABA-blocking agents, and possibly also of 
other, unrelated convulsants. Layer IV therefore appears to play a cardinal role in the 
generation of bicuculline/penicillin-induced abnormalities seen in in vivo and in vitro 
recordings and current source density analysis. Several research groups have focused
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on these possible "generator zones", which have been identified in various regions 
within the brain, and which have revealed the important role not only of layer IV in 
the neocortex, but also of several limbic regions (area CA3 in the hippocampus and 
amygdala), and of the area tempestas, an epileptogenic trigger zone in the deep 
prepiriform cortex (Piredda and Gale, 1985). The presence of a unique population of 
'intrinsic burst' neurones in layers IV-V (Connors et a l, 1982) provides one 
mechanism by which seizures may be initiated in the neocortex. Layer IV is also the 
target for most of the thalamic input (the main afferent system within the cortex), and 
it easy to envisage it as the most vulnerable region to the potentiating effect of 
GABA antagonists, as it can be regarded as the starting point for the cortical signal 
processing pathway. Consequently, the peak sensitivity of layer IV discovered by 
Holmes and Lockton (1982) was taken to indicate the site of generation of cortical 
epileptiform events (a conclusion based on the assumption that GABA receptor 
density is uniform throughout the cortex) and led to the assumption that barrels, 
which are a prominent feature of SI layer IV in the rat, might be the basic unit of 
epileptogenesis.
In the in vitro experiments, epileptiform spiking was induced by superfusing the 
tissue with magnesium-free artificial cerebrospinal fluid (ACSF). The physiological 
roles of magnesium ions in neuronal function include the stabilisation of neuronal 
membranes by screening membrane surface charges, the regulation of 
neurotransmitter release by the partial antagonism of presynaptic calcium ion entry, a 
voltage-sensitive block of the NMDA-receptor linked channel, and the involvement 
in a number of cellular metabolic processes such as the regulation of ATP and cyclic 
nucleotides which themselves affect neuronal excitability. It is therefore not 
surprising that nominally magnesium-free ACSF leads to a distinctly altered neuronal 
excitability, resulting in several types of epileptiform activity: spontaneous EPSP-like 
depolarisations, epileptiform bursts, spreading depression, and even full-blown 
electrographic seizures - hence the use of parenteral magnesium sulphate for the 
treatment of eclampsia (Lindheimer, 1993) and alcohol withdrawal seizures (it has to 
be noted, however, that its clinical use is limited by its failure to reach adequate 
levels in the brain: in a patient suffering from intractable status epilepticus treated
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with magnesium sulphate, cerebrospinal fluid magnesium levels were only slightly 
above baseline, despite an increase in serum magnesium levels to 7 . 1 m  /°f (Fisher 
etal., 1988)).
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2 M e t h o d s
2 .1  Experiments in vivo
For the in vivo experiments, a total of 46 male Sprague-Dawley Albino rats 
(weighing 200 - 300 g) bred in the animal house of the University were used. (The 
rat, being a lissencephalic animal, is particularly useful for in vivo studies involving 
the cerebral cortex.) Prior to an experiment, each animal was deeply anaesthetised 
using ethyl chloride vapour and a subsequent intraperitoneal injection of urethane 
(ethyl carbamate, 25% w/v in distilled water) 1.2 to 1.6 ml, equivalent to 2 g/kg of 
body weight. The depth of anaesthesia was arranged to be such that the animal just 
failed to exhibit a withdrawal reflex when the toes of a hind limb were pinched. A 
midline incision 3 cm long was performed in the skin of the throat, and the 
sternohyoid muscles were parted by blunt dissection to expose a section of the 
trachea; a tracheal cannula was then inserted and secured with thread to facilitate 
spontaneous respiration (some animals had a mild throat infection, which would have 
led to the accumulation of fluid in the trachea).
Bregma
Lambda
Figure 5: Rat skull; the shaded square indicates the area of bone removed prior to recording 
(illustration adapted from Paxinos and Watson, 1986)
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The head of the animal was mounted in a stereotaxic frame and held at three points: 
two metal rods with conical ends were pushed one into each auditory meatus, and the 
snout was gripped with a screw clamp. The body temperature was kept at 37°C by a 
heating pad warmed from a water bath. The skull was exposed, and after the removal 
of part of the left temporal muscle to expose the parietal bone, a unilateral 
craniotomy ( 3 x 3  mm) was made using a Kaltenbach and Voigt dental drill to expose 
a region of the left hemisphere centred around the intersection of the coronal suture 
and the sagittal ridge, as this point lies almost directly over the forepaw area of the 
primary sensory cortex (see Fig. 5). Under a Zeiss binocular dissecting microscope to 
provide a 10- to 16-fold magnification, the dura mater was carefully resected by first 
piercing it with a fine surgical needle and then carefully cutting it back to expose the 
arachnoid; during the resection, the exposed neural tissue was covered with a thin 
film of saline to keep it moist. Once any bleeding had stopped, the exposed cortex 
was covered with liquid paraffin oil at 37°C to prevent it from drying out. Finally, 
stimulating electrodes consisting of a fine silver wire loop coated with electrode gel 
were connected to the second and fourth digit of the right forepaw; the stimulation 
consisted of rectangular voltage pulses of 0.1 msec duration and an amplitude of 10 
to 90 V applied every 4 seconds.
Cerebral cortical mass potentials were recorded by means of glass microelectrodes at 
depth. All recordings were taken with respect to an indifferent chlorided silver ball 
electrode placed near the midline on the exposed skull, unless otherwise stated. The 
signals were fed through source followers and amplified 500 to 2000-fold using 
Digitimer Neurolog NL 103 preamplifiers. The output was led to a Tektronix dual 
beam oscilloscope and recorded on both an Ampex FM tape recorder and (after 
analog-to-digital conversion) on a DEC 350 workstation. Stimulation of the forepaw 
was from a Devices isolated stimulator Mk H  A Devices digitimer was used to 
synchronise the stimulation and the recording equipment. All microelectrodes were 
made from borosilicate glass capillaries (Kwik-Fil, Clark Electromedical 
Instruments) pulled on a two-stage laboratory-made vertical puller. Recording 
electrodes (tip size 1 pm, resistance around 2 M£2) were backfilled with 4 molar 
sodium chloride solution. Iontophoresis was used to eject a controlled flow of
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penicillin into a discrete area of the cortex. To this end, a separate glass micropipette 
with slightly larger tip diameter was used to avoid clogging of the electrode tip; a tip 
size of between 5 and 10 pm could be regularly achieved by breaking back the tip of 
a normal electrode under visual guidance on a 40x binocular microscope.
These electrodes were then backfilled with sodium penicillin G (500 mM) solution. 
After checking that the electrode resistance was below 5 M fl, and after careful 
rinsing of the tip to remove penicillin solution adhering to the outside of the tip, the 
electrodes were ready for use. Because penicillin is a negatively charged ion, it is 
retained within the electrode by the application of a positive (holding or backing) 
current of +100 nA, and expelled by a negative current (-100 to -500 nA) once the 
electrode has been placed at the required cortical depth. After ejection, the 
iontophoretic current was reversed to reimpose the backing current, and the electrode 
was removed from the cortex to minimise passive leakage. The cortical depth of 0.7 
mm for both the recording and iontophoresis electrodes was based on previous 
studies performed in this laboratory (Holmes and Lockton, 1982) indicating that layer 
IV is the most sensitive layer to the epileptogenic actions of penicillin and other 
GABA-blocking agents.
2.1.1 Isolation procedure
One hour after the cortex had been exposed, the recording electrode was placed on 
the surface of the cortex near the location of the forepaw area of the primary 
somatosensory cortex (estimated from anatomical landmarks) and advanced into the 
cortex to a depth of 700 pm until the correct position was found; this was confirmed 
by the presence of strong negative going evoked potentials triggered by the 
stimulating electrodes at a rate of 4 Hz. For the comparison of the enhancement of 
evoked potentials and of the generation of epileptiform spiking, the isolations were 
performed within the forepaw area; if the isolation was to be within the barrel field 
area, the final location of the isolation was more medial. As no evoked potentials
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were recorded in the latter case, the correct placement of the isolation had to be 
controlled by histological means after the end of the experiment.
After a control period of up to 30 minutes, the recording electrode was withdrawn 
and a partial isolation of the area around the electrode track was performed. Round 
isolations were achieved by using a tungsten wire helix (see Fig. 6) with an 
electrolytically sharpened tip, while rectangular isolations were performed by using 
an L-shaped tungsten microelectrode. In both cases, the isolation was performed by 
carefully introducing the tip of the wire underneath the pia before pushing the cutting 
edge down to the required depth. If the isolation was performed properly, the 
resulting bleeding was minimal and of a transient nature; the recording electrode 
could then be reintroduced along the same track and to the same depth, and more 
transients were recorded until the amplitude of the evoked potentials had stabilised at 
or near the pre-isolation level. Then, a sodium penicillin G-filled iontophoretic 
electrode was lowered into the cortex as close as possible to the recording electrode, 
and a given amount of penicillin was expelled.
Ideally, the isolations should contain a single cortical unit, or module. The diameters 
of individual barrels in the primary sensory cortex of the adult rat range from around 
200 pm for the smallest ones up to 500 - 600 pm for the large posteromedial barrel 
subfield (PMBSF) barrels, and from 150 pm (small barrels) to 350 pm  (PMBSF 
barrels) in the mouse. If one accepts the hypothesis that barrels represent single 
cortical modules (see Introduction), the diameter of 'cortical units' should vary over a 
similar range throughout the primary somatosensory cortex, with a median value of 
350 pm. As a starting value, a helix of tungsten wire with a diameter of 600 pm was 
therefore manufactured and used.
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Figure 6: Isolator used for the round subpial partial isolations. Left: schematic drawing. A 24 gauge 
wire carrying the tungsten helix turns inside a 36 gauge hypodermic cannula glued to a supporting rod 
which is connected to the micromanipulator. Right: The tip of the tungsten wire (diameter 180 pm) 
was sharpened electrolytically in KN02 as described by Hubei (1957). The helix is glued to its 
supporting wire using dental wax to allow repositioning under heat.
2.1.2 Histology
At the end of each experiment, the brains were removed and fixed in 10% neutral 
formalin. To assess the depth of the isolation, coronal sections 20 pm in thickness 
were cut on a cryostat and thaw-mounted onto slides before embedding in Burr 
Aquamount (see Fig. 14). Alternatively, the entire brain was sectioned at the level of 
the isolation and photographed. In those experiments where the position of the 
isolation relative to the barrel field cortex had to be visualised, the brains were 
treated according to the method described by Strominger and Woolsey (1987): the 
cortex of the left cerebral hemisphere was gently divided from the underlying white 
matter with a moistened spatula and placed between two coated glass slides separated 
1 mm by spacers. The flattened cortex was stained and fixed by immersion in 10% 
neutral formaline / thionine nuclear stain solution for three weeks, and wax
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embedded. Subsequently, serial sections were cut horizontally, that is, parallel to the 
pial surface, to reveal the location of the isolation relative to the barrel field and the 
cortical strata.
2.1.3 Data analysis
The field potentials were filtered, amplified and digitised. Digital data sampling was 
either continuous (to record spontaneous spikes) or triggered by the forepaw stimulus 
(to record evoked potentials). Continuous data could then be processed using digital 
bandpass filtering: evoked potentials were averaged. Acquisition and data analysis 
were carried out using a computer program written by Dr. O. Holmes (CompA). The 
results obtained in the in vivo experiments were stored on magnetic tape and re­
analysed off-line where necessary. A UV recorder was available for the production of 
permanent records of the EEG trace displayed on a dual beam oscilloscope.
2.2 Experiments in vitro
For the in vitro experiments described below and in Part Two of the study, a total of 
90 male Wistar rats (weighing 160 - 260 g) bred in the animal house of the 
University, and 97 female BalbC mice (weighing 25 - 40 g) obtained from a 
commercial supplier were used. The animals were injected with urethane 2.5 g/kg (as 
25% w/v in water) and decapitated by guillotine while in a state of heavy sedation or 
unconsciousness (previous studies had indicated that urethane appears to interfere 
minimally with the outcome of electrophysiological and pharmacological studies in 
the brain slice [Feldman and Felder, 1988]). The surface of the cortex was then 
rapidly exposed under a constant stream of cold, oxygenated artificial cerebrospinal 
fluid (ACSF; composition [in mM]: NaCl 120, KC1 1.1, CaCh 2, MgS04 1, KH2PO4 
2.2, NaHC03 26, glucose 10) by inserting a pair of forceps into the rostral end of a 
fine cut made along the right temporal ridge and then lifting the whole tectum and 
dura off in one movement.
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At first, the cylinders were excised using a glass punch manufactured by drawing out 
a piece of glass microelectrode tubing containing a metal rod of given diameter (300 
- 1000 pm) over a gas flame; this resulted in a glass punch with extremely fine walls 
and a sharp cutting edge. The resulting neocortical cylinders were 
electrophysiologically viable, but the method did not yield sufficiently standardised 
preparations and was therefore abandoned. All experiments described on the 
following pages were therefore performed in tissue preparations obtained as follows: 
After exposing the surface of the cortex, a slab of cortical tissue centred around the 
SI area of the left hemisphere was sliced off using a small razor blade. The slab was 
positioned upside down (i.e. with the white matter uppermost) on a McDwain tissue 
chopper and cut at the required thickness, turned by 90° and cut again. Although the 
resulting tissue sections were blocks of rectangular shape, they will be referred to as 
'cylinders' to illustrate the fact that they represent a model of the cortical column, in 
analogy to the term 'column', which has been used to describe functional units such 
as the ocular dominance stripes in the visual cortex (interestingly, the basic 
cylindrical module has an equivalent in computer modelled neuronal networks, 
where a cylindrical configuration of the hypothetical layers is often adopted in order 
to avoid edge discontinuities and wrap-around connections (Walker and Akers, 
1988)). Positioning the slab upside down ensured that all cuts were perpendicular to 
the pial surface. The moistened filter paper with the cross-sectioned slab was then 
transferred to a petri dish containing oxygenated, cold (5°C) ACSF, and the cortical 
'cylinders' were gently teased apart using two glass electrodes with firepolished 
rounded tips. Finally, the individual cylinders were transferred to a petri dish placed 
in an incubation chamber constantly bubbled with carbogen (95% 0 2 / 5 %  CO2) and 
left to recover at room temperature for at least one hour. Cooling of the incubation 
chamber to 5°C for the length of the incubation period in an effort to improve the 
recovery of the slices did not have the desired effect. If anything, the slices were less 
viable; this could be due to the inhibition of essential enzymatic reparation processes 
occurring after the severe perturbations inflicted by the excision. After a period of at 
least one hour, a single cylinder was then placed in a submersion-type recording 
chamber, pinned down with two blunt glass microelectrodes and superfused by 
gravity at a rate of 5 ml/min with ACSF saturated with 95% O2 / 5% CO2 and 
maintained at 29°C. The medium had the following composition [in mM]: NaCl 120,
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KC1 1.1, CaCk 2, MgS04 1, KH2PO4 2.2, NaHC03 26, glucose 10. Magnesium-free 
ACSF was prepared by omitting MgSC>4 from the normal ACSF. Glass 
microelectrodes were pulled on a single-stage puller, and backfilled with Ca2+- and 
glucose-free ACSF. The tips of the microelectrodes were broken back under visual 
guidance to a tip diameter of around 2 pm; this resulted in electrode resistances of 2 - 
5M Q.
For the localised application of Mg++ solutions, small amounts of magnesium 
sulphate solution (100 mM in distilled water) were injected at various cortical depths 
in mouse cortical cylinders (diameter 450 pm) displaying spontaneous spiking in 
low-magnesium ACSF. To this end, a micropipette (tip diameter 10 pm) filled with 
MgS04 solution was connected to a syringe driver via rigid small-diameter tubing, 
and brief ( 2 - 5  seconds) pressure pulses were applied after the micropipette had been 
positioned at the required depth. The pipette was then removed from the bath to 
minimise passive leakage. The duration of the pulse was chosen to be such that a 
single droplet of fluid could be observed to form at the tip of the micropipette when 
the pipette was outside the bath.
Data were recorded both as continuous chart recorder tracings at slow speed for the 
assessment of spiking frequencies, and as print-outs of a Gould digital oscilloscope to 
record single events at a higher resolution. For illustration purposes, chart recordings 
were scanned using a Hewlett Packard scanner with a resolution of 600 x 600 dpi and 
re-traced in a graphics program (CorelDraw, version 3.0) to allow the inclusion into 
graphs independently of the originally used chart speed and amplification factor. It 
should be noted that the chart record is of a semiquantitative nature: each upstroke 
represents one burst discharge, but the deflections (which usually had an amplitude 
of 0.1 to 1 mV) do not accurately reflect the burst amplitude due to the low-pass 
filtering effect of the chart recorder; therefore, only the records obtained on the 
digital oscilloscope are voltage-calibrated.
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In order to illustrate the correlation between the barrel field structure in layer IV and 
the cuts made to obtain the tissue cylinders, a slab of cortex from the left hemisphere 
of a rat brain was cross-cut at 450 pm as shown in Fig. 7, fixed in 10% formaline 
solution and then placed in liquid gelatine (5%) for 30 minutes before the addition of 
two drops of the hardening agent glutaraldehyde (25%); this method was found to be 
the best way of embedding which ensured that the spatial relationship between the 
isolated tissue segments was retained. The tissue was then covered in gelatine (15%) 
to which more glutaraldehyde had been added, and left to cool down to room 
temperature. Subsequently, the preparation was sectioned at 45 pm on a cryostat, and 
the sections were transferred to phosphate buffer (0.1 M), placed on microscope 
slides and left to dry. After staining the sections by the Nissl method (rinse in aqua 
dest. for 5 minutes, sodium acetate 0.1 M (pH = 5) for 5 minutes, staining with cresyl 
violet (in sodium acetate, pH = 4.2) for 3 to 5 minutes, and a further rinse with aqua 
dest.), the sections were dehydrated in an alcohol series (70% for 20 seconds, 90% 
for 20 seconds, 96% for 1 minute, 100% for two minutes (repeated twice), and xylol 
for 10 minutes (repeated 3 times)), embedded in DePeX Entellan, and covered.
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Removal of a  slab of cortex 
from area SI (barrel cortex)
Cutting of the removed 
tissue on a  Mcllwain 
chopper; the pial surface 
is facing downwards
The tissue slab is cut a 
second time at a 90° angle 
relative to the first cuts 
and placed in ice-cold, 
oxygenated ACSF
Individual neocortical 
"tissue cylinders" 
are gently teased apart
Figure 7: Cortical cylinders were prepared by removing a slab of primary somatosensory cortex which 
was placed on moistened filter paper with the pial side facing downwards to ensure that cuts were 
vertical to the pial surface. The slab was then sliced on a Macllwain tissue chopper at the required 
thickness, turned by 90 degrees and cut again. After transfer to a petri dish filled with ice-cold, 
oxygenated ACSF, the individual tissue sections were gently teased apart using fire-polished glass 
micropipettes, and transferred to a holding chamber.
The tissue sections were photographed on a Nikon Biphot (Japan) microscope 
equipped with Nikon Plan 20x and lOx objectives, using Agfa XR 100 film.
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Figure Nissl-stained cryostat section through layer IV of primary somatosensory cortex
which had been cross-sectioned (dashed lines; cf. Fig. 7) on a Campden Vibroslice at 450 pm, 
embedded in gelatine to preserve the spatial orientation of the cylinders, stained with cresyl violet, and 
sectioned at 45 pm  (Histology: Gaby Klausa). The approximate position of several barrels is indicated 
by thick black circles; the area indicated by the white rectangle is expanded in Fig. 9. The small circles 
(arrow) indicate small arterioles.
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Figure 9: Detail of Figure 8 at higher magnification. Only 2 out of 10 barrels are entirely within the 
boundaries of the tissue sections demarcated by a zone of shrunk cell bodies approximately 50 pm 
wide (cf. Fig. 10).
Figure 10: Zone of damage along a cut perpendicular to the pial surface. The extent o f the damaged 
area (recognisable by collapsed pyramidal cell somata) varied from cut to cut, but averaged 50 pm on 
either side. In the schematic drawing, damaged cell somata are indicated by filled shapes.
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3 R esults
3.1 Results in vivo
3.1.1 Epileptiform activity: Spontaneous spikes and evoked potentials
Once the cortex had been exposed, finding the region targeted by the forepaw 
afferents was usually straightforward. The microelectrode penetrations produced no 
major damage, and it was usually sufficient to record from three or four locations to 
find a site presenting with large amplitude evoked potentials (as shown in Fig. 13, 
these were near maximal at the recording depth of 700 pm, which was chosen for its 
reported high sensitivity to GABAergic blockade). After the application of penicillin 
(either by topical application to the pial surface, or by iontophoresis at depth), the 
amplitude of the evoked potentials increased, indicating a disinhibition of the 
physiological circuitry. If the amount of penicillin applied to the cortex was large 
enough, the appearance of high voltage, sharp negative epileptiform potentials 
characterised by a greater latency and massively increased amplitude (the 'interictal 
spikes') could then be observed. Evoked potentials and spontaneously occurring 
interictal spikes were the main parameters used to assess the viability of the isolation, 
and its ability to support either an enhanced somatosensory evoked potential, or 
epileptiform activity, or both.
>
E
1 sec
Figure 11: Large amplitude interictal spikes recorded from undamaged cortex after the application of 
a dilute penicillin solution to the exposed pial surface
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Figure 12: Effects of topically applied penicillin solution on SI evoked potentials, recorded at a depth 
of 700 pm: each trace represents the average of 10 forepaw potentials, evoked at a rate o f 15/min. The 
record covers a period of 2 min, starting at the time of penicillin application. The inset (scale same as 
main graph) shows a single trace taken at t = 20 min. As in all following traces, the stimulus artefact 
has been blanked for clarity.
*
10 msec
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Figure 13: 100 pm interval evoked field potential profile in the forepaw area of rat primary 
somatosensory cortex, correlated to a photomicrograph of a nuclear-stained cross-section through SI 
cortex. The evoked negativities are strongest in the middle layers; no evoked potentials were seen in 
deep layers.
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3.1.2 Round isolations
Round isolations were performed by introducing a small, sharpened tungsten wire 
loop underneath the pia and pushing it down to the required depth (1500 pm). The 
loop was then retracted, and the recording electrode was reinserted into the tissue. 
Two factors were found to affect the quality of the isolation: the precision with which 
the tip of the wire turned around the centre of the isolation (this was the crucial factor 
determining the extent to which penetrating blood vessels were damaged), and the 
resistance met by the wire as it was introduced into the cortex. Small isolations 
presented with the highest resistance, and in practice, the second point proved to be 
the limiting factor. However, most isolations achieved in this way were successful; 
approximately half were performed in the forepaw area of SI, where the evoked 
potentials allowed an assessment the functional viability of the isolated cortex, and 
half were done more laterally inside the barrel area to assess the effects of 
iontophoretically applied penicillin on the spontaneous activity inside the isolations.
The amplitude of the evoked potentials recovered within 30 minutes after the 
isolation, although in some cases to a level which was below the control value. This 
may have been due to the fact that the isolation was not centred exactly around the 
location of the thalamocortical afferents (which enter the cortex in a slightly oblique 
fashion), rather than to irreversible damage to the tissue, as the application of a single 
incision with an L-shaped wire (see below) through the forepaw area often resulted in 
the recovery of the evoked potentials on one side of the incision only; this indicates 
that the afferent input to discrete locations within the cortex and is propagated 
intracortically via horizontal connections. The spiking observed in these isolations in 
response to the topical application of penicillin (cf. for example the spiking observed 
in an isolation with a nominal diameter of 600 pm shown in Figure 14) showed a 
characteristic spike/afterdischarge pattern, suggesting that isolations of that size were 
capable of generating epileptiform discharges.
52
A)
Putamen
'K rt
iTrV..-* V*; . *
( y .
Figure 14: Spike/afterdischarge complexes recorded inside a round isolation (diameter 600 pm) after 
topical application of penicillin solution (A), and coronal cryostat section (30 pm) of a different rat 
brain at the level o f a round isolation, after fixation in 10% neutral formalin solution (B): two parallel 
incisions (indicated by the arrow) reaching from underneath the pia down to the white matter can be 
clearly seen. Embedding medium: Burr Aquamount.
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3.1.3 Rectangular isolations
Despite the problems associated with the use of L-shaped wires mentioned in 
previous studies (i.e. difficulties in achieving complete isolations) which had 
prompted the development of the helical isolator, they offered several advantages: it 
was possible to perform isolations of all diameters between 0.5" and 1 mm, and the 
insertion of the isolator into the tissue was facilitated by the smaller surface of the 
wire tip. A second series of experiments was therefore performed using an L-shaped 
wire with a 1 mm tip.
In preliminary experiments, the influence of the location of the isolation and the 
effects of the damage to the tissue were assessed. When penicillin was applied to the 
middle of an incision of 1 mm length and 1 mm depth, the evoked potentials 
recovered within 40 minutes on one side of the cut only; penicillin application to the 
same location led to strong enhancement within 20 seconds, which abated within 30 
minutes. Spontaneous spikes also occurred, even though the depression caused by 
cutting had been rather severe. As suspected after the round isolations, the isolation 
clearly had to be around the target zone of the specific forepaw afferents if one were 
to use the evoked potentials as a means of assessing functional viability and the 
strength of the response to penicillin; but the incision itself had no effect on the 
spiking; therefore damage to the surrounding tissue is of minor relevance to the 
outcome of the experiment.
To achieve a series of subpial isolations of decreasing diameter in one animal and 
within one cortical area, nested isolations were made which resulted in isolations of 
three different sizes (see Fig. 15). In the experiment shown overleaf, the evoked 
potentials in two of the smallest incisions (= quadrants) recovered quite readily, 
especially in quadrant D, where the amplitude and short latency suggest a close 
proximity to the forepaw region whereas they appeared blunt in the other two, 
indicating a deafferentiation as described above. Enhancement of evoked potentials 
after the application of penicillin occurred in all but the smallest isolation. This
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appeared to indicate that the lower limit was reached which, at 0.25 mm2, was quite 
close in size to that of an average cortical barrel.
(Following page:)
Figure 15: Effects of iontophoretically applied penicillin solution on somatosensory evoked potentials 
inside a progressively smaller subpial isolation (rat neocortex). The uppermost trace represents a 
control evoked potential; the following 5 pairs of traces represent evoked potentials recorded at the 
site marked by a circle in the corresponding schematic drawing of the isolation (length of each cut: 1 
mm) before (top) and after (bottom) the iontophoretic application of penicillin. Each trace is the 
average of 5 recordings. The amplitude of the control evoked potentials remains constant, but the 
penicillin-induced enhancement is absent in the smallest isolation (size: 0.5 x 0.5 mm)
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The picture that emerged from these in vivo studies was that relatively small sections 
of tissue needed to be affected by convulsants to cause a transition from normal to 
ictal behaviour throughout the depth of the cortex; however, the pathways involved, 
and the role played by hypothetical cortical modules, remained to be elucidated. The 
size of the tissue block needed for the generation of epileptiform activity 
(approximately 0.5 x 0.5 mm) appeared to be amenable to in vitro studies; therefore, 
an in vitro model of the cortical column was developed. It was felt that because the in 
vivo and in vitro studies each had their particular advantages, the development of an 
in vitro model which paralleled the in vivo experiments would offer significant 
additional insights relating to the question of whether the rodent barrel is the minimal 
epileptogenic aggregate. The main problem in developing an in vitro approach was 
that unlike the situation in vivo, the orientation of an isolated tissue section with 
respect to the barrel field cannot be ascertained in vitro. Therefore, a mathematical 
solution was devised, the rationale of the procedure being that the coincidence of 
suspected cortical modules with a random series of adjacent isolations may be 
subjected to statistical analysis (see Discussion).
3.2 Results in vitro
Cortical cylinders were prepared, as described in the Methods section, by cross- 
sectioning a slab of cortex taken from the somatosensory region. Although it was not 
possible to ascertain the origin of individual cylinders in relation to the barrel field, 
the regional extent of the barrel field in the rat (see Fig. 2) is such that the cylinders 
could be assumed to originate from within the barrel field with a high degree of 
certainty. Furthermore, statistical considerations (see below) allowed an analysis of 
the results which did not depend on a knowledge of the location of a given cylinder 
in relation to the barrels. Each preparation yielded 10 to 20 cortical 'cylinders' which 
remained viable for up to 12 hours. After transfer to the recording chamber and 
superfusion with nominally magnesium-free medium for five to 20 minutes, 
spontaneous epileptiform discharges were routinely observed. The discharges 
consisted of a large initial spike followed by gradually developing, recurring clusters 
of afterdischarges separated by short silent intervals of increasing duration which
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lasted up to 20 seconds. In some instances, the discharges of several individual 
neurones could be discriminated (multiple action potential recordings). These 
recordings were usually only obtained in layer III; the main repetitive discharges 
could be recorded at all cortical depths.
Time after start of 
superfusion with 
Mg2+-free ACSF
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Figure 16: Gradual development of afterdischarges in a spontaneously spiking rat neocortical cylinder 
(diameter 500 pm). Perfusion with magnesium-free ACSF started at time = 0’00". Traces were 
bandpass-filtered to remove low frequency components.
In Fig. 17, details of the activity in spontaneously spiking tissue cylinders are shown. 
Small, nonsynchronous action potentials and EPSPs which increase in number over 
time and summate temporally can be seen to form clusters that appear as irregular 
depolarisations. These depolarisations progressively become larger in amplitude and
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higher in frequency, finally giving rise to an epileptiform burst, consisting of a large 
population burst followed by a series of smaller bursts (afterdischarges) riding on a 
prolonged depolarisation wave, which invades the entire cylinder. The electrographic 
pattern mirrors the situation in epileptic foci in vivo: while the discharging focus is 
characterised by sporadic, random discharges during the interictal period, the seizure 
activity during an epileptic seizure is regular, rhythmical and organised into relatively 
long bursts which are synchronous throughout the focus.
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Figure 17: Epileptiform activity in mouse neocortical tissue cylinders (diameter 450 pm) in Mg2+-ffee 
ACSF. Traces A and B are (low-pass filtered) chart recordings, while traces C and D are plots from a 
digital oscilloscope. In some instances, the high level of spontaneous background activity which 
precedes the main spike could be recorded (= multiple action potential recording, B); small interictal 
spikes can be seen to occur with increasing frequency before a large spike/afterdischarge complex. 
Only the latter (C) can be called ’epileptic', as it represents a recurrent, synchronised discharge 
involving the entire substrate. Trace D shows an action potential burst fired by a single neurone during 
an afterdischarge.
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Ey analogy to the experiments performed in vivo, attempts were made to elicit 
epileptiform discharges with penicillin, and also with other GABA antagonists (e.g. 
bicuculline), manipulation of K+ conductances (elevation of extracellular potassium, 
or superfusion with K+ channel blockers), or excitatory amino acid agonists like 
glutamate. Contrary to expectations, penicillin (at concentrations up to 10 mM) was 
not effective in the in vitro model of the cortical column. Similarly, the addition of 4- 
aminopyridine (4-AP) 50 pM, picrotoxin, or bicuculline 10 pM only rarely resulted 
in spontaneous epileptiform activity (Fig. 18).
A)
4-Aminopyridine [50 pM]
B)
-4-M-------h
K+ [10 mM]
c)
Penicillin [1000 U/ml]
5 min
H
Figure 18: Epileptiform activity in mouse neocortical tissue cylinders (diameter 450 pm) could 
routinely be induced by superfusing the tissue with Mg2+-free ACSF, but very little spontaneous 
epileptiform activity could be observed upon switching to 1.2 mM magnesium ACSF containing 4- 
aminopyridine (trace A), elevated potassium (trace B), or penicillin at concentrations similar to those 
used in vivo (trace C). Traces shown are from three different experiments.
Therefore, the superfusion with nominally magnesium-free solution was used in all 
subsequent experiments to achieve a rapid and reliable induction of interictal spiking 
mediated by NMDA receptor activation. The spiking could be completely abolished 
by aminophosphonovaleric acid (APV) 50 pM, with half-maximal suppression 
occurring at a concentration of 1 pM. The GABAb agonist baclofen inhibited the
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epileptiform activity induced with Mg++-free solution with an approximate IC50 of 70 
nM (not shown)
3.2.1 Smallest cylinders
With practice, it was found that it was possible to reproducibly obtain cortical 
cylinders which covered a large range of diameters. In the rat, nominal cylinder 
diameters ranging from 1000 pm down to 350 pm were studied; diameters beyond 
1000 pm would mean that because of the limited diffusion capacity of oxygen in 
brain tissue, a hypoxic core would develop. As can be seen in Fig. 19, which 
summarises the results of an extensive series of experiments aimed at finding the 
incidence of epileptiform spiking in cortical cylinders of decreasing diameter, all 
tissue sections with a nominal diameter greater than 400 pm were found to display 
spontaneous spiking (surface area, rather than nominal diameter, is indicated, as it is 
more directly related to volume).
In the mouse, it was found that no sufficiently small cylinders could be achieved on 
the McHwain tissue chopper: at cutting widths of 350 pm and below, the tissue 
tended to be displaced by the razor blade to such an extent that subsequent sections 
would be squashed. As a diameter of 350 pm is only slightly less than the size of 
large barrels in the mouse (Woolsey and van der Loos, 1970), a congruence of barrels 
and the minimal mass could not be excluded with this method. Therefore, the 
presence of generator zones within these cylinders was investigated in an attempt to 
confirm or exclude the layer IV barrels as generators of epileptic activity in the 
vertical plane. However, a comparison of the results obtained in the rat (Fig. 19; little 
or no paroxysmal activity is seen in small cylinders) with tissue of similar 
proportions which yielded robust spiking in the mouse (Fig. 20), already appeared to 
indicate that the degree of connectivity, rather than the absolute cell number, is the 
determining factor in the ability of a tissue segment to generate paroxysmal 
discharges (Chesi, 1992).
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Figure 19: Representative records from sets of rat cortical cylinders of increasing diameter which 
displayed spontaneous spiking in magnesium-free ACSF; for each of the three smallest sizes, a total of 
20 cylinders from the left SI cortex of one rat were used. Traces for larger diameters are included for 
illustration purposes. The smallest diameter for which spiking could still be regularly observed was 
400 pm (= surface area of 0.20 mm2)
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Spontaneous spiking in cortical tissue cylinders - Mouse
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Figure 20: Representative records of epileptiform spiking observed in mouse cortical cylinders of 
increasing diameter incubated in magnesium-free ACSF. The traces are shown for illustration 
purposes; spiking could even be observed in the smallest technically feasible cylinders (surface area 
0.123 mm2).
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3.2.2 Origin o f spiking: magnesium injections
The use of cylinders of decreasing diameter was aimed at finding a limit for the 
horizontal extent of an isolation capable to generate epileptiform spiking. However, a 
lower limit may also apply to the vertical extent of the 'cortical column'. In order to 
determine whether specific layers within the cortical cylinder were generating the 
paroxysmal discharges, it was attempted to selectively block the increased 
excitability evoked by the absence of magnesium ions in given cortical layers by 
applying magnesium sulphate solution through a pressure ejection system. If a
generator zone can be defined in a cortical cylinder displaying spontaneous interictal
' ' } . 
spikes in low-magnesium medium, then the focal application of magnesium ions to
that zone should abolish spiking in the entire cylinder - in a way, the reverse of focal
penicillin injections into the cortex described for the in vivo experiments. In fact, it is
only due to the small lateral extension of the cortical cylinders, where the diameter is
of the same magnitude as the thickness of individual layers, that an injection could be
achieved which affected an entire cortical layer without spreading to adjacent layers.
Magnesium sulphate injections into the core of a cylinder were performed at various
cortical depths; repeated applications were made possible by the fact that the
inhibitory effect of magnesium was fully reversible: spiking usually recovered within
10 minutes. Recordings were performed in both upper and lower layers to allow an
assessment of spiking frequency and amplitude which was independent of the site of
magnesium injections. The results of two experiments are shown in Fig. 21: in the
first, the recording electrode was placed in layer VI, arid magnesium sulphate
solution was injected at depths of 120 pm, 380 pm, 750 pm, 1000 pm, 1200 pm and
1500 pm from the pial surface. In the second experiment, the recording electrode was
placed in deep layer IH, and magnesium injections were performed at depths of 380
pm, 450 pm, 750 pm and 1200 pm. In both cases, the inhibitory effects of
magnesium on spiking amplitude were most visible where the injecting electrode was
close to the recording electrode, as expected. However, no location was found to
suppress spiking frequency in a preferential fashion; this is in contradiction to a
postulated generator zone in layers II - IV. Several other experiments using different
strengths of magnesium sulphate solutions, injection times and recording sites were
performed, with essentially identical results to those illustrated below.
A MgSO«[100 mM] 
pressure ejection
*  = recording site
Figure 21: Pressure ejection of magnesium sulphate solution into different layers in two mouse 
neocortical cylinders. The recording electrode was placed in either layer III (A) or VI (B), and 
injections were made into layers III, IV, V and VI (A) and into I, III, V, VI and white matter (B) at the 
time indicated by the arrow.
MgSO, [100 mM] |
pressure ejection 5 min
1224
66
pia
hypothetical trigger zone 
activ ated by the loss of 
voltage-dependent block 
of NMDA receptors
white
matter
MgS04
R ecording electrode in layer 
Amplitude
Pia
White
matter
t = 8 mint = 0
R ecording electrode in layer VI 
Amplitude
t = 7 min
Frequency F requency
Pia
White
matter
t = 8 mint = 0 t = 7 mint = 0
Figure 22: Rationale of magnesium injections (top) and an analysis of the experiments shown in Fig. 
21 (bottom) which reveals that magnesium injections, while showing a marked site-dependent effect 
on the amplitude of spiking recorded at the level of layer III (upper left hand panel) or layer VI (upper 
right hand panel), led to an overall decrease in spiking frequency which was relatively independent of 
the site of injection, suggesting that the spiking observed in magnesium-free ACSF does not originate 
in a discrete 'trigger zone'. Dashed lines represent a decrease relative to control, while solid lines mark 
an increase relative to control; the distance between two lines corresponds to a change of 20%.
67
3.2.3 Hemisectioned cylinders
As mentioned earlier, the generation of interictal spiking has generally been assumed 
to involve a paroxysmal amplification of excitation throughout the vertically-oriented 
signal processing pathways of the cortex, with the starting point for this activity 
being rather clearly defined as lying within or close to layer IV. The magnesium 
injections, however, had indicated that in no case did the suppression of 
hyperexcitability in a given layer suppress the spiking in the remainder of the tissue. 
Therefore, an alternative possibility is that all layers of the cortex are able to generate 
paroxysmal discharges, even in isolation. To test for this possibility, single cortical 
cylinders were subdivided with horizontal cuts using small glass or razor blade 
splinters, yielding small tissue blocks which only contained given layers. Cutting the 
cylinders did not markedly affect spiking; however, a transient suppression of spiking 
was seen in some cases, and the spiking frequency was decreased in most cases 
respective to the intact control. The results of a number of experiments performed in 
mouse neocortex (representative traces are shown in Fig. 23) showed that even 
cylinders containing only the bottom 25% (nominal diameter 450 pm) or the lower 
half (nominal diameter 350 pm) of the cortical depth were displaying spontaneous 
spiking.
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Nominal diameter 450 pm
1 sec
[0.081 mm3]
Nominal diameter 350 pm
Figure 23: Recordings from five representative experiments using hemisectioned mouse neocortical 
'cylinders’ (nominal diameters 450 or 350 pm): spontaneous spiking could be observed even in 
preparations containing only either layers I - III (top left) or the lower half of layer VI (middle right), 
indicating that layer IV or an intact vertical information processing pathway is not needed for the 
generation of interictal spikes. The approximate volume of the segments in which spikes were 
recorded is indicated in square brackets. The inset (lower right) expands the discharges shown in the 
adjacent recording: a secondary burst resembling an afterdischarge can be seen.
[0.051 mm3 ]
5 min
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4  D is c u s s io n
In the present study, it was attempted to find evidence for or against the existence of 
cortical columns as the basic unit of epileptogenesis, by analysing the relationship 
between the minimal mass and modular units. In 1992, Tasker et al. stated that 
"compared with the hippocampus, relatively little is known about the physiology of 
local synaptic circuits in the neocortex. Because of the multilaminar organisation of 
the neocortex, however, synaptic interconnectivity among cortical neurones is 
probably much more complex than that among hippocampal neurones". Modular 
units ('columns') represent an attractive attempt at reducing the complexity of this 
structure, as they allow a simplified description of both normal (signal processing) 
and abnormal (epileptogenesis) behaviour. In its most categorical form, this idea was 
stated by J Szentagothai (1987): "Architectural modularity of neural tissue requires 
that large chunks of this tissue be grouped into modules on the basis of the shared 
spaces of dendritic and axonal arborization patterns. Columns defined by groups of 
corticocortical afferents have the usual diameter of 200 - 300 pm. Even in the stripes 
of visual cortex, columnar discontinuities of columnar shape can be found. It is hence 
safe to visualise vertically oriented columnar spaces of cortical tissues as some kind 
of basic unit of the cortical neuronal network. The size and cell number of such 
cortical columnar units shows considerable stability in mammals. Apart from the 
higher cell density in the primary visual cortex, especially prominent in primates, the 
average basic cortical column contains about 5000 nerve cells per column, and the 
ratios of various cortical cell types remain remarkably stable from mouse to humans."
However, from theoretical considerations (listed and discussed below) and from the 
results obtained both in in vivo and in vitro experiments, previously claimed 
requirements for the generation of epileptiform discharges (i.e. unidirectional, 
polysynaptic pathways initiating in layer IV, and a minimal mass coinciding with an 
area of cortex occupied by a single barrel) do not appear to be essential.
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4.1 In vivo isolations
The first series of subpial isolations was performed using a helical, sharpened wire 
developed for this purpose. The main reason for using a helical wire for the subpial 
isolation of a small island of cortical tissue was that it would keep the damage caused 
by the isolation to a minimum, as the insertion of the wire loop (which had an 
electrolytically sharpened tip) was made through a single hole in the pia: because the 
helix had been centred with high accuracy, the turning underneath the pia occurred 
along a single track. Also, the resulting isolation would be complete, regular, and of a 
precisely defined diameter, unlike the isolations performed with L-shaped wire hooks 
(see below), which often left gaps at the corners of the rectangular isolation, where 
the diameter of the isolation varied between experiments, and where the introduction 
had to be performed four times, through two holes in the pia. It was felt that the 
circular and complete isolation was the best possible way of isolating tissue 
corresponding in size and shape to the somatosensory barrels, without causing too 
much damage to the arachnoid. That the isolation had to be complete for the 
experiment to be valid is indicated by the results of a study by Boakes et al. (1988), 
who found that as little as 20% of the cortical depth needed to be intact for 
epileptiform activity to spread past the incision.
The resulting isolations were shown to support the spike/afterdischarge patterns of 
electrographic activity typically seen in comparable isolations of larger size (as first 
suggested by Echlin et al. in 1952, the spikes/afterdischarges observed in isolated 
cortex may be caused in part by the de-afferentiation due to the isolation procedure: 
similar electroencephalographic patterns were noted adjacent to a brain tumour in a 
patient). However, it was found that the method could not be used for larger series of 
experiments, as the results were not easily reproducible. The main technical difficulty 
with the helical isolator lay in the high mechanical resistance of the tissue: a slow 
insertion of the helix using the micromanipulator drive resulted in a depression of the 
cortex by more than half a millimetre before the pressure was high enough for the 
helix to cut through the tissue. Therefore, the insertion had to be performed by giving 
a sharp blow to the supporting structure. As a result, although the isolation would be
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complete and of a known diameter, the insertion depth could not be guided, and the 
blow to the isolator often resulted in a skewed track, which meant that when the helix 
was retracted, it was along a different track, resulting in a higher degree of damage. 
Also, the manufacturing of the wire loop was technically demanding and time- 
consuming; therefore, the range of diameters for the subpial isolations was limited, 
and a series of isolations of graded diameter to determine the minimal diameter for 
the induction of epileptiform spiking would have been extremely difficult to perform.
The subsequently used rectangular isolations showed that isolations with a diameter 
of 500 pm  approached the limit for the generation of interictal spikes, as penicillin- 
induced enhancement of somatosensory evoked potentials was no longer present after 
an isolation measuring 0.5 x 1.0 mm was subdivided into two smaller cortical 
isolations measuring 0.5 x 0.5 mm (Fig. 15). However, the use of the L-shaped 
isolator frequently resulted in incomplete isolations still connected to the surrounding 
tissue by tissue bridges. At the same time, other groups had perfected the in vivo 
penicillin model to overcome the inherent limitations of the current approach. In fact,
r  .
exact assessments of the amount of tissue involved in the generation of interictal 
spiking after the focal application of penicillin are hampered by the inability to 
measure the radial diffusion velocity of the drug molecules, although several models 
have been developed to this end (e.g. Holmes and Lockton, 1982). At the same time, 
the borders of the cuts constituting the partial isolation do not represent a diffusion 
barrier. Therefore, it becomes increasingly difficult to achieve high localised 
penicillin concentrations within an ever smaller isolation, even if the iontophoretic 
current is increased substantially, as the radially diffusing penicillin will always 
affect the surrounding tissue as well. Both limitations were elegantly overcome by 
Lehmenkiihler et a l  (1991), who applied penicillin to the motor cortex of 
anaesthetised rats via a pressure ejection system and used co-applied 
tetramethylammonium chloride as a marker substance (TMA+ is a quaternary 
ammonium compound which cannot cross the cell membrane, and which can 
therefore be used as a marker for the extracellular space). Using this approach, they 
found that spikes could be elicited if penicillin concentrations of 1-2 mM were 
achieved in a tissue sphere with a diameter of 300 pm. No differential sensitivity
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profile was reported, but they remarked that no spikes could be induced below a 
cortical depth of 1300 pm, i.e. below middle to deep layer V; this is in extension to 
the findings by Chatt and Ebersole (1984) that injections of radioactively labelled 
penicillin shown to be limited to either of the non-granular layers (IE or Y) did not 
induce epileptogenesis.
4.2 In vitro columns (cortical cylinders)
The experiments described in the first part of the study had been performed in vivo, 
as the architecture and normal function of neural tissue is best preserved in model 
systems based on the intact brain. The neocortex was used both because it was the 
most amenable structure for surgical manipulations, and because its highly complex 
yet repetitive architecture represents a major challenge to the understanding of the 
organisation of the brain. The main object was to find the minimal mass required for 
the initiation and expression of 'epileptogenesis', that is, of paroxysmal discharges 
(’spikes'), and to evaluate whether this minimal mass coincides in any way with the 
barrels found in layer IV of the rodent somatosensory cortex. The results from the in 
vivo studies had indicated that the minimal mass of cortical tissue needed for the 
generation of epileptiform discharges was not only small enough to be investigated in 
vitro (i.e. with a diameter below 500 pm), but also possibly smaller than a single 
cortical column, i.e. only a fraction of the cortical module accessible in vivo. 
Therefore, an in vitro model of the cortical column was developed (referred to as 
'cortical cylinder') which had to fulfil the following requirements: it had to be similar 
in shape to the in vivo isolation, and the paroxysmal activity observed in vitro had to 
be comparable to that recorded in vivo.
The cortical cylinders developed as an in vitro model for the study for the 
mechanisms involved in the generation of epileptiform spiking are similar in size and 
shape to the cortical column postulated by several workers, that is, cylindrical and 
perpendicular to the pial surface; the cylindrical shape had also the advantage of 
allowing easier access to oxygen and drugs. In fact, the tissue p 0 2 generally
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decreases at the core of the tissue as the brain slice increases in thickness; it has been 
reported (Fujii et al., 1982) that the maximum section thickness for viable slices is 
430-600 pm. Tissue cylinders permit a better perfusion of the tissue with oxygen and 
drugs, thus allowing larger tissue diameters to be achieved. Also, pyramidal cell- 
dense laminae (D/m and V-VI) appear much more translucent than layers containing 
fewer somata and a higher percentage of myelinated fibres in epi-illuminated 
sections. Accordingly, transverse cuts could be performed under a binocular 
microscope, and the locations of both superficial and deep laminae accurately 
targeted by virtue of their well-defined cytoarchitectural characteristics. Similar to 
the experiments in vivo, it was first attempted to obtain round isolations by retrieving 
the tissue sections with a glass punch; because individual sections could be obtained 
from an otherwise intact brain, this would have allowed to perform histological 
sections of the cortex after the experiment to determine the position of the isolation 
relative to the barrel field. However, the method was found to be too unreliable for 
extended studies, because the tissue sections were of poor quality (possibly because 
the cortex could not be cooled down sufficiently in situ, or because the sections were 
squashed during the insertion of the punch). Therefore, rectangular sections cut on a 
conventional tissue chopper were used for most experiments.
Contrary to expectations, penicillin could not be used to generate 
spikes/afterdischarges in the in vitro model, although it displayed proconvulsant 
effects when spiking had been induced by other means, e.g. by superfusing the 
cylinders with (nominally) magnesium-free ACSF (the concentration of magnesium 
ions in 'magnesium-free' ACSF prepared with standard reagents is below 1 pM). This 
is in accordance with studies in human temporal lobe neocortical slices maintained in 
vitro (Hwa et al., 1991), where the GABAa blocker bicuculline (50 pM) failed to 
evoke spontaneously occurring epileptiform activity (which could however be 
elicited by single-shock stimuli) in over 60 slices examined, and in rat neocortical 
slices, where superfusion with penicillin (3.4 mM) did not result in depolarisation 
shifts "in contrast to the in vivo focus" (Gutnick et al., 1982). Similarly, Mattia et al. 
(1993) observed that bath application of 4-aminopyridine (100 pM) only induced 
spontaneous epileptiform potentials in 6% of rat neocortical slices. On the other
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hand, several other studies, e.g. by Aram et a l  (1989) report the reliable induction of 
spontaneous epileptiform bursts with bicuculline 5 - 1 0 0  pM, picrotoxin (another 
GABAa receptor antagonist) 50 - 100 pM, 4-aminopyridine (4-AP) 20 - 100 pM, 
tetraethylammonium (TEA) 2 - 4 pM, and carbachol 10 - 100 pM. The induction of 
spontaneous epileptiform activity is even more easily achieved in immature 
neocortex, suggesting that the developing brain has a propensity for generating 
paroxysmal discharges: Lee and Hablitz (1991) elicited prolonged ictal discharges in 
neocortical slices from young ( 8 - 1 5  days of age) animals superfused with 50 pM 
picrotoxin. This contrasts with the reliable induction of spiking by penicillin 
observed in adult rats (this study) in vivo. A possible explanation for the failure of 
penicillin to induce spontaneous spiking in the in vitro cortical cylinder would be that 
GABA antagonists may depend on intrinsic cortical activity for the induction of 
paroxysmal discharges, i.e. that GABA blockade amplifies existent activity, rather 
than being involved in the generation of paroxysmal discharges. In the usually 
quiescent in vitro preparation, this basal activity (that is, the input via thalamic 
afferents) is lacking, and must be provided experimentally by an electrical or 
chemical stimulus (Connors, 1984). Therefore, the superfusion with magnesium-free 
ACSF was chosen as the epileptogenic stimulus, and the assumption of the 
equivalence of the epileptiform activity recorded in the in vivo and in vitro models of 
the isolated cortical column was based on the similarity of the spike/afterdischarge 
patterns.
Afterdischarges are more complex than the single synchronised population burst 
('interictal spike') that is the predominant feature of the in vivo epileptiform activity 
which was evoked by the topical application of penicillin to the intact cortex, but 
clearly similar to the activity recorded in the isolated cortex in vivo both in this study 
(Fig. 14) and in other studies reported in the literature (e.g. the activity in chronically 
isolated cat neocortex after the topical application of eserine which was reported by 
Kristiansen and Courtois in 1949). At the cellular level, they consist of a series of 
synchronised bursts at about 65 to 85 ms intervals (Miles et al., 1984), where the first 
burst is longer than later (secondary) bursts, as the latter occur when the cell 
membrane is shunted by intrinsic synaptic conductances and consequently requires
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more current for their activation; the sequence is terminated by a prolonged after­
hyperpolarization. Their substrates are the recurrent excitatory synapses which 
terminate on the dendritic regions of pyramidal cells which generate repetitive 
calcium spikes in response to the sustained depolarisation provided for example by 
NMD A receptor activation in the low-magnesium model. The resulting dendritic 
calcium potentials are thought to initiate somatic bursts which propagate axonally to 
re-activate non-NMDA receptors at recurrent synapses with a timing that helps to 
maintain afterdischarge synchrony (Traub et a l, 1993).
After it had been shown that the cortical cylinders obtained by cross-sectioning a slab 
of somatosensory cortex displayed regular, spontaneously recurring 
spikes/afterdischarges very similar to those previously recorded in vivo, a series of 
progressively smaller cylinders was made until a diameter was reached at which 
spontaneous spiking could no longer be observed. Theoretical considerations (Fig. 
24) show that when a group of adjacent segments is isolated from an array of 
contiguous modular units, the probability of any one of the segments containing at 
least one intact module increases gradually from p = 0 to p = 1 as the diameter of the 
isolation increases from d  (the mean distance between the centres of the modules) to 
2.1547 * d. This calculation is based on the assumption that the modules in question 
are densely packed, and that they are fixed in space; it does not depend on the shape 
of the isolation (round or square). It essentially indicates that not all isolations of a 
given diameter, which presumably are placed randomly with regard to compartmental 
boundaries, should display epileptiform activity if the diameter of the isolation is 
below 2.16 * d, and that the probability of observing spikes should reach 0 for 
isolations of diameter d or less. The range of diameters over which spiking is only 
occasionally observed becomes even wider if the modules in question are of varying 
sizes or not arranged in a regular array, as is the case for the barrels of the 
somatosensory cortex; the range [d; 2.16 * d] therefore represents a conservative 
estimate.
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Figure 24: In a regularly spaced array of hypothetical modules, the diameter of an isolation which is to 
contain an entire module must be at least as large as the mean distance between the centres of these 
modules (d ). It can then be shown that an isolation large enough to contain 3 modules (diameter D = d  
+ 2/V3 d) will always contain at least one intact module (see text). Hence, the probability p  that a 
randomly placed isolation will contain at least one module rises from p = 0 for diameters < d to p = 1 
for diameters > 2.55 d (bottom left). However, if the 'minimal mass' depends purely on cell number, 
the probability of isolating the minimal mass will jump from 0 to 1 at the diameter corresponding to 
that cell number (bottom right). The drawing of the barrel field region (inset) illustrates the range of 
barrel diameters observed in situ.
While the randomly cross-chopped tissue cylinders cannot provide direct evidence 
concerning the topology of the isolations within the barrel field cortex, the above 
calculations allow to place approximate lower and upper bounds on the average
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width of the epileptogenic module. The estimates are based on the fact that nearly 
every cylinder with a diameter of 450 pm displayed epileptiform activity: spiking 
should have been observed down to an isolation diameter of 210 pm (if one assumes 
modules of constant size) or less (if the variability of barrel diameters is taken into 
account). Given that this did not occur - in fact, a sharp cut-off was found between 
325 and 375 pm in the mouse, and between 400 and 450 pm in the rat - it is inferred 
that the minimal mass is a function of cell number and the degree to which the cells 
are linked by recurrent connections, rather than being linked to modules such as the 
barrels of the somatosensory cortex.
It is not known whether the differences in the minimal diameters reflect an actual 
species difference in, for example, the degree of connectivity. In theory, the cut-off 
value should be identical for both species if the minimal mass only depended on the 
cell number, if one accepts the postulate by Rockel et al. (1980) that the same 
absolute number of neurones are present in a column throughout the depth of the 
neocortex: they reported an average of 110 neurones under a 30 x 25 pm surface area 
in several functional neocortical areas of a variety of species. Therefore, the critical 
value d  (i.e. the minimal diameter of an isolation able to generate an epileptiform 
discharge) should be similar for both species if the minimal mass only depends on 
the cell number. However, the difference may have simply been due to the fact that 
the rat neocortex is thicker than the murine cortex (1500 pm vs. 1000 pm): hence, it 
was more difficult to obtain tissue segments with a diameter below 350 pm which 
were perfectly vertical to the pial surface in the rat. It might be argued that the 
present experiments do not exclude the possibility that the cortex consists of cortical 
modules of very small diameter (< 100 pm); however, it * a  ppctvrs
I i U«4 y  that a column of cortical tissue containing an intact barrel is not a
prerequisite for the generation of epileptiform activity.
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Layer boundaries
Layer I Layers II, III Layer IV Layer V Layer VI
Cell density 
(xl000/mm3)
Mouse 0-150 nm 150-350 |im 350-480 (im 480-650 jim 650-1000 fim
Rat 0-100 \im 100-400 400-600 600-900 gm 900-1500 pm
Rat Neurones 12 71 88 46 47
GABA 6 18 23 15 10
Table 1: Average cortical thickness of rat and mouse barrel cortex. Data are taken from Ren et al. 
(1992) for the rat, and from Welker et al. (1993) for the mouse.
The idea of the rodent barrel as the minimal mass for the generation of discharges 
stems from the observation of a unit of functionally co-active neurones congruent 
with the anatomical barrel, and therefore obviously presumes that these modular units 
are invariant in size and over time. The results from the present study indicated that, 
at least as far as the generation of paroxysmal discharges is concerned, no modular 
parcellation exists; however, this may not hold true for the processing of 
physiological activity. Therefore, the definition of the functional role of modular 
units in the neocortex hinges on the question of whether the connections subserving a 
single computational task are of a fixed nature. For the representation of motor tasks, 
a number of hypotheses have been listed by Montgomery et a l  (1992):
a) The cardinal cell hypothesis, which holds that behavioural functions are uniquely 
and consistently encoded in the discharge activity of single neurones;
b) The mass action hypothesis: behavioural function is represented not in individual 
neurones, but in the combined activities of groups of neurones; macroscopic states 
emerge as a continuum from the discrete activities of large groups of neurones
c) The 'parallel distributed processing' hypothesis favoured by the authors, which they 
define ty analogy to parallel processing in computer science, where the solution to a 
computational problem is represented in the pattern of interconnections and not in the 
states of the processors themselves.
Similarly, physiological functions would be represented in the patterns of neuronal 
interactions and not in the activities of single neurones: the response to any input is 
distributed over a population of neurones, with each neurone contributing a small
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amount to the final response. Thus, neurones may be multipotential with respect to 
their functional roles, and their connections may be viewed as physiological rather 
than strictly anatomical. Variable weighing of individual connections by inhibition of 
intemeurones or presynaptic inhibition, as well as short-term enhancement of 
excitatory synapses may allow neuronal activation through specific anatomical 
linkages in one task and a different set of linkages in a different task. Corroborative 
experimental evidence for this hypothesis comes from demonstrations of neuronal 
multipotentiality in both invertebrate (Hooper and Moulins, 1989) and vertebrate 
(Grillner, 1991) nervous systems.
Also, the long-held belief that the cortical representation of the sensory periphery is 
'hard wired' in adults has become less and less tenable; moreover, the potential for 
change is not restricted to the primary sensory cortical areas, but has also been 
described for motor areas: when bicuculline is infused into an identified movement 
representation such as the forelimb zone, subsequent intracortical microstimulation 
mapping reveals that stimulation in nearby sites that originally elicited vibrissa 
movements now gives rise to forelimb movements (Jacobs and Donoghue, 1991), 
leading to the assertion that "inhibitory circuits are critically placed to maintain or 
readjust the form of cortical motor representations". This is at variance with earlier 
results from cat visual cortex (Gabor et a l, 1979), which had indicated that 
physiologically defined neuronal populations remain intact in the presence of GABA 
antagonists (in this case, penicillin). The broadening of receptive fields after the 
application of picrotoxin (Batuev et a l, 1982) or bicuculline also points towards a 
crucial role of intracortical inhibition (e.g. the strong surround inhibition that 
characterises barrel neurone receptive fields - Kyriazi and Simons, 1991) in defining 
the shape of modular units; therefore, the use of GABA antagonists like penicillin is 
bound to interfere with investigations of cortical columns. Enhancement of excitatory 
amino acid transmission on the other hand should interfere less with the definition of 
columns by their inhibitory influences and give a more accurate picture of the true 
effects of intracortical boundaries on the generation of epileptiform activity. It has to 
be mentioned that the receptive fields (as the main categorising point of columns) in 
somatosensory cortex have also been shown to be affected by deep anaesthesia
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(Armstrong-James and George, 1988) and by the attentive state of the animal 
(Hyvarinen et al., 1980); urethane, the anaesthetic used in this study, has also been 
claimed by Simons et al. (1992) to dramatically alter cortical responses to peripheral 
stimulation, although interictal-like epileptiform events in kindled rats were reported 
to be relatively unaffected (Haberly and Sutula, 1992).
Finally, boundaries of cortical representation can also be subject to chronic changes. 
A striking example for re-wiring of the cortical representation comes from the work 
of Siucinska and Kossut (1994), who demonstrated that the common fur of mystacial 
pads after vibrissectomy performed in adult rats can be shown to shift its cortical 
representation to the site of the barrel field over a time course of several weeks; in 
intact rats, the fur representation is located outside the barrel field (Sharp et al., 
1988). In Man, a physiological correlate of the well-known remodelling of the 
sensory map which can occur after limb amputation (Ramachandran, 1994) was 
demonstrated by magnetic source imaging techniques (Flor et al., 1995; a similar 
degree of cortical reorganization was recently demonstrated to occur outside the 
somatosensory cortex by Seitz et al. (1995)). In the somatosensory cortex of adult 
owl and squirrel monkeys, alterations of input due to nerve section or the repeated 
imposition of particular stimuli can lead to changes in individual map boundaries 
(Kaas et al., 1983). These changes occur both acutely and chronically. Before and 
after the changes, the maps have receptive fields with sharp continuous borders no 
thicker than one or two cell diameters, despite the fact that the arbours of input axons 
from the thalamus extend over much wider distances (Landry and Deschenes, 1981). 
This constitutes a powerful argument against cell bodies as the defining principle of 
cortical units: if single neurones were units of selection during such alterations, one 
would not expect continuous sharp boundaries; therefore, module boundaries are 
determined by an organizatory principle with higher resolution. Whether this 
principle is based on the shaping influence of inhibitory connections or on more 
complex forms of computational interaction remains to be elucidated; but the 
demonstration of a high functional, spatial and temporal variability of the processing 
patterns found in the physiologically active neocortex suggest that the absence of a
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spatially fixed 'modular' structure of the cortex found for the minimal epileptogenic 
aggregate in this study also extends to the functional level.
4.3 Layer IV is not essential for the generation of epileptiform
activity
Next to the question of whether the minimally active epileptogenic combinate 
represents (or is coincidental with) a cortical column, this study had also aimed at 
investigating the requirements for the generation of epileptiform activity within a 
column, i.e. along the vertical extent of the tissue. Results from previous studies had 
indicated that certain layers within the cortex may be involved in the generation of 
epileptiform discharges: layer IV in the penicillin model (Holmes and Lockton, 1982) 
and in the in vitro application of glutamate and high potassium (Connors, 1984), and 
layer II in the strychnine model (Ebersole and Chatt, 1986); based on current source 
density analysis, Barth et al. (1990) postulated a trigger zone in the supragranular 
layers. The observations led to the hypothesis that a network of intrinsically bursting 
neurones located in middle (Chagnac-Amitai and Connors, 1989) or upper (Langdon 
and Sur, 1990) cortical layers initiate synchronous epileptiform activity. This gave 
rise to a theory on the generation of cortical epileptiform activity which assigns a 
critical role to the excitatory interneurones (spiny stellate cells - Lund, 1984) within 
the thalamocortical networks in layer IV of many primary sensory areas (Faingold 
and Fromm, 1992), and which envisages the initiation to be mediated by the 
recruitment of reciprocal, recurrent AMP A receptor-mediated excitation between 
neurones in this layer (Jones and Lambert, 1990). This would be followed by 
amplifying activation of pyramidal cells near the border of layers IH/TV, subsequent 
hypersynchronised depolarisation of other supragranular pyramidal cells, and finally, 
activation of large pyramidal cells in the infragranular layer (Ebersole and Chatt, 
1986). Obviously, the theory that the mechanisms involved in the generation of ictal 
activity require the same pathways as physiological activity, i.e. generator cells 
(intrinsic burst generators) at the starting point of a diverging polysynaptic pathway 
with feed-forward amplification starting from the layer receiving most of the 
thalamic input (IV) would have major implications for the explanation of the
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mechanism involved in the generation of seizures. There have been reports that 
kainate injections into various layers of the neocortex in vivo did not result in a 
sensitivity profile similar to that observed with penicillin (Faingold and Fromm, 
1992); however, these models also assumed that the columnar pathways (which have 
been modelled for the primary visual cortex by Patton et al. [1992] in a recent study) 
within the cortex needed to be intact for the epileptiform discharge to be sustained. 
Indeed, in a recent publication by Jones (1994), the suggestion that epileptiform 
activity elicited in the entorhinal cortex (the major source of afferent input to the 
hippocampus) by depletion of magnesium or GAB A^ receptor blockade is initiated in 
layers IV/V and that activity in other cortical layers is synaptically driven by these 
structures was re-iterated for a cortical region outside the somatosensory area.
It was therefore surprising to find that in sectioned cortical cylinders which contained 
only layers I to HI, or the lower half of layer VI, were still able to generate and 
sustain spontaneous epileptiform activity, indicating that layer IV, which had clearly 
been shown to be necessary for the generation of spiking in vivo (Lockton and 
Holmes, 1980, Ebersole and Chatt, 1980), could be excluded from a cortical cylinder 
in vitro. This suggests that the pathways used in the generation of interictal spikes do 
not coincide with those involved in the normal processing of somatosensory 
information, on which the previously mentioned models had been based. In theory, 
the central role played by layer IV of primary somatosensory cortex (which is not 
only the main target for the extracortical input, but also possesses the highest density 
of GABA receptors and GABAergic intemeurones [Chudler et al., 1988]) in vivo 
may not be present in vitro, and under circumstances where increased glutamatergic 
activity, rather than decreased GABAergic inhibition, present the epileptogenic 
stimulus. However, this is not substantiated by the results of work performed by 
Connors (1984) on the laminar sensitivity profile of adult guinea pig somatosensory 
cortex to the focal application of convulsants in vitro. Here, the pressure ejection of 
bicuculline, high potassium or glutamate led to synchronised bursts which 
propagated through the whole slice; however, the threshold level of convulsant 
needed was found to vary systematically across laminae, with a sharp minimum 
always observed in the middle layers (either layer IV or upper layer V).
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In summary, the findings of the present study indicate that the paroxysmal activity 
did not depend on intact cortical modules (columns) for either its generation or its 
propagation, as subsections excluding the layer IV barrel structure and containing 
only layer VI, or only layers I-m, were still able to generate population spikes. The 
results are in keeping with the assumption that the generation of paroxysmal activity 
is an inherent property of all neuronal tissue satisfying basic parameters of 
connectivity (recurrence and/or divergence and sufficient synaptic strength; the 
requirement for recurrent connections is demonstrated by the observation that the 
cerebellar cortex, which lacks a recurrent excitatory system, fails to develop interictal 
spikes in response to topically applied strychnine - Brookhart et a l, 1950). This view 
is supported by theoretical modelling (in their much-cited computer model of an 
unstable neuronal network, Traub and Wong (1983) showed that a small (100 cells) 
highly interconnected excitatory network can generate a paroxysmal discharge), and 
by the observation that hippocampal microcultures, where synaptic connections were 
present in almost all instances between any two neurones, had a 'minimal mass' of 
two cells (Segal and Furshpan, 1990; M. Segal reported a further refinement of this 
technique in 1994, where epileptiform activity was measured in a single hippocampal 
neurone possessing excitatory autapses). The question of what amount of CNS tissue 
is needed to produce this epileptiform activity was first addressed by Miles et a l 
(1984), who recorded from progressively smaller pieces of the CA3 region of the 
hippocampus. The smallest pieces that supported picrotoxin-induced epileptiform 
activity were estimated to contain about 2000 pyramidal neurones; the connectivity 
has been estimated at 1 - 5% (Miles and Wong, 1986).
The smallest viable tissue section displaying epileptiform spiking in the present study 
measured 450 x 450 x 250 pm (based on an average cortical thickness of the mouse 
of 1000 pm), giving a total volume of 0.051 m m l If one accepts (in analogy to the 
observations made by Prince and Tseng (1993) in subpial isolations of rat cortex) that 
the shrunken pyramidal neurones lining the cut in Fig. 10 demarcate the zone of 
damage caused by cutting, this zone appears to extend to a depth of 50 pm (see Fig. 
10); therefore, the volume of tissue containing viable cells can be estimated to be 
around 0.032 mm^. A volume of 0.032 mitf corresponds to a total cell number of
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roughly 1200 neurones, according to the quantitative analysis published by Ren et al. 
(1992). The results from the present study therefore indicate that epileptiform spiking 
can arise from and be sustained by isolated portions of the rodent somatosensory 
neocortex containing less than 2000 pyramidal cells (to put it into perspective, it has 
been estimated that large barrels in layer IV of rat somatosensory cortex consist of an 
average of 2500 neurones). This also suggests that the degree of connectivity of 
pyramidal cells in deep layers of the neocortex is comparable to that observed in the 
hippocampus. It should be noted that the estimates of the cell numbers involved in 
paroxysmal activity assume that a hemisectioned cortical cylinder represents a 
physiological substrate for neuronal activity. However, some components such as the 
calcium-mediated dendritic electrogenesis implied in the recurrent afterdischarge 
activity regarded as 'true epileptiform activity' may no longer be generated in tissue 
sections lacking these apical dendrites. It could also be argued that sectioning of the 
apical dendrites would inflict serious damage to most pyramidal cells within the 
tissue, therefore distorting the response properties of the tissue; however, 
intracellular recordings by M. Gutnick (personal communication) during a study on 
active conductances in the dendritic tree have shown that those neurones that survive 
dendrotomy appear to be physiologically healthy. Also, Prince and Tseng (1993) 
reported that in contrast to results from axotomised spinal motoneurones, axotomised 
neurones from undercut cortex showed no signs of damage during intracellular 
recordings.
The results regarding the physiological substrate for the generation of epileptiform 
activity which were obtained in the present study also point to a methodological 
shortcoming inherent in many studies concerning the computational abilities of the 
neocortex: the working of the cortex has frequently been defined by its reaction to 
specific somatic afferent inputs. The activity defined by a given experimental 
approach only represent a snapshot of the cortical activity - it would be necessary to 
record from a given cell during all physiologically possible inputs to be able to say 
conclusively in which processes the cell in question takes part. This reductionist 
approach resulted in impressive and important discoveries on the primary targets of 
afferent inputs and their organisation, but is of necessity partially or wholly blind to
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parallel or subsequent stages of information processing, or purely intracortical 
processes, and therefore to a (presumably) substantial fraction of computational 
power of the cortex. As we now know, thalamic axons contribute no more than about 
20% of the excitatory synapses in layer IV, the main layer of termination of thalamic 
axons (White, 1989). Most of the remaining excitatory synapses are from 
intracortical sources (Douglas and Martin, 1991), and the results from the present 
study indicate that the intracortical network forms a substantial part of the substrate 
for neuronal computing.
In summary, although a columnar organisation in the sense that the sequence of 
afferent informational relay within the cortex often occurs in a strictly vertical 
fashion has been amply demonstrated with electrophysiological and anatomical 
means, the 'columnar' organisation of the cortex has to be qualified in two ways: it is 
columnar mainly with respect to the first stages of afferent sensory input, and the 
shape of the columns is determined by inhibitory mechanisms (which will vary over 
time) at least as much as by 'hard' synaptic wiring, implying that boundaries between 
columns can shift depending on the task performed by that region of the cortex. Both 
restrictions are an acknowledgement of the high degree of synaptic connectivity, 
which is also the basic requirement for the generation of paroxysmal discharges. In 
conclusion, both the results from the present study, which indicate that the excitatory 
connections within the cortex are sufficiently dense to allow the generation and 
maintenance of a paroxysmal discharge in tissue segments containing only a fraction 
of the vertical extent of the 'cortical column', and data from other studies on the 
influence of inhibitory connections point to a view of the cortex as a highly 
interconnected excitatory matrix shaped by inhibitory influences which can change 
over time, rather than a static array of hard-wired, parallel circuits.
4.4 Pertinence to human epilepsy
The surgical treatment of refractory epilepsy devised by Frank Morrell and co­
workers was based mainly on evidence obtained in animal models of epilepsy
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involving GABA blockade. However, it is becoming increasingly clear that 
GABAergic mechanisms play a more differentiated role in epileptic neural networks. 
For example, it has been suggested (Lytton and Sejnowski, 1991) that in absence 
epilepsy, a form of human epilepsy in which GABAergic inhibition remains intact 
throughout the seizure, it is the firing of inhibitory intemeurones that may be the 
main mechanism of phase-locking. The limited range of axonal arborization of most 
inhibitory intemeurones (generally < 1 mm) could limit the spatial extent of this 
mechanism of synchronisation to a single 'column', thereby providing a means of 
synchronising information processing without the risk of this synchrony spreading to 
adjacent cortical areas. This again postulates that cortical 'columns' (i.e. co-active 
units) are shaped by their inhibitory input, therefore complicating the search for a 
correlation between columns and penicillin-triggered epileptiform activity. What are 
the conclusions that can be drawn from the present study? The positive results 
obtained with the 'multiple subpial transection' technique were probably not due to 
the fact that the remaining brain tissue strips were below the absolute critical mass 
needed for the generation of epileptic activity. The procedure either prevented the 
spread of epileptic activity from a focus which was still active (Albowitz and Kuhnt 
(1995) have recently shown that the spread of epileptiform activity in neocortical 
slices is quite effectively blocked by cuts through the supragranular layers), or else - 
since no epileptiform activity was recorded from the transected region - the 
underlying disturbance was more subtle and disseminated in these patients than is the 
case with chemically induced epileptiform activity in the experimental setting, and 
probably required the synchronisation of abnormal activity over a large mass of 
contiguous brain tissue. The therapeutic success obtained by Morrell and co-workers 
is not in itself sufficient evidence for the existence of cortical modules responsible 
for the generation of seizures; rather, it illustrates the difference between ictogenesis 
(the generation of paroxysmal activity) and epilepsy (the tendency of a brain to suffer 
recurrent seizures): while the modification of almost any parameter of neuronal 
function, such as connectivity, ionic conductances, the extracellular environment, or 
synaptic divergence, can be used to induce epileptiform activity, little is known about 
the actual physiopathological changes which cause seizures in the patient.
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The preparation developed in this study, the 'cortical cylinder', does not represent the 
'basic modular unit' proposed by several workers, but it has several appealing 
features: it preserves the basic radial organisation of the cortex in the smallest 
possible preparation, and it appeared to be a suitable model for further 
pharmacological investigations into the generation of epileptiform discharges. It was 
therefore also used in some of the experiments presented in the second part of this 
study, which concerned itself with the pharmacological aspects of epileptogenesis, 
rather than its physiology, and which centred on the role played by adenosine in 
epilepsy: purinergic transmission has been the subject of active research ever since 
the first demonstration of adenosine’s cardinal role as inhibitory neuromodulator, and 
adenosine agonists may even have therapeutic potential as novel antiepileptic drugs.
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5 In t r o d u c t io n  t o  P a r t  T w o
The epilepsies are characterised by the periodic occurrence of abnormal neuronal 
discharges which can present as one or more of a wide variety of seizure types which 
are classified according to their localisation, their onset, and the degree of the 
concomitant impairment or loss of consciousness. The existing antiepileptic drugs 
(AED) reflect this broad spectrum, with some drugs reliably controlling seizures of 
one type while being ineffective or even proconvulsant in others. Despite their 
multiple and often overlapping effects, antiepileptic drugs can be broadly grouped 
into two major classes: those which decrease excitation, and those which potentiate 
inhibitory mechanisms. Examples for the former would include activity-dependent 
sodium channel blockers such as phenytoin and valproate, and calcium channel 
blockers like ethosuximide. The latter include drugs which enhance GABAergic 
transmission; these include the benzodiazepines and barbiturates, and a group of four 
recently introduced agents, felbamate, gabapentin, lamotrigine and vigabatrin 
(Kalviainen et al., 1993). Despite the existence of these effective anticonvulsants 
which may satisfactorily control seizures in the majority of individuals with epilepsy, 
the number of intractable cases still exceeds the number of people suffering from 
brain tumours, multiple sclerosis, amyotrophic lateral sclerosis and many other 
'unsolved' neurological illnesses (Kurtzke, 1982). The need for more effective, less 
toxic antiepileptic drugs is therefore as great as ever, but advances have not been as 
quick as expected. One problem, discussed in Part One, lies in the gap between our 
understanding of the mechanisms of ictogenesis (i.e. the precise cellular changes 
which occur during seizures) and epileptogenesis (i.e. the pathophysiological changes 
which predispose a patient to recurrent epileptic fits). Another difficulty lies in 
transforming advances in the laboratory into clinical therapies. Several promising 
developments, such as the NMDA antagonists, had to be halted due to toxicity, side- 
effects, pharmacodynamic problems (inability to cross the blood brain barrier, poor 
solubility) or other reasons; yet, the development of antiepileptic drugs based on 
novel mechanisms of action remains one of the most hopeful avenues of research. 
One example would be the use of the purinergic modulation of neuronal excitability. 
The following chapters report some studies on the "endogenous anticonvulsant 
adenosine and discuss its antiepileptic potential.
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5.1 Adenosine: a neuromodulatory purine
Since the first description by Sattin and Rail (1970) of the membrane-bound receptor- 
mediated effects of the endogenous purine adenosine on adenylyl cyclase in guinea 
pig cerebral cortex, a multitude of other effects mediated by the nucleoside have been 
described. Adenosine has been shown to inhibit lipolysis (Londos et a l, 1978), to 
affect cardiac rate and contractility, modulate myometrial and vascular smooth 
muscle tone, renal vasoconstriction and white blood cell function (Olsson and 
Pearson, 1990; Matias et al., 1991), to cause vasodilation in coronary (Berne, 1980) 
and cerebral blood vessels, inhibit platelet aggregation (Haslam and Rosson, 1975), 
to exert potent bronchoconstriction (Driver et a l, 1993), and neuromodulatory 
actions at both peripheral and central sites in the nervous system (see Nicoll et al., 
1990; Stone, 1991; Stone and Simmons, 1991): accumulation of extracellular 
adenosine has been suggested to play a role in inhibiting the brainstem and basal 
forebrain cholinergic neurones implied in EEG arousal and wakefulness (Rainnie et 
a l, 1994).
5.1.1 Origin
Adenosine is a metabolic breakdown product of nucleotide (i.e., 5'-AMP and cAMP - 
Gereau and Conn, 1994) hydrolysis. Its tissue levels are governed mainly by the state 
of metabolic activity. The rate-limiting factor of intracellular adenosine production is 
the limited availability of AMP; as the cytosolic AMP concentration is an order of 
magnitude below the Km of 5'-nucleotidase, the catalytic rate is directly proportional 
to substrate concentration. Adenosine levels therefore rise concomitantly with any 
mismatch between energy supply and demand; as the initial concentration of ATP is 
approximately 50 times higher than that of AMP, a small percentage fall in ATP 
concentration can lead to a large proportional rise in AMP, which is then hydrolysed 
via cytosolic 5’-nucleotidases (Meghji, 1993). A second pathway, which involves the 
hydrolysis of S-adenosyl-L-homocysteine, is oxygen insensitive and is therefore not 
accelerated during hypoxia and ischemia (Lloyd et a l, 1988).
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Adenosine is also formed extracellularly through the sequential hydrolysis of ATP by 
(almost exclusively glia-bound [Kreutzberg et a l ,  1986]) ecto-5'-nucleotidases. ATP 
is stored and co-released with several excitatory transmitters, e.g. noradrenaline in 
postganglionic sympathetic neurones (Bumstock, 1986), acetylcholine, or glutamate 
at CNS terminals (Zimmermann, 1994a). Both ATP and ADP exert a feed-forward 
inhibition on the 5'-ectonucleotidase: this leads to a delayed production of adenosine 
from released ATP, which only reaches significant levels once the concentrations of 
ATP and ADP have fallen substantially (Meghji, 1993). Adenosine is then either 
catabolised by adenosine deaminase to the relatively inactive compound inosine, or 
transported back into the cell by a bi-directional nucleoside transporter (Geiger and 
Fyda, 1991) where it is inactivated either by adenosine deaminase or by adenosine 
kinase (see Fig. 25).
5.1.2 Extracellular levels
Unlike most other neurotransmitters known to date, intracellular adenosine is not 
released by exocytosis of synaptic vesicles, but by direct diffusion across the cell 
membrane. Adenosine crosses cell membranes by a combination of simple and 
facilitated diffusion, that is, it moves down a concentration gradient. Although the 
cytosolic free adenosine concentration was once assumed to lie within the low 
micromolar range (Prince and Stevens [1992] estimated the interstitial concentration 
to be about 10 pM), this probably represents an overestimate due to the invasive 
assay procedures; more recent estimates give a figure of around 80 nM under 
normoxic conditions, rising to around 2 pM during hypoxia. The interstitial 
concentration of adenosine of intracellular origin will vary over a similar range, 
although at lower absolute values, as three intracellular metabolic processes 
(deamination, rephosphorylation, and sequestration through conversion into S- 
adenosyl-L-homocysteine) will compete with the adenosine transport system. Under 
resting conditions, the larger fraction of extracellular adenosine originates from the 
hydrolysis of ATP. Unfortunately, the direct assessment of the extracellular 
concentration, which in the case of adenosine (which exerts its actions mainly via cell 
surface adenosine receptors) represents the physiologically active concentration, is
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almost impossible to determine due to the many factors regulating the concentration 
in the interstitial compartment. Most estimates in the literature range from a few 
hundred nanomolar down to a median value well under 100 nM under resting 
conditions; similar levels (190 nM) have been found to be present in whole venous 
blood samples from human patients (Guieu et a l, 1994).
However, the extracellular adenosine concentration may become considerably 
elevated - either as a by-product of increased intracellular metabolic activity, or as the 
result of activity-dependent ATP release - during periods of ischemia, intense 
neuronal activity or physical brain injury. This response to factors that increase 
cellular metabolic demand relative to available metabolites leads to the enhancement 
of a voltage-dependent, non-GABAergic chloride conductance (Mager et al., 1990), 
and a hyperpolarization of pyramidal cells via a G-protein mediated increase of a 
postsynaptic K+ conductance (Thompson et a l, 1992, Pan et a l, 1994) shared by 
GABAb receptors and 5-HTla receptors (McCormick and Williamson, 1989). A 
presynaptic reduction in excitatory (but not inhibitory - Lambert and Teyler, 1991) 
transmitter release (possibly via the inhibition of an axon terminal co-conotoxin- 
sensitive Ca2+ current) has been described in the hippocampus (but cf. Ulrich and 
Huguenard, 1995). In addition, adenosine has several other non-neuronal effects, like 
vasodilation (Linden, 1991) and the increase of glucose uptake, that also serve to 
adapt to excessive metabolic demand, and has therefore been termed a "retaliatory 
metabolite" (Newby et a l, 1990) mediating a metabolic negative feedback.
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Figure 25: Adenosine: origin, metabolism and effector pathways (adapted from Murray et al., 1993 
[metabolism] and Zimmermann, 1994 [mechanism of action]). SAH, S-adenosyl-L-homocysteine; 
PKA, protein kinase A; PDE, Ca2+/calmodulin-dependent phosphodiesterase. Adenosine is produced 
either intracellularly by one of the pathways indicated at the top, or extracellularly through the 
sequential hydrolysis of ATP, and mediates its effects through adenylyl-cyclase-linked G-protein- 
coupled receptors by either increasing (A2) or decreasing (A l) cAMP levels.
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5.1.3 Receptors
On the basis of both pharmacological and biochemical studies, adenosine receptors 
have been subdivided into two subtypes, termed A l and A2. By definition, adenosine 
A l receptors are negatively coupled to adenylate cyclase via an inhibitory (Gi) 
guanosine 5'-triphosphate (GTP)-binding protein (although a number of cAMP- 
independent actions of adenosine Al receptor activation have since been described), 
whereas A2 receptors are positively coupled to adenylate cyclase via a stimulatory 
(Gs) G protein (Stiles, 1992). The affinity of the Al receptor for adenosine is about 
three orders of magnitude higher than that of the A2 receptor (with the exception of 
the high-affinity striatal A2 receptor). Al receptors couple indiscriminately to all 
pertussis toxin-sensitive G-proteins (Munshi and Linden, 1990; Jockers et al., 1994) 
and are able to mediate effects on a variety of effector systems including potassium- 
(Trussel and Jackson, 1985) and calcium-(MacDonald et al., 1986) channels, the 
Na+-Ca2+ exchange, phospholipase C (Dickenson and Hill, 1993), adenylate cyclase, 
guanylate cyclase, and enhancement or inhibition of phosphatidylinositol hydrolysis 
(Alexander et al., 1990). Al receptors are located both postsynaptically on the 
dendrites, and presynaptically on axon terminals, with quite a large proportion of 
receptors being extrasynaptic (Tetzlaff et a l, 1987), suggesting a diffuse 
neuromodulatory role in addition to the regulation of synaptic activity. They are 
widely distributed in the CNS, with particularly high numbers being encountered in 
cortical and cerebellar regions. A2 receptors have been shown to enhance synaptic 
transmission by acting on P-type calcium channels (Umerniya and Berger, 1994). 
Based on agonist potencies, the A2 receptors have been further subdivided into high- 
affinity (striatal A2a, localised to dopamine-rich regions of the brain) and low- 
affinity (peripheral A2b) receptors (Bruns et al., 1986); both have been successfully 
cloned (Libert et al., 1991; Maenhaut et al., 1990), and there is evidence for two A2- 
like genes on the human genome.
The existence of an A3 receptor (Zhou et al., 1992) which binds the 125I- 
radiolabelled A 1-selective agonist N6-2-(4-amino-3-iodophenyl)-ethyladenosine 
(APNEA), but not the xanthine antagonists DPCPX (1,3-dipropyl-8-cyclopentyl-
94
xanthine) and XAC (xanthine amine congener), has recently been reported (Fozard 
and Carruthers, 1993). It is more closely related to the Al than the A2 receptor and 
displays marked species variability, with the rat A3 receptor amino acid sequence 
showing only 74% sequence homology with the receptors from the other species that 
have been cloned (sheep and human; Linden, 1994). Its importance lays in the fact 
that A3 receptors can trigger mast cell degranulation (Doyle et a l, 1994) and may 
therefore be involved in both the bronchoconstrictor action of adenosine, and the 
antiasthmatic properties of theophylline and related compounds.
i i
Finally, a fourth adenosine binding site (the so-called P-site) located intracellularly 
on the catalytic unit of adenylate cyclase exists which inhibits cAMP formation at 
supraphysiological adenosine concentrations (Londos et al., 1983).
5.1.4 Binding mechanics
Adenosine receptor affinity for agonists is strongly dependent on the state of G 
protein interaction. The Al receptor exists in two affinity states for agonist binding, 
which correspond to the receptors coupled and uncoupled to a G-protein, respectively 
(Lohse et a l, 1984); agonist binding promotes the conversion from a high- to a low- 
affinity state (Casado et a l, 1991). A l receptors couple largely indiscriminately to 
pertussis-sensitive GTP binding proteins (but cf. Fredholm et a l, 1989), and the 
coupling between the A l receptor and the G-protein appears to be very tight: in 
solubilised receptors, 80% appear to be in the high-affinity form; addition of guanine 
nucleotides (GTP or its stable analogue 5'-guanylylimidodiphosphate (Gpp(NH)p)) 
partially shifts the agonist-specific high-affinity state of the receptor (reflecting the 
ternary complex between agonist, receptor and G-protein) into the low-affinity state 
(Stroher et a l, 1989), which represents the receptor dissociated from the G-protein. 
In slices, a large percentage of the receptors appears to be coupled to G-proteins, 
although the intracellular concentrations of GTP present in intact cells (around 1 mM 
- Fredholm and Jonzon, 1988) should suffice to convert a proportion of receptors to 
the low-affinity state. Estimates for the proportion of Al receptors in the high-affinity
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state range from 33% (Green and Stiles, 1986) in rat cortical slices to 81% in calf 
brain membranes (Garritsen et a l, 1990); in human hippocampal slices, binding of 
[3H]PIA to the low affinity state could not be reliably detected in the absence of GTP 
(Ulas et al., 1993). Following chronic caffeine treatment, a higher percentage of 
receptors is in the high-affinity form, but at the same time the ternary complex is 
more sensitive to GTP; this results in an increased efficiency of adenosine (Green 
and Stiles, 1986) either as a consequence of changes in the adenosine receptor or Gi 
protein quantity or functionality. More recent reports (Ramkumar et al., 1988) 
suggest an increase in Gi proteins (evidenced by increased pertussis toxin-catalysed 
[32p]NAD incorporation into the a i subunit).
The high adenosine occupancy of the A l receptor has also led to continuing debate 
about the existence of two affinity states for antagonist binding. The increase in 
Bmax of DPCPX binding after the addition of Gpp(NH)p (Klotz et a l, 1990) had 
originally been taken to represent preferential binding of antagonists to the uncoupled 
state of the receptor. However, the effect may be due to the dissociation of 
endogenous adenosine from receptor sites (Parkinson and Fredholm, 1992); in these 
binding studies performed in rat striatal slices, endogenous adenosine was found to 
be continuously present despite the addition of adenosine deaminase (2 IU/ml). Mg2+ 
was found to decrease the dissociation rate of bound endogenous adenosine from Al 
receptors, thus limiting the access of DPCPX to the binding site; this may also 
explain the apparent inhibitory effects of Mg2+ on antagonist binding (Reddington et 
a l, 1989a). Additional evidence for an indiscriminate binding of adenosine Al 
antagonists to both states of the receptor came from studies showing that antagonists 
can bind to both coupled receptor-G protein complexes and small uncoupled 
receptors (Reddington et a l, 1989b). Furthermore, the concept that adenosine 
antagonists bind preferentially to uncoupled receptors (Leung et a l, 1990), implying 
"negative efficacy", that is the ability to trigger inverse agonist responses even in the 
absence of agonists (Klotz et a l, 1990), may be based on the erroneous assumption 
that membrane-bound and solubilised receptor preparations are devoid of 
endogenous adenosine. In fact, Schiemann et a l  (1990) showed that the increase in 
Bmax for DPCPX observed in smooth muscle membrane preparations after the
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addition of GTP analogues was due to residual adenosine trapped in inside-out 
vesicles (and therefore inaccessible to adenosine deaminase) in concentrations of up 
to 400 nM; and Prater et al. (1992) demonstrated the continued presence of a 'cryptic' 
adenosine pool in CHAPS-solubilised receptor preparations by radio-immuno assay 
which was inaccessible to degradation by adenosine deaminase, showing that a Mg2+- 
dependent GTPyS-induced increase in antagonist binding to solubilised receptors is 
also due to the unmasking of binding sites occupied by contamination with residual 
adenosine. Despite these observations, reverse intrinsic activity of antagonists on G 
protein-coupled receptors continues to be a subject of speculation (Schutz and 
Freissmuth, 1992).
5.1.5 Effects in vivo
In the experimental animal, adenosine agonists possess psychomotor depressant 
effects. They have been shown to produce a marked decrease in locomotor activity in 
rodents (Heffner et a l, 1989), a decrease in schedule-controlled behaviour of rodents 
and monkeys, and catalepsy when given intracerebroventricularly at higher doses 
(Ferre et al., 1991). Adenosine has also demonstrated anticonvulsant properties in 
audiogenic (Maitre et al., 1974), chemically induced (Murray and Szot, 1985), and 
kindling models of epilepsy: adenosine, adenosine agonists and the adenosine uptake 
blocker papaverine reduce the severity and duration of amygdala-kindled seizures 
(Albertson et al., 1983). These results suggest that endogenous adenosine is an 
important regulator of the spread and duration of seizures, and adenosine analogues 
may represent a novel and effective treatment for epilepsy (Chin, 1989).
Adenosine antagonists on the other hand, which include the dietary methylxanthines 
caffeine and theophylline, not only inhibit adenosine analogue psychomotor 
depressant effects, but, when administered alone, have psychomotor stimulant 
effects: they increase locomotion in mice (Seale et al., 1986), and caffeine has been 
found clinically to increase anxiety in healthy volunteers (Loke et al., 1985). These 
central effects of methylxanthines, as well as their multiple peripheral effects
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(lipolysis in adipose tissue, increased renal blood flow, increased heart rate) have 
been proposed to be mainly due to antagonism of endogenous adenosine (Snyder, 
1985), a suggestion based on the assumption that adenosine exerts a tonic inhibitory 
action referred to as "purinergic tone".
5.1.6 Adenosine effects: A l or A2 mediated?
Originally, the central stimulant actions of methylxanthines were thought to be 
related exclusively to their Al antagonist properties, as their activity correlated well 
with their capacity to compete with radioligand binding to A l receptors; however, 
more recent data suggest that the A2 receptor subtype may also be responsible for 
these effects (Nikodijevic et a l, 1990), confirming the assumption of Spealman and 
Coffin (1986) that most of the behavioural effects of adenosine agonists (Phillis, 
1990) and low-dosed antagonists are likely mediated by the A2 receptor, while highly 
selective A l antagonist compounds like KFM 19 (a potential cognitive enhancer - 
Schingnitz et a l, 1991) and DPCPX (see below) exert relatively minor effects in the 
central nervous system.
In fact, the potencies of different methylxanthines to produce an increase in schedule- 
controlled behaviour in monkeys correlate better with their affinities for A2 
receptors. Also, caffeine induces a c-fos expression in mouse brain which cannot be 
antagonised by an A 1 adenosine analogue, but is blocked by a potent non-specific A2 
adenosine analogue (Nakajima et a l, 1989). Additionally, a postsynaptic A2-induced 
decrease in agonist binding to dopamine D2 receptors may explain some of the 
stimulatory effects of low doses of caffeine (Fredholm et a l, 1993). In support of this 
theory, Ferre et a l  (1993) have described a potent A2/dopamine D2 receptor 
interaction after the application of low-dosed xanthines, with A2 receptor activation 
inhibiting the effects of dopamine D2 receptor stimulation (although some doubts 
have now been raised as to the relevance of these effects). Interestingly, the effects of 
low doses of caffeine (10 mg/kg) in rats generalise not only to other adenosine 
antagonist xanthines, but also to dopamine stimulating agents (Mumford and
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Holtzman, 1991) which are known to act mainly in striatal regions with a high 
density of A2 receptors. High-affinity A2a receptors are restricted mainly to the basal 
ganglia, although A2a mRNA has been shown to be expressed in the hippocampus 
and cerebral cortex as well (Cunha et a l, 1994). Therefore, and despite the lower 
affinity of A2 receptors, low doses of methylxanthines in vivo appear to act mainly 
via A2 receptors, and most of the behavioural effects of low-dosed adenosine 
agonists and antagonists can therefore be explained by actions at A2 receptors. The 
convulsant properties of adenosine antagonists on the other hand appear to be 
mediated by A l receptor blockade.
5.2 Adenosine antagonists
The acute administration of methylxanthines at high doses can cause severe CNS 
side-effects: Caffeine can produce seizures in rats at high doses (200-400 mg/kg) 
(Chu, 1981), reduces the threshold for the initial (tonic) phase of electroconvulsive 
seizures at 100 mg/kg in mice (Chen et a l, 1968), and prolongs post-stimulation 
afterdischarges in the amygdaloid kindling model of partial seizures (50 mg/kg) 
(Albertson et a l, 1983); the acute intraperitoneal administration of caffeine 20-40 
mg/kg was found to be associated with increased rates of seizure upon challenge with 
pentylenetetrazole (File et a l, 1988); and chronically ingested caffeine (20-100 
mg/kg/day) increases the percentage of rats having convulsions in response to low- 
dosed PTZ (File et a l, 1988; Cutrufo et a l, 1992). While paraxanthine is its main 
metabolite, caffeine is also partly metabolised to theophylline (Tang-Liu et a l, 
1983); in rats, a dose of 25 mg/kg i.p. can be estimated to correspond to a peak brain 
concentration of 60 pM. In the maximal electroshock seizure test in mice (a model 
for human grand mal seizures), aminophylline, but not 8-(p-sulfophenyl)- 
theophylline (a theophylline derivative unable to cross the blood-brain barrier) in the 
dose of 238 p mol/kg, impaired the protective action of several anticonvulsants, 
indicating a central site of action of methylxanthines (Borowicz et a l, 1993). Acute 
intraperitoneal administration of theophylline base up to 280 pM resulted in 
increased activity and slight toxic side-effects in rats (Thithapandha et a l, 1972). 
Oral doses of theophylline up to 100 mg/kg stimulated locomotor activity in rats,
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although no wet dog shakes or other behaviours characteristic of limbic seizures 
could be observed in the absence of additional stimulation with subcutaneously 
administered kainic acid (Ault et a l, 1987). Similarly, aminophylline at 100 mg/kg 
i.p. did not affect motor activity significantly or alter the EEG in chronic amygdala- 
kindled rats (Handforth and Treiman, 1994). Acute intravenous infusions of 
theophylline and some of its derivatives at higher doses invariably lead to 
convulsions; the EDso is around 175 mg/kg in the rat (Norenberg and Chu, 1977), 
and decreases with increasing phylogenetic brain complexity. In man, as in primates, 
side-effects are commonly, although not always, observed at concentrations above 20 
pg/ml, and seizures are most often seen at theophylline serum levels of more than 50 
pg/ml (Zwillich et a l, 1975). Theophylline-induced seizures have been reported in 
patients with no previous history of epilepsy and no gross brain pathology (Mori et 
a l, 1992); they are often initially focal or unilateral (Nakada et a l, 1983), and 
respond poorly to antiepileptic medication with intravenous diazepam, phenytoin and 
phenobarbital (Zwillich et a l, 1975); it is worth noting, however, that 
methylxanthines have also been deliberately used in an attempt to increase the 
therapeutic effect of electroconvulsive shock (ECS): Swartz and Lewis (1991) report 
that in patients undergoing electroconvulsive shock (ECS) treatment, premedication 
with theophylline significantly lengthened seizure duration without causing adverse 
effects. In vitro, theophylline-induced interictal spiking can be routinely achieved in 
the hippocampal slice (Ault and Wang, 1986).
Since the discovery that the methylxanthines caffeine and theophylline act partly via 
antagonism of endogenous adenosine at A l receptors, a large number of highly 
selective synthetic analogues have been developed by introducing substitutions at the 
N -l, N-3, N-7 and C-8 positions of xanthines. General problems with some of these 
compounds are poor aqueous solubilities and variable activities as cyclic nucleotide 
phosphodiesterase inhibitors; the problems are avoided with polar compounds like 
BWA-1433U and l,3-dipropyl-8-sulfophenylxanthine, which do not cross the cell 
membrane. Substitutions at the methylxanthine structure led to the development of 
compounds with increasing selectivity and potency, such as 8-phenyltheophylline 
(Collis et a l, 1985) or 8-cyclopentyltheophylline (CPT). The most potent and
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selective A l agonist resulted from the combination of a 1,3-dipropyl-substitution and 
an 8-cyclopentyl-substitution: 8-cyclopentyl-l,3-dipropylxanthine, or DPCPX (Bruns 
et a l, 1987). DPCPX binds to rat brain membrane A l receptors with a Kd of 0.42 
nM and possesses a 700-fold selectivity for the A l over the A2 receptor (Lohse et a l, 
1987).
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antagonists used (or mentioned) in this study
101
However, despite its high affinity for the adenosine A l receptor, DPCPX has few 
effects when administered in uninjured and unstimulated tissue: in organotypic rat 
hippocampal slice cultures, Thompson et a l  (1992) reported that bath application of 
DPCPX 200 nM did not affect either the resting membrane potential or the amplitude 
of synaptic responses. It also concords with the results of numerous in vivo studies: 
the intravenous infusion of DPCPX 100 pg/kg/min over several hours was well 
tolerated in a displacement study in anaesthetised rats (Kuan et al., 1992); bolus 
intravenous injections of DPCPX 0.1 mg/kg (Knight et al., 1993) had no discernible 
effects on mean arterial blood pressure or heart rate in anaesthetised rats in studies on 
the effects of A l blockade on renal function; in a behavioural study by Griebel et al. 
(1991) in freely moving mice, the intraperitoneal administration of DPCPX did not 
produce a caffeine-like motor stimulation in the way a non-xanthine, mildly selective 
A2 antagonist triazolo-quinazoline did. At the highest dose (6 mg/kg), slightly 
decreased locomotion and rearing responses, ataxia and lack of co-ordination were 
noted. Wood et al. (1989) observed that DPCPX did not alter gross motor behaviour 
but did block the motor depressant effects of CHA, in rats injected with 25 mg/kg i.p. 
and observed for a period of 135 minutes. Similarly, Dawid-Milner et a l (1994) did 
not record any adverse effects when they analysed the responses to hypothalamic 
electrical stimulation in anaesthetised cats after the administration of DPCPX 
(dissolved in ethanol) at a dose of 3 mg/kg iv. This lack of effect is not due to a poor 
blood-brain-barrier penetration; while the blood-brain barrier permeability is highest 
for compounds with a partitioning coefficient (logP) of around 2 and decreases both 
with more polar and less polar substances, Bisserbe et a l  (1992) found a blood/brain 
concentration ratio below one after the intravenous administration of DPCPX 50 to 
80 nmol to rats. Finally, DPCPX was found to have no effects of its own in a variety 
of experimental paradigms, including calcitonin gene-related peptide-like 
immunoreactivity release in rat spinal cord in vitro (Santicioli et a l, 1993), and 
orthodromically evoked population spike amplitude in rat hippocampal slices 
(Sebastiao et a l, 1990).
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5.3 Object of study
The (mainly) inhibitory effects of adenosine on cell excitability and metabolism have 
stimulated the search for therapeutic indications of compounds which mimic its 
physiological effects. Research has concentrated mainly on cardioprotective (Engler, 
1994) and neuroprotective (MacGregor et a l ,  1993; Schubert and Kreutzberg, 1993) 
mechanisms with a view to limiting the tissue damage ('reperfusion injury') observed 
after myocardial or cerebral ischemia. Adenosine agonists have also been suggested 
to be potentially useful antiepileptic compounds, prompted partly by the marked 
inhibitory effects of adenosine on neuronal excitability, but mainly by the 
proconvulsant effects of compounds (such as the methylxanthines) known to be 
adenosine receptor antagonist. However, the mechanisms involved in the generation 
of methylxanthine-induced seizures are not fully understood. Originally, the 
discovery of highly selective antagonists such as the alkylxanthine DPCPX had led to 
the hope that the antagonism of endogenous adenosine may be unambiguously 
identified as the cause for methylxanthine-induced convulsions. However, results 
from several recent studies have rather confused the picture. In particular, the 
administration of relatively high doses of DPCPX has been shown to produce little 
more than slight behavioural disturbances in intact animals, while reliably inhibiting 
the effects of exogenous adenosine receptor agonists (see above). Also, several 
reports had indicated that transient blockade of Al receptors in vitro resulted in 
persistent epileptiform activity: in 1989, Alzheimer et al. reported that "a transient 
suppression of an inhibitory purinergic tonus by DPCPX leads to sustained interictal- 
like epileptiform activity arising in area CA3 [in guinea pig hippocampal slices]. 
Once induced, the spontaneous burst discharges were apparently irreversible within 
the observation period, even after prolonged washout (2-3 hr) in normal solution. In 
contrast, the hyperpolarising action of exogenous adenosine, which was substantially 
reduced by DPCPX, recovered within 30-60 min of drug washout, indicating that 
DPCPX was not irreversibly bound to the Al receptor"; and in 1993, the same group 
stated that "our data do not allow us to determine how and to what extent the 
different A l receptor-mediated pathways [i.e. activation of a potassium conductance, 
decrease of a calcium conductance, and inhibition of adenylyl cyclase] contribute to 
the long-term effects observed after a transient removal of endogenous adenosinergic
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inhibition. Further research will be required to explain the delicate relationship 
between adenosine tonus and neuronal excitability in terms of its molecular 
machinery". This poses some important questions relating to the presence or absence 
of the inhibitory purinergic tonus postulated by several groups, and to the role of 
adenosine in epilepsy. Therefore, the effects of DPCPX and two other structurally 
related xanthines on epileptiform activity were investigated in the in vitro mouse 
neocortical cylinder and the rat hippocampal slice in an effort to answer the following 
questions: What is the persistent effect of DPCPX due to? Is there a basal purinergic 
(inhibitory) tone? And what are the implications for the use of purinergic 
mechanisms in the treatment of epilepsy?
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6  M e t h o d s
Mouse neocortical cylinders were prepared as described in Chapter 2, usually with a 
nominal diameter of 450 pm. Hippocampal slices were prepared as follows: Male 
Wistar rats (180-240 g) were anaesthetised with intraperitoneally injected urethane 
(25% w/v, 5 ml/kg body weight) and decapitated. The brain was quickly removed, 
and the hippocampus was dissected free in ice cold, oxygenated ACSF (composition 
[in mM]: NaCl 120, K Q  1.1, CaCh 2, MgSCU 1, KH2PO4 2.2, NaHCOs 26, glucose 
10; prepared freshly each day). Slices (450 mm thick) were cut perpendicular to the 
long hippocampal axis on a Mcllwain tissue chopper, placed on moistened filter 
paper in a Petri dish together with a small amount of ACSF, and transferred to an 
interface holding chamber constantly bubbled with carbogen (95% 0 2 / 5 %  CO2) to 
equilibrate. After a period of at least one hour, a single slice was then placed in a 
submersion-type recording chamber, pinned down with two blunt glass 
microelectrodes and superfused by gravity at a rate of 5 ml/min with ACSF saturated 
with 95% O2 / 5% CO2 and maintained at 29°C. Magnesium-free ACSF was 
prepared by omitting MgS04 from the normal ACSF, without adjusting for molarity. 
Glass microelectrodes were pulled on a single-stage puller, and backfilled with Ca2+- 
and glucose-free ACSF. The tips of the microelectrodes were broken back under 
visual guidance to obtain a resistance of 2 to 5 MQ. Extracellular field potentials 
were recorded from the stratum pyramidale in the CA3 subfield.
The following drugs were used: l,3-dipropyl-8-cyclopentylxanthine (DPCPX), 
cyclopentyltheophylline (CPT) (both RBI), theophylline, adenosine (both Sigma), 
adenosine deaminase (ADA; the enzyme which converts adenosine to inosine), and 
N6-cyclopentyladenosine (CPA, a synthetic adenosine analogue). DPCPX was 
dissolved in 10% dimethylsulfoxide (DMSO), while CPT was dissolved in NaOH 1 
M; both were stored as 100 pM stock solutions at 4°C. Theophylline (dissolved in 
NaOH 0.5 M to a final concentration of 50 mM) and adenosine (dissolved in 
calcium-free ACSF to a final concentration of 10 mM) stock solutions were prepared 
freshly each day. Further dilutions were made with calcium-free medium. Equivalent 
quantities of the solvent had no effect. Different drugs were switched to the bath
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perfusion system by means of three-way taps. At the flow rate of about 5 ml/min, 
about 15 seconds were required until the drug reached the bath.
CA1
Subiculum
DG PF
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Figure 27: The rat hippocampal slice (schematic drawing): extracellular field potentials were recorded 
in the stratum pyramidale of the CA3 subfield, which is innervated by the mossy fibre (MF) pathway 
from the dentate gyrus (DG, innervated by a projection from the entorhinal cortex - PF [perforant 
pathway]) and projects to the CA1 subfield via the Schaffer collaterals (SC). The schematic is 
intentionally simplified and omits a number of important connections.
In some instances, slices were incubated in individual wells of a 24-well tissue 
culture plate containing 0.5 ml of oxygenated ACSF per well after the initial resting 
period of 60 minutes. The tissue culture plate was left to float in a holding chamber 
containing 300 ml of constantly bubbled ACSF. This resulted in a continuous gentle 
movement of the plate in a humidified 0 2/C 0 2 atmosphere. Where this was done to 
assess the amount of adenosine and its metabolites secreted by the slices, ACSF 
samples were then withdrawn from the wells at various time points during the 
incubation period, as described in the results section. For the incubation of individual 
slices with DPCPX, a further 500 pi of ACSF containing a defined amount of the 
drug were added to the wells after an incubation period of 30 minutes, and the slices 
were transferred to the recording chamber at the end of a further incubation period, 
which ranged from 15 minutes to one hour.
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Figure 28: Method used for the incubation of up to 24 hippocampal slices in defined amounts of drug- 
containing ACSF. The slices are placed in individual wells containing 0.2 ml ACSF, to which a further 
200 pi are added after a given equilibration period. The culture plate is floating on constantly bubbled 
ACSF inside a holding chamber; the continuous movement in moistened carbogen ensures optimal 
oxygenation.
Data were recorded both as continuous chart recorder tracings at slow speed for the 
assessment of spiking frequencies, and as print-outs of a Gould digital oscilloscope to 
record single events at a higher resolution. For illustration purposes, chart recordings 
were scanned using a Hewlett Packard scanner with a resolution of 600 x 600 dpi and 
re-traced in a graphics program (CorelDraw, version 3.0) to allow the inclusion into 
graphs independently of the originally used chart speed and amplification factor. 
Both the amplitude and the frequency are reproduced faithfully (see Figure 29 
below), except where the frequency was so high as to prevent an adequate resolution: 
in these cases, the trace was included as the original bitmap. It should be noted that 
the chart record is of a semiquantitative nature: each upstroke represents one burst 
discharge, but the deflections (which usually had an amplitude of 0.1 to 1 mV) do not
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accurately reflect the burst amplitude due to the low-pass filtering effect of the chart 
recorder; therefore, only the records obtained on the digital oscilloscope are voltage- 
calibrated. Spiking frequencies were measured during the last five minutes of each 
observation period (ie. control, drug application, or washout). Results are given as 
arithmetic means ± standard deviation (S.D.) and compared using Student's t test; the 
statistical significance level was set at 5%.
2 min
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Figure 29: Equivalence of original and re-traced Y-t chart recordings. Shown are the results of an 
experiment testing the time needed for DPCPX (5 nM)-induced spiking in a rat hippocampal slice to 
reach a stable level. The drug was added to the superfusate at the point indicated by the arrow; the 
time to steady state is plotted below. The top trace is a bitmap image of the original recording, while 
the bottom trace represents the re-drawn copy. The illustrations of spiking frequencies used in the 
figures are re-traced, unless otherwise stated.
Start of superfusion of DPCPX [5 nM]
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7 R e su l t s
7.1 Adenosine effects in hippocampal and neocortical preparations
Adenosine rapidly and reversibly suppressed spontaneous spiking induced by 
perfusion with magnesium-free medium in mouse neocortical cylinders. Spiking 
frequency decreased to a similar extent upon consecutive exposures to adenosine 1 0 0  
pM, indicating that the response to adenosine did not desensitise. The apparent IC50 
of the adenosine-mediated inhibition was found to be 87.9 ± 1.3 pM, and decreased 
with increasing magnesium concentrations; this magnesium-dependency has been 
described previously: the depression of single pulse-evoked responses by adenosine 
(20 pM) is blocked in Mg2+-free medium (Bartrup and Stone, 1988).
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Figure 30: Adenosine effects on spontaneous spiking in neocortical cylinders superfused with ACSF 
containing 0, 50, 100 or 200 pM magnesium sulphate (n = 6 for each magnesium concentration). 
Adenosine displays a tendency towards enhancing effects at low doses (10 pM) in magnesium-free 
ACSF.
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The fitting of a sigmoidal function to the data gave no satisfactory result, possibly 
due to the fact that the effects of adenosine are markedly affected by uptake and 
metabolism. The fit improved when a basal interstitial concentration of 2 pM was 
included to account for the increase in extracellular adenosine levels reported to 
occur during seizure-like activity. In some cases, perfusion with low doses of 
adenosine (10 pM) was observed to result in a facilitatory effect, which however 
failed to reach statistical significance (Fig. 30). A seemingly unrelated, but possibly 
very germane observation was that after the perfusion with adenosine, a transient 
rebound increase in the spiking frequency to above control levels was observed; this 
is illustrated in Fig. 31 (A). A record of the activity of several individual neurones 
located in proximity to the recording electrode (B) suggests that the rebound increase 
in epileptiform burst frequency is due to a reduction in the bursting threshold: 
whereas the continuous firing by individual cells only occasionally results in 
spike/afterdischarges under control conditions, this gradual build-up is missing 
almost entirely during the washout of adenosine.
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Figure 31: Response of a mouse neocortical cylinder (450 pm) to repeated applications of adenosine 
100 pM  in zero M g2+ ACSF: During washout, a transient rebound increase in spiking frequency is 
observed (illustrated in a recording of the activity of several individual neurones in the vicinity of the 
electrode, below; the spike/afterdischarge bursts are indicated by arrows).
I l l
An increased efficacy of adenosine was observed when the sensitivity to adenosine 
was compared in whole and freshly subdivided cylinders (Fig. 32): after horizontally 
hemisectioning a 450 pm-cylinder from mouse neocortex, the IC50 for adenosine was 
reduced to 10 pM. Cylinders hemisectioned immediately after the dissection and 
incubated for one hour show a lower sensitivity to adenosine comparable to that seen 
in whole cylinders.
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Figure 32: Acutely hemisectioned cylinders were markedly more sensitive to the superfusion with 
adenosine 100 pM. This sensitivity returned to control levels in hemisectioned cylinders incubated for 
several hours (A: intact cylinder; B: cut cylinder - 10 minutes after hemisection; C: cut cylinder - 150 
minutes after hemisection). ***: p < 0.001 (unpaired t-test).
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A similar marked increase in sensitivity to the inhibitory effects of adenosine on 
epileptiform activity was observed in a series of experiments using hypo-osmolar 
solution to achieve cell swelling similar to that reported to occur in damaged slices. 
The osmolarity of the ACSF was decreased by adding distilled water (10% v/v). The 
experiments with hypo-osmolar ACSF demonstrated both an increased excitability of 
the tissue, and a significantly increased response to adenosine (Fig. 33).
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Figure 33: Effects of osmolarity on spiking frequency (A, in 13% hypotonic ACSF) and sensitivity to 
adenosine (B, in 10% hypotonic ACSF). Mouse neocortical cylinders displaying spontaneous spiking 
in magnesium-free ACSF were exposed to hypo-osmolar medium obtained by dilution. The increased 
spiking frequency, and the enhanced responsiveness to the effects of adenosine displayed in (B) are the 
results (mean ± SD) obtained in five experiments. * and ***: p<0.05 and p<0.001 vs. control; §: 
p<0.05 vs. first adenosine superfusion (two-sided t-test).
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7.2 Methylxanthine effects in hippocampal and neocortical
preparations
Both the naturally occurring methylxanthines caffeine and theophylline, and synthetic 
analogues with higher affinity for the adenosine Al receptor have been shown to be 
potent proconvulsants in animal studies (see Introduction). The compounds used for 
the assessment of the role of purinergic neuromodulation in epileptiform activity 
included three alkylxanthines with different degrees of selectivity and affinity for the 
adenosine A l receptor: theophylline, cyclopentyltheophylline (CPT) and 1,3- 
dipropyl-8-cyclopentylxanthine (DPCPX). Their proconvulsant activity was first 
assessed on zero-magnesium induced spiking in the neocortical tissue cylinder, the 
model developed for the first part of this study. Theophylline was observed to 
increase the duration of afterdischarges in a dose-dependent fashion; an inhibition of 
adenosine-stimulated potassium currents (Haas and Greene, 1984) is the most likely 
mechanism, as these mainly determine the duration of the burst 
afterhyperpolarization, and therefore the interburst interval, in cylinders in which 
spiking was induced by superfusion with low magnesium ACSF.
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Theophylline: effects on afterdischarge duration
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Figure 34: Rat cortical cylinder (nominal diameter 600 pm) incubated in 0 Mg++ ACSF and increasing 
concentrations of theophylline. Whereas the spiking frequency remains relatively constant, the 
duration of the afterdischarge (seen as high frequency/low amplitude bursts immediately following 
each interictal spike) is greatly prolonged, and becomes continuous at a theophylline concentration of 
640 pM (compare with Fig. 17).
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This pronounced effect on afterdischarge duration illustrates the drawback of the use 
of the spontaneous spiking frequency of neocortical cylinders as the main parameter 
for assessing drug actions: proconvulsant and anticonvulsant drugs (the effects of 4- 
aminopyridine and phenytoin are shown in Fig. 35) resulted in either a change in 
spiking frequency, a change in afterdischarge duration, or both. The correlation 
between the two parameters was highly variable, even for a given drug and cylinder 
size: for example, the lengthening of afterdischarge duration over time (Fig. 16) 
resulted in a decreased spontaneous spiking frequency. Also, spontaneous spiking in 
neocortical cylinders could only be induced by magnesium-free ACSF (Fig. 18). The 
absence of magnesium ions in the ACSF could have affected the actions of both 
adenosine agonists and antagonists, while the activation of NMDA-type receptors can 
contribute to long-term potentiation (LTP)-type facilitating effects. Therefore, 
hippocampal slices were used in most subsequent experiments. Hippocampal slices 
typically exhibit frequent, brief interictal spike-like discharges in response to a 
variety of proconvulsant drugs, but not the prominent afterdischarges seen in isolated 
neocortical tissue.
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Figure 35: Variable effect of phenytoin and 4-AP on spiking frequency and afterdischarge (AD) 
duration (expressed as number of afterdischarges/burst). Preliminary experiments showed that 
neocortical cylinders, while being an adequate model for the sensorimotor colum n, could not be used 
for quantitative studies on the effects of drugs, as the parameters used (spontaneous spiking frequency, 
or number of afterdischarges) were correlated in a variable fashion. As can be seen, phenytoin at 
clinically relevant concentrations led to an increase in spiking and a concomitant decrease in the 
number of afterdischarges, while 4-AP led to a transient increase in the number of 
afterdischarges/spike, but a persistent increase in the spiking frequency.
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7.2.1 Time course o f methylxanthine-mediated effects
The main effect to be examined, the apparently persistent convulsant effect produced 
by DPCPX in the hippocampal slice, is illustrated in Fig. 36. All three 
methylxanthines tested in this study induced spontaneous spiking in normal medium 
containing 1.2 mM magnesium. Theophylline, a relatively water-soluble 
methylxanthine with a low affinity for the Al receptor, induced spontaneous 
interictal spiking which reached stable levels within two to three minutes at 
concentrations of 50 pM; as this was approximately the time needed for the drug to 
reach the slice via the perfusion system at the flow rate used, the effect can be 
considered to occur almost immediately. The effect of theophylline was reversed 
within 20 minutes of washout (but see below). Cyclopentyltheophylline (CPT) 
demonstrated higher potency and a slower wash-out, taking approximately one hour 
to wash out. DPCPX induced spiking which did not abate even after a prolonged 
washout (6 hours). A monoexponential decay with a half-life ([TVi) of 80 minutes 
could be fitted to a subset of washout data; however, a sizeable proportion of slices 
displayed spiking which did not abate to any significant extent even after several 
hours (an example for this is shown in Fig. 36). This was the original finding by 
Alzheimer et a l  (1989) which had prompted us to investigate whether DPCPX 
caused long-term effects not related to persistent A l receptor blockade.
A paradoxical effect of DPCPX is that despite its marked convulsant effect in the 
slice preparation, it appears to have little convulsant effects in vivo: the systemic 
administration of DPCPX in animals has only relatively minor effects (see 
Introduction to Part Two). This could be due either to an efficient A l blockade in the 
absence of a physiologically relevant purinergic tone, or to an inaccessibility of the 
A l receptor for DPCPX under basal conditions.
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Figure 36: Time course of decay of spontaneous spiking frequency after the application of 
methylxanthines. Representative traces from three single experiments using theophylline, CPT or 
DPCPX (A), and averaged values (mean ± SD, n=5 per compound; B). Theophylline washed out 
within 20 minutes, while the proconvulsant effects of CPT abated within 80 minutes. DPCPX-induced 
spiking lasted for several hours.
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During the experiments in which the effects of DPCPX and CPT were assessed on 
slices bathed in normal ACSF solution containing 1.2 mM magnesium, it was noted 
that spiking could often only be induced after the excitability of the slice had been 
increased, for example by a brief application of magnesium-free ACSF, or after the 
administration of a brief train of electrical stimuli through a concentric bipolar 
stimulation electrode placed in the mossy fibre pathway. The superfusion with 
magnesium-free ACSF alone did not markedly contribute to the permanently 
increased excitability observed after DPCPX application, as spiking evoked by 
omitting magnesium ions from the ACSF for extended periods (> 1 hour) was 
observed to abate almost immediately when the superfusion was switched back to 
normal ACSF containing 1.2 mM magnesium. Subsequently, this procedure was used 
as a reliable screening test for the physiological state of the slice, as damaged slices 
responded to the application of magnesium-free ACSF with persistent spiking. The 
failure of DPCPX to induce spiking in "healthy", i.e. unstimulated slices held equally 
true for minimally effective concentrations of the methylxanthine, and for maximal 
concentrations, and was therefore not a concentration-dependent effect.
When the transient superfusion with magnesium-free ACSF was used to evoke 
spontaneous spiking in slices previously superfused with DPCPX-containing medium 
to assess the extent to which DPCPX could be retained by the tissue in the absence of 
physiological effects, it was noted that the time-course with which DPCPX-induced 
spiking set in showed a delay which was similar to the lag period observed when 
DPCPX was applied to a slice in which spontaneous spiking had been induced 
previously with magnesium-free ACSF (Fig. 37); the delay between the start of 
superfusion of DPCPX and the first DPCPX-induced spike was 11.4 ± 5.3 min (n=4) 
in slices pretreated with magnesium-free ACSF, whereas it was 15 ± 2.6 min (n=3) 
after the onset of spiking induced by magnesium-free ACSF in slices pretreated with 
DPCPX.
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A)
Mg-free ACSF DPCPX [10 nM]
B)
10 min
DPCPX [10 nM] Mg-free ACSF
Figure 37: In slices pre-treated by superfusion with Mg2+-free ACSF, DPCPX induced spontaneous 
spiking (results of 4 experiments shown in A); by contrast, naive slices did not respond to DPCPX 
with spontaneous spiking until superfused with Mg2+-free ACSF (B, 3 experiments): in the latter case, 
DPCPX-induced spiking appeared with a characteristic lag period which could last several minutes.
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Figure 38: In order to further characterise the effects of DPCPX and magnesium-free ACSF on the 
excitability of the hippocampal slice (see previous figure), the gap between DPCPX superfusion and 
induction of spiking was prolonged (A), or the time span during which DPCPX was applied was 
prolonged (B). It can be seen that increasing the delay after which spiking is induced results in a lower 
spiking frequency, and that longer-lasting superfusion with DPCPX results in a more pronounced 
proconvulsant effect.
The main question to be answered was whether the persistent spiking observed after 
the application of DPCPX was due to adenosine receptor blockade. A series of 
experiments was devised where the sensitivity of spontaneously spiking neocortical 
cylinders to adenosine (100 pM) was assessed before and after a brief superfusion 
with DPCPX (20 or 100 nM) or CPT (100 nM). The reason for using the zero 
magnesium paradigm was that a control parameter for the potency of adenosine 
before the application of the methylxanthines was needed, as direct intracellular 
measurements of the adenosine-induced hyperpolarization were not possible. The 
effects of a brief (10 min) application of adenosine (100 pM) were assessed at 30 
minute intervals before and after the application of each of the three antagonists, i.e.
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theophylline, CPT and DPCPX. The results are shown in Figure 3?. Spiking 
frequency was increased to 129 ± 24.3% and 171 ± 9.7% of control by 20 and 100 
nM DPCPX, respectively, and to 172 ± 15.2 % of control by 100 nM CPT. The 
maximal decrease in adenosine-mediated inhibition was 5.4% after CPT 100 nM and 
35% after DPCPX 100 nM; the degree of inhibition after DPCPX 20 nM was not 
different from control. Importantly, however, the time course of the recovery of the 
sensitivity to adenosine was not significantly different from that of the decrease in 
spiking frequency after the application of the methylxanthines, suggesting that the 
proconvulsant effect was largely due to the antagonism of endogenous adenosine.
t
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Figure 39: Inhibiton of zero Mg-^-induced spiking in rat hippocampal slices by adenosine before and 
after the application of CPT (100 nM) or DPCPX (20 nM or 100 nM) (n=5 for each graph). 
**=P<0.01; ***=P<0.001 vs. control; §§=P<0.01, §§§=P<0.001 vs. first superfusion with adenosine, 
(x axis: time in minutes before/after methylxanthine application).
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7.2.2 Adenosine deaminase and DPCPX
A second approach to the elucidation of the mechanism of action of DPCPX 
involved the use of adenosine deaminase. Adenosine deaminase (ADA) is the 
enzyme which converts adenosine to inosine; it has convulsant effects when applied 
in vitro, which have been linked to the removal of the adenosinergic inhibitory tone 
(see Discussion). Therefore, if the convulsant effects of DPCPX are due to the 
inhibition of a basal purinergic inhibitory tone in the slice, addition of DPCPX after 
the superfusion with ADA should not result in an increase in spiking frequency. The 
results from three experiments are shown below (Fig. 40): a modest increase in 
activity was observed ([mean +/- S.D.; n=3]: ADA: 6.5 +/- 0.64 spikes/min; DPCPX 
added: 8.5 +/- 2.08 spikes/min), suggesting that most of the effects of DPCPX are 
mediated by a block of purinergic inhibition.
Adenosine deaminase 20 qg/ml + DPCPX 100nM
Adenosine deaminase 20 Mg/ml + DPCPX 100nM
Adenosine deaminase 20 |jg/ml + DPCPX 100nM
5 min
Figure 40: Adenosine deaminase and DPCPX: effects on the frequency of spontaneous spiking in rat 
hippocampal slices. Shown are the traces from three separate experiments. The increase in adenosine 
deaminase (ADA)-induced spiking by DPCPX (100 nM) was slight, suggesting that most of the 
proconvulsant efffects o f DPCPX are mediated by A l blockade.
3560^413433286837514^35^60^8875278811728449729608921^904043538^^
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7 .2 .3  Adenosine and metabolite concentrations - HPLC assay
The second question to be answered with respect to the actions of DPCPX was the 
nature of the persistent convulsant effect of DPCPX reported by Alzheimer et al. 
(1989) and also observed in the present study. Several possibilities had to be 
considered: The persistent effect could simply be due to a persistence of the drug at 
the receptor, or to a persistence of the drug in the experimental setup (i.e., an 
artefact), or to the induction of long-term, secondary changes in the tissue.
The results from the present experiments had indicated that the spiking observed 
after the addition of DPCPX to the perfusate was most likely exclusively due to the 
blockade of adenosine Al receptors. However, the application of DPCPX via the 
perfusing solution introduced two uncontrollable variables: because of the avid non­
specific accumulation of lipophilic drugs by brain slices, the end concentration of 
DPCPX within the slice was unknown (although the concentration in the aqueous 
phase - that is, the extracellular space and cytosolic compartment - will not exceed 
the concentration of the drug in the perfusate); and a persistent residual effect may 
even be caused by the slow elution of the drug from the tubing used in the setup. 
Indeed, a colleague working in our lab reported a residual contaminating effect of 
DPCPX persisting for two to three weeks in his setup (H. Hosseinzadeh, personal 
communication); similar difficulties have been reported for haloperidol (a lipid- 
soluble dopamine antagonist) perfused through silicone tubing (Starke et al., 1978). 
Other researchers have tried to avoid this problem by using local applications of 
small amounts of drug: Pape (1992) applied 5 to 20 pi of a 10 pM  DPCPX solution 
to the surface of thalamic slices in an interface chamber and reported that the 
responses to adenosine had almost completely recovered from block within 33 
minutes. A final proof for the persistence of the drug in the tissue and for the degree 
of accumulation in the lipid phase could have been obtained by measuring the drug 
levels by HPLC. However, the system in use in the Department was a reverse phase 
liquid chromatography system and therefore unable to assay lipophilic compounds.
At first, it was attempted to minimise the problems introduced by the adsorption of 
DPCPX to tubing by using two separate perfusion systems for DPCPX-containing
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ACSF and control medium. However, this still left the problem of not knowing the 
amount of drug bound by the tissue. To circumvent both problems (i.e. contamination 
of the setup, and accumulation of drug at non-specific binding sites in the tissue), a 
method was devised by which individual slices could be incubated in small amounts 
of ACSF for extended periods of time before assessing the excitability in the 
experimental setup. Because the accumulation of endogenous adenosine and other 
metabolites could have interfered with the binding of the drug (see Introduction to 
Part Two), it was also necessary to assess the amount of adenosine and its 
metabolites secreted by the slices over time. To this end, ACSF samples were taken 
from the wells and analysed by HPLC, as described below.
The amount of endogenous adenosine which accumulated in the incubation medium 
was an important factor for several reasons: firstly, it can give an indication of the 
state of the slices, as damaged or hyperexcitable slices are known to secrete increased 
amounts of adenosine; and second, endogenous adenosine could have interfered with 
the binding of purinergic compounds (cf. Schiemann et al., 1990). To assess the 
amount of adenosine and adenosine metabolites secreted by the slices, ACSF samples 
(50 pi) were withdrawn from two wells (containing one slice from each hippocampus 
each in an initial volume of 450 pi) before, and at 0, 10, 30, 60 and 120 min after 
transfer of the slices. A third slice was incubated in parallel and assessed for 
electrophysiological viability after two hours. Purines were analysed by parallel high 
performance liquid chromatography (HPLC, Severn Analytical Solvent Delivery 
System SA6410B) and UV detection at 254 nm (Severn Analytical UV/vis 
Absorbance Detector SA6500). A Techsphere C l8 3 pm microsphere column (10 cm 
x 4.6 mm) was used to separate adenosine, inosine, hypoxanthine and xanthine by 
isocratic reverse phase chromatography. The mobile phase was 0.01 M sodium 
phosphate (NaHzPO) with 6% methanol (HPLC grade) pH 6.1 at a flow rate of 0.8 
ml/min. The detection limit for adenosine was 0.5 pmol.
The calibration curves for adenosine, inosine and xanthine (range 0.05 - 20 pM) and 
for hypoxanthine (range 0.025 - 5 pM) were linear over the entire range. The 
concentrations were calculated from peak absorption heights according to the
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formula x = (y-c)/m, with the constants c and m being determined graphically. The 
spread of the values (mean ± S.D.) is given below:
Adenosine m = 3.269 +/- 0.024 c = -0.183+/- 0.166
Inosine m = 9.399+/- 0.123 c = -0.639+/- 0.429
Xanthine m = 7.260+/- 0.056 c =  -0.030+/- 0.197
Hypoxanthine m = 12.414+/- 0.195 c = -0.210+/- 0.360
The population spike of the control slice (measured in the CA1 subfield after
orthodromic stimulation) had an amplitude of 6 mV and remained stable over time, 
1 I
indicating good electrophysiological viability.
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Figure 41: Principal intermediates and enzyme-catalysed transformations involved in adenosine 
metabolism.
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The results from the two hippocampal slices incubated in parallel were as follows (in 
pM):
Slice A
0 min 10 min 30 min 60 min 120 min
Adenosine - - 0.065 0.097 0.129
Inosine - 0.028 0.128 0.100 0.167
Xanthine - - 0.128 0.128 0.205
Hypoxanthine - 0.070 0.435 0.383 0.644
Slice B
0 min 10 min 30 min 60 min 120 min
Adenosine - - 0.032 0.065 0.129
Inosine - - 0.056 0.122 0.200
Xanthine - - 0.077 0.205 0.308
Hypoxanthine - 0.044 0.148 0.522 0.800
X [pmol/slice/min] 0 6.4 18.2 4.7 3.5
Table 2: Adenosine and metabolite concentrations
Under the (simplified) assumption that large part of the metabolites measured results 
from adenosine degradation, the data translate into an average adenosine production 
of 6.5 pmol/min/slice, peaking at 10-30 minutes after the start of incubation.
The results of the HPLC analysis suggest a continuous production of adenosine by 
the slice (indicated by the increasing levels of both adenosine and its metabolites 
over time), but at a relatively low level: the overall concentration of adenosine in the 
tissue culture wells over a two hour period remained well below 200 nM and 
therefore at levels similar to those reported to be present in brain tissue in vivo, 
although of course the measurement of adenosine concentration in the bulk medium 
may not truly reflect the local concentration present in the immediate vicinity of the 
adenosine receptors. The values compare with 0.5 pM adenosine found by Fowler 
(1993) after the incubation of rat hippocampal slices (thickness 400 pm) in a volume 
of 1.7 ml for one hour.
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Figure 42: Adenosine and metabolite concentrations during incubation of hippocampal slices. Top: 
Elution of reference standards (1 pM each of hypoxanthine, xanthine, inosine and adenosine). Inset: 
Test for electrophysiological viability of a hippocampal slice from the same animal incubated in 
parallel. The population spike recorded in area CA1 after orthodromic stimulation remained stable 
over time. Bottom: Adenosine and metabolite concentrations secreted by hippocampal slices incubated 
in 400 pi ACSF over a 2 hour incubation period. Pooled results from two slices (one from each 
hemisphere)
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7.2.4 DPCPX: minimally effective concentration
Individual rat hippocampal slices were transferred to tissue culture wells containing 
0.2 ml of oxygenated ACSF after a pre-incubation period of one hour in a storage 
bath. After a further 60 minutes, 0.2 ml of ACSF containing DPCPX were added to 
give a final DPCPX concentration in the wells of between 0.2 and 10 nM. Slices 
were transferred to the recording chamber after incubation with DPCPX ranging from 
30 minutes to 2 hours, and superfused with drug-free ACSF. DPCPX itself is known 
to be metabolically stable, as thin layer chromatographic analysis of plasmatic extract 
obtained after high-dosed DPCPX injections revealed no major metabolic 
degradation in the first 20 minutes after administration (Bisserbe et al., 1992).
The slices had a wet weight of around 3 mg; with reference to the values published 
by Fowler (1993), this implies a dry weight of 0.62 mg, and a protein content of 0.3 
mg. The Bmax for DPCPX binding to rat hippocampal slices given in the literature 
(Johansson et a l, 1993) is 269 fmol/mg protein. In the present experiment, the 
amount of DPCPX added equalled 340 fmol/mg protein for incubations in 200 pi 
ACSF containing 0.5 nM DPCPX, and 13.5 pmol/mg protein for incubations in 400 
pi ACSF containing 10 nM DPCPX; this corresponds to a 1.3-fold and a 50-fold 
excess of drug, respectively.
As already mentioned, the washout of DPCPX may be prolonged due to sequestration 
of the lipophilic compound at hydrophobic sites such as fat and proteins, leading to a 
substantial accumulation (see Fig. 57; and cf. Lullman et a l, 1979), and resulting in a 
'depot action' of the perfused drug. The degree to which absorption to lipophilic sites 
may affect both the extent of receptor occupancy and the duration of the washout was 
analysed by incubating slices in varying, but limited amounts of DPCPX. However, 
the difference in response patterns of slices incubated in either 200 or 400 pi of 
ACSF containing either 2 or 5 nM DPCPX was not statistically significant. 
Therefore, the data from experiments using 200 pi of incubation medium were 
pooled with those using 400 pi to give the results shown in Fig. 43. It was obviously
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not possible to define the degree of A l blockade, as electrophysiological 
measurements were only started during the washout phase; however, a semi- 
quantitative dose-response curve could be constructed by classifying the spiking 
patterns observed in slices incubated in various concentrations of DPCPX, which 
indicated that concentrations as low as 500 pM had a proconvulsant effect.
>
DPCPX 0 0.2 0.5 1 2 5 10 [nM]
(11) (3) (6) (17) (20) (18) (2)
Spiking patterns:
no spiking after 0 Mg** delayed spiking after 0 Mg+
0 Mg4
immediate spiking after 0 Mg4
- m -
0 Mg4
spontaneous spiking
10 min
-EO- 
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Figure 43: Incubation of rat hippocampal slices in small volumes of ACSF containing defined 
amounts of DPCPX (see text). The columns (top) illustrate the frequency of occurrence of the four 
spiking patterns (defined below): no DPCPX-induced spiking after the induction of zero-magnesium 
spikes; appearance of DPCPX-induced spikes after a lag period; DPCPX-induced spiking immediately 
after zero-magnesium-induced spiking; appearance of spontaneous spikes upon transfer of the slice to 
the recording chamber. The number of slices used at each concentration is given in brackets. Slices 
were from a total of 12 animals.
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7.2.5 DPCPX: Displacement by theophylline
In preliminary experiments, the minimal concentration of DPCPX needed to induce 
robust spontaneous spiking in the CA3 subfield was found to be around 5 nM. 
However, even at these relatively low concentrations, a complete cessation of spiking 
similar to that observed after theophylline or CPT was not usually observed. To 
evaluate whether this persistent epileptogenic effect was due to the persistent 
presence of DPCPX at the receptors, an attempt was made to displace the drug using 
short-acting methylxanthines. Displacement with agonists had not been observed in 
the previous experiments; however, it was known from reports in the literature that 
adenosine agonists and antagonists may bind to different domains of the binding site. 
Indeed, superfusion with theophylline 50 pM resulted in a temporary cessation of 
spikes which suggested that DPCPX had been successfully displaced from its 
receptor. While spiking reoccurred after the washout of theophylline, indicating that 
DPCPX re-associated with the receptor after the removal of the less selective 
xanthine, the subsequent spiking frequency was markedly reduced. As DPCPX is a 
very lipophilic compound, this could be due at least in part to a non-specific 
accumulation within the slice, resulting in a significant 'depot action', with a 
subsequent slow elution from this compartment preventing a complete washout. The 
concentration of drug being eluted from non-specific binding sites may have been 
high enough to result in the reappearance of spiking after displacement by 
theophylline.
The effects of theophylline on DPCPX-induced spiking (Fig. 44) were quantified by 
comparing the observed spiking frequency (Ft) following superfusion with 
theophylline 50 pM for one or two 5 min periods during the DPCPX washout phase 
with the expected frequency (Ft1) calculated from Ft' = Fo * e( k using the half-life 
of drug washout measured in 6 control slices briefly superfused with DPCPX 5-10 
nM (Ti/2, 80 min) under identical conditions. As can be seen from Fig. 44, the 
observed decrease in spiking frequency is highly significant; this indicates a 
displacement of DPCPX from Al receptors. It also suggests that most of the spiking 
observed during the prolonged washout is due to the persistence of DPCPX at the
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receptors. Interestingly, no decrease in spiking frequency was observed after the 
transient application of adenosine or cyclopentyladenosine (CPA), suggesting that the 
effect was specific for adenosine antagonists. Similarly, a transient suppression of 
spiking using high magnesium concentrations (10 mM), or the excitatory acid 
antagonist kynurenate (1 pM) was without effect o* mjJ ' f rrJ UiMSJ
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Figure 44: Theophylline 50 |iM transiently inhibited DPCPX-induced spiking, indicating a 
displacement of DPCPX from its receptor (A). Re-association takes place from a reservoir within the 
tissue, probably the lipid phase; however, spiking frequency decreases below the value expected from 
washout data (Fig. 36): (B) illustrates the decrease induced by single (lx ) and repeated (2x) brief 
applications o f theophylline (50 pM) expressed as percentage of the expected value (n = 6, *. p < 
0.05, ***: p < 0.001)
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7.2.6 Persistent effects o f DPCPX
The results obtained so far had suggested that of the various factors presumed to be 
involved in the 'persistent spiking' described in the literature for DPCPX, those 
associated with the high lipophilicity and the high affinity for the Al receptor could 
explain most of the prolonged proconvulsant effect. In particular, the results obtained 
with the use of a weak Al antagonist (theophylline) as a displacing agent provided 
clear evidence for the persistent A l blockade as the main cause for the persistent 
interictal-type spiking. However, both the affinity for the lipid phase of the slice 
tissue and the affinity for the Al receptor cannot explain the fact that in some slices, 
spiking did not abate despite the use of a very low concentration of DPCPX. An 
indication of the mechanisms involved in this persistent spiking comes from the 
observation that in some slices which appeared to be physiologically viable according 
to the definition given earlier (no spontaneous epileptiform activity in response to 
DPCPX before stimulation; immediate cessation of 0 Mg++-induced spiking upon 
application of magnesium-containing ACSF; noticeable gap before the onset of 
DPCPX-induced spiking), the transient application of theophylline did not result in a 
decrease in spiking frequency if used after several hours of DPCPX-induced spiking 
(Fig. 45).
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Figure 45: Theophylline 50 pM was no longer able to reduce DPCPX-induced spiking when used 
several hours into the experiment. The spiking pattern observed in a rat hippocampal slice is shown in 
(A); the last section is expanded in (B). For comparison, a trace obtained when theophylline was used 
20 minutes after the induction of spiking is shown in (C).
7.2.7 Persistent effects o f theophylline
Finally, a related observation is shown in Fig. 46. Ault et al. (1987) had described 
persistent spiking after the application of theophylline in a concentration similar to 
that used in the present experiments in the isolated rat hippocampus in vitro. They 
ascribed this phenomenon to a 'kindling' effect. However, it could be demonstrated in 
the present study that this persistent spiking only occurred after the application of 
theophylline when the slice had been damaged in some way during the preparation or 
the subsequent incubation. The state of the slice can be easily assessed by measuring 
the peak height of evoked population spikes in the CA3 subfield over time (not 
shown). By convention, damaged slices are characterised by an unusually large or
07
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small population spike which decreases in size within 20 to 30 minutes; and slices 
which displayed this behaviour usually reacted to the application of theophylline in 
the fashion shown below (Fig. 46).
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Figure 46: Persistence of theophylline-induced spiking in damaged hippocampal slices: persistent 
spiking in rat hippocampal slice induced by brief (5 min, indicated by scale bar) superfusion with 
theophylline 50 pM (A) and similar result in hippocampal slice superfused with theophylline 30 pM  as 
reported by Ault et al. (1987) (B)
The exact mechanism of this damage remains to be elucidated; attempts to reproduce 
this damage by either mechanically squashing the tissue after the slice had been 
placed in the recording chamber, or by introducing a brief (10 minute) period of 
hypoxia, did not result in a different response to theophylline (Fig. 47). However, an 
indication of the mechanisms involved may come from an experiment in which a low 
concentration of adenosine (5 pM) was present for one hour during the washout of 
DPCPX 5 nM. Here, the application of theophylline after one hour resulted in a 
markedly prolonged proconvulsant effect (Fig. 48).
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Figure 47: Repeated brief superfusion of rat hippocampal slices with theophylline (50 pM) did not 
affect the duration of the washout, indicating that this response is a reliable indicator for the 
assessment of the state of the slice. In the example shown, theophylline was applied four times at 30 
minute intervals; the prolonged spiking often observed in response to brief superfusion with 
theophylline in slices judged to be damaged by other electrophysiological means could not be induced 
by acute mechanical injury or brief superfusion with oxygen-free ACSF.
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8 D iscussion  of  Part  T w o
The experiments described in Part Two of this study were performed in order to 
evaluate the role played by adenosine in the modulation of neuronal activity, as a 
better understanding of these effects may allow‘to use the therapeutic potential of 
purinergic drugs in the treatment of epilepsy. By analogy to antiepileptic drugs which 
enhance the action of endogenous GABA, such as the benzodiazepines or the 
irreversible GABA aminotransferase inhibitor vigabatrin, compounds which enhance 
or mimic the effects of endogenous adenosine may in theory be effective antiepileptic 
drugs. However, the mechanisms involved in the seizures generated by adenosine 
antagonists (xanthine-induced convulsions were one of the main reasons for 
suggesting adenosine as an endogenous anticonvulsant) continue to be the subject of 
debate. While it is acknowledged that adenosine and adenosine agonists exert their 
physiological actions in the CNS mainly via G protein-coupled receptors of the Al 
and A2 subtype, the extent and physiological relevance of this modulation is not 
clear: adenosine has variously been suggested to exert a 'basal' inhibitory tone on 
neuronal transmission, or to be brought into play only by pathological processes such 
as ischemia or seizures. Also, the relative importance of the adenosine Al and A2 
receptor subclasses in effects mediated by purinergic drugs is still being discussed. 
Even more intriguingly, some of the features of seizures induced by alkylxanthine 
adenosine antagonists both in the experimental setting and in clinical practice present 
features which appear to be incompatible with a competitive inhibition of 
endogenous adenosine, suggesting either that the modulatory effect of adenosine can 
be downregulated under some circumstances, or that secondary effects are involved 
in the proconvulsant action of alkylxanthines. A better understanding of these effects 
is clearly cardinal to an assessment of adenosine's physiological role and therapeutic 
potential.
8.1 Effects of adenosine
The effects of adenosine on both the neocortical tissue cylinder and the hippocampal 
slice preparation were characterised first in order to be able to assess the extent to
L
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which adenosine can modulate excitatory activity in vitro. It needs to be said that, 
similar to the attempts to use round isolations (both in vivo and in vitro) in the first 
part of this study, the originally planned experimental design (which was to be an 
extension of the method used by Aram et al., 1989) proved not to be practical: it was 
found that the spontaneous spiking frequency of neocortical cylinders, which was to 
be used as the main parameter to test for the effects of various purinergic compounds 
on epileptiform activity, was too variable (see Fig. 35). In the original publication by 
Aram et al. (1989), both the frequency of burst discharges and the number of 
afterpotentials per burst were measured in spontaneously spiking neocortical slices 
superfused with magnesium-free ACSF: the differential sensitivity of both 
parameters to various antiepileptic drugs was used by the authors to elucidate the 
mechanisms contributing to spiking frequency and afterdischarge generation. 
However, this feature (that is, the differential response of two related parameters) 
was felt to be a disadvantage in the present study, as the temporal variability in the 
number of afterdischarges, and their unpredictable effect on spiking frequency 
imposed significant variability on the data (a similar effect was noted by Watts and 
Jefferys (1993): "longer bursts were followed by brief periods of inactivity before the 
re-emergence of short bursts"). Therefore, neocortical cylinders were only used in 
those instances where the modulation of epileptiform activity induced by 
magnesium-free ACSF was to be studied. All other experiments, that is, those 
involving spontaneous spiking induced by other means, were conducted in 
hippocampal slices. Hippocampal slices obtained from adult rats usually display only 
interictal-type activity, whereas both interictal and ictal activity can be evoked in 
hippocampal slices from young (12-18 days old) rats (Fueta and Avoli, 1993).
Three aspects of adenosine's action were studied: the extent to which adenosinergic 
modulation is influenced by the absence of magnesium ions, since magnesium-free 
ACSF was used to induce epileptiform spiking in both the cortex and the 
hippocampus; the response to adenosine under various experimental conditions, such 
as repeated application (to assess desensitisation), osmotic changes, or mechanical 
injury to the tissue; and the basal rate of adenosine production and metabolism.
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8.1.1 Role o f magnesium ions
Adenosine consistently inhibited the 0 Mg2+-induced spiking observed in both 
neocortical cylinders and hippocampal slices in a dose-dependent fashion, although 
the data could not be described by a simple sigmoidal function, suggesting the 
involvement of additional factors such as a high basal adenosine concentration or 
saturable uptake sites; the concentration needed to evoke a half-maximal inhibition 
of spiking induced by magnesium-free ACSF ( I C 5 0 )  was estimated at 88 pM (Fig. 
30). It should be noted, however, that this represents an underestimate due to the avid 
uptake mechanisms for adenosine present in the tissue, which result in a decreased 
concentration in the extracellular space surrounding the receptor. The affinity 
constant of adenosine at Al receptors has been inferred to be very close to that of 2- 
chloroadenosine (2-CA, a non-metabolised analogue of adenosine), i.e. 12.8 nM 
(Bruns et al., 1986); an exact assessment of its potency may be possible in 
hippocampal monolayer slice cultures (Thompson et al., 1992) and, to a lesser extent 
(due to the receptor antagonist activity inherent to most uptake blockers), by using 
dipyridamole or other uptake blocking agents. Interestingly, a tendency towards an 
enhancing effect of adenosine on epileptiform spiking was noticed at low 
concentrations (1 to 10 pM; Fig. 30), which however failed to reach statistical 
significance. It will be discussed in more detail in section 8.2.
When the magnesium concentration of the ACSF , was gradually increased, an 
apparent increase in the potency of adenosine was observed (Fig. 30), in accordance 
with a study by Bartrup and Stone (1988) reporting that the inhibition mediated by 
adenosine may be reduced in magnesium-free solution; this suggested that the 
spiking observed in magnesium-free ACSF may be due in part to the loss of 
adenosinergic inhibition. A low concentration of magnesium ions may influence the 
actions of adenosine by several mechanisms. Mono- and divalent cations can 
modulate receptors by either affecting their conformational states or their coupling 
with second messenger systems. Nanomolar concentrations of magnesium ions 
(which are present even in nominally magnesium-free ACSF due to impurities of the 
salts used) are required for GTPase activity (Gilman, 1987). The magnesium
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dependency of adenosine's effects in the hippocampus has been reported to be due to 
the enhancement of adenosine receptor agonist binding by divalent cations (Yeung et 
al., 1985): magnesium ions are a necessary prerequisite for the induction of the high- 
affinity state of the A l receptor coupled to a G-protein (Goodman et al., 1982) and 
inhibit the coupling of GTP (and therefore the conversion of the receptor to the low- 
affinity state). Indeed, a reduction of the magnesium concentration to 0.5 mM 
decreased radio-iodinated hydroxyphenyl-isopropyladenosine binding to rat brain Al 
receptors by 45% (Stroher et al., 1989), and both Ca2+ and Mg2+ have been shown to 
be necessary for the maximal binding of cyclohexyladenosine in rat cortical 
synaptosomes (Traversa et al., 1990), as well as to obtain the maximum binding of 
R-PLA to A l receptors from rat cortical membranes (Yeung et al., 1987). Parkinson 
and Fredholm (1992), while failing to find an effect on equilibrium binding 
constants, noted that magnesium had pronounced effects on the kinetics of both 
agonist and antagonist binding, reducing both association and dissociation rates. In 
electrophysiological studies, a reduction in the sensitivity to adenosine has been 
observed in magnesium-free medium in the rat hippocampus in vitro (Bartrup and 
Stone, 1988). The residual effects of adenosine in magnesium-free solution may be 
due to the depression of stimulus train-evoked Ca2+
entry (Schubert et al., 1993). Alternatively, the reduced presynaptic sensitivity to 
adenosine in low magnesium medium has been suggested to be due mainly to higher 
amounts of Ca2+ ions entering the nerve terminals (Smith and Dunwiddie, 1993). 
Under these circumstances, the decreased efficacy of adenosine would reflect a 
nonspecific enhancement of synaptic transmission, rather than a direct inhibition of 
its binding to the receptor. It appears likely that both the reduction in adenosine's 
postsynaptic effects (the activation of potassium conductances) and an enhancement 
of activity-dependent presynaptic calcium entry play a role in the observed decrease 
in adenosine-mediated inhibition. The magnesium dependence of adenosine's effects 
was not the subject of the present study; however, it is relevant in so far as 
magnesium-free ACSF was used to induce paroxysmal spiking in some experiments 
performed to assess the mechanism of action of drugs acting at adenosine receptors. 
Magnesium ions may alter the binding of endogenous adenosine and therefore the 
percentage of available receptors; they also affect the gating / voltage-dependency of 
the NMDA receptor channel, and therefore the development of LTP-type effects. The
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influences of these factors are discussed under the appropriate headings in the 
following chapters.
8.1.2 Increased sensitivity to adenosine
An increased efficacy of adenosine was observed when the sensitivity to adenosine 
was compared in whole and freshly subdivided cylinders (Fig. 32). That this is not 
due to permanent changes caused for example by the sectioning of the apical 
dendrites is shown by the finding that cylinders hemisectioned immediately after the 
dissection and incubated for one hour show a lower sensitivity to adenosine 
comparable to that seen in whole cylinders. The results from the differential 
sensitivity to adenosine in cylinders cut during the preparation and cylinders cut 
acutely prior to recording indicate that the heightened reactivity is a transient effect, 
which could be related to an increase of basal adenosine release in response to injury 
(Fig. 49); it confirms the role of adenosine as a protective metabolite.
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Alternatively, the enhanced sensitivity to exogenous adenosine observed in acutely 
hemisectioned cylinders may be related to a swelling of neuronal cell bodies due to 
injury qualitatively similar to that observed in hypo-osmotic solution (Andrew and 
Macvicar, 1994), and would imply that purinergic neuromodulators may be effective 
anticonvulsants in situations where brain oedema or swelling is present. The use of 
hypo-osmolar ACSF revealed an increased excitability of the tissue (Fig. 33) similar 
to that reported by Lochner et a l  (1992) and Saly and Andrew (1993). ACSF 
compositions reported in the literature vary widely; a survey of all papers published 
in Brain Research in 1993 (103 publications in volumes 600 to 632; see Appendix 
A) which mention the composition of the artificial CSF solution used reveals that in 
the hypo-osmolar ACSF used in the present study, only the sodium and chloride ion 
concentrations are outside the normal range (defined as ± 2 SD), resulting in a 
significantly reduced osmolarity. Therefore, the increase in epileptiform activity is 
most probably an osmotic effect. Water retention or water intoxication has been 
reported to increase seizure frequency in known epileptics, and may even precipitate 
seizures in otherwise healthy individuals (Dawson et a l, 1961). Conversely, the 
hypo-osmotic symptoms (restlessness, muscle twitching, seizures) caused for 
example by hypersecretion of antidiuretic hormone or water intoxication can be 
reversed by the infusion of hypertonic solutions or water restriction. Cortical 
excitability could be influenced by the osmolarity of the CSF in several possible 
ways: cell swelling may increase the extracellular resistance so that a voltage 
transient across that resistance (such as those caused by population spikes during 
epileptiform activity) will increase in amplitude (although Saly and Andrew (1993) 
found the EPSP/IPSP sequence evoked from mossy fibres or stratum oriens, resting 
membrane potential, cell input resistance, and the action potential threshold 
measured at the soma to be unaltered by osmotic change). Neuronal synchrony is 
likely to increase through the enhancement of ephaptic field effects. A second factor 
related to cell swelling is that potassium ions released into the reduced extracellular 
space by discharging neurones will be more concentrated. This will depolarise 
surrounding neurones and glia more than if the cells were not swollen (Osehobo et 
a l, 1992), further increasing excitability. Heinemann et a l  (1994) reported that 
epileptiform activity in the hippocampal slice is accompanied by a shrinkage of the 
extracellular space of between 10 and 20%, suggesting that increased excitability and
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cell swelling are positively coupled. In the present study, the use of 10% hypo- 
osmolar ACSF was associated with a transient increase in spontaneous spiking 
frequency in mouse neocortical cylinders by an average of 77%, and a concomitant 
increase in the sensitivity to the anticonvulsant effects of exogenous adenosine. 
Kimelberg et a l  (1990) have speculated that swelling may nonsynaptically release 
amino acids and other potential neuroactive substances, either from surrounding 
neurones or from glial cells; hyperosmotic media were found to inhibit voltage- 
dependent calcium influx and peptide release in Aplysia neurones (Lochner et al.,
1992). The results from the present study (Fig. 33) suggest that the activity of 
exogenous neuromodulators can be enhanced in hypo-osmotic medium; however, 
further research will be required to explain the exact mechanisms of the enhanced 
responsiveness to adenosine observed in acutely hemisectioned cortical cylinders or 
following acute overhydration.
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Figure 50: A comparison of the composition of the hypo-osmolar solution used in the present study 
(filled circles; see also Fig. 33) with ACSF compositions reported in the literature. The unfilled circles 
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vitro mammalian brain slice preparations which were published in the 1993 volumes of the journal 
Brain Research (see Appendix A).
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8.2 Effects of alkylxanthines
An understanding of the mechanisms involved in the effects exerted by adenosine in 
the intact brain is of major importance for the assessment of a possible therapeutic 
role of adenosinergic compounds in the treatment of epilepsy. As stated earlier, the 
involvement of Al receptor blockade has been implied in some models of in vitro 
epileptogenesis. In the present study, three chemically related antagonists at the 
adenosine A l receptor were used in order to evaluate the physiological role played by 
adenosine in normal and 'epileptic' brain tissue: the methylxanthine theophylline (1,3- 
dimethylxanthine), a naturally occurring, non-selective adenosine antagonist and 
phosphodiesterase inhibitor, and the two synthetic alkylxanthine derivatives 
cyclopentyltheophylline (which exhibits 130-fold selectivity for the A l over the A2 
receptor - Bruns et a l,  1986), and DPCPX, one of the most selective (740-fold - 
Bruns et al., 1987) adenosine Al antagonists available to date.
8.2.1 Is the convulsant effect o f DPCPX due to A l  antagonism?
The mechanism by which DPCPX generates epileptiform spiking in the in vitro slice 
preparation is central to the question of the role of adenosine in epileptic seizures. 
While the convulsant effects of alkylxanthines observed in various in vivo and in 
vitro paradigms (including the hippocampal slice used in this study) are well known, 
the use of non-selective adenosine antagonists for the induction of epileptic activity 
failed to conclusively prove an exclusive role of A l receptor blockade in their 
proconvulsant effect. A certain degree of controversy remained, which is echoed in 
several recent papers (McCall et al., 1993; Hornfeldt and Larson, 1994); Dimmock 
and Baker (1994) tested the effects of a novel antiepileptic compound on adenosine 
uptake after stating that "adenosine is considered to be involved in the central actions 
of benzodiazepines (Phillis and O'Regan, 1988a, b); therefore, anticonvulsants that 
bind at benzodiazepine receptors inhibit the action of adenosine". The working 
hypothesis on which the present study was based, namely that the proconvulsant 
effects of DPCPX cannot be caused by a mechanism other than A l receptor 
blockade, was based on the exclusion of several alternative explanations for both the
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generation and the persistence of the epileptiform activity: The effects of 
alkylxanthines on intracellular calcium mobilisation (caffeine modulates the ATP- 
dependent calcium uptake by binding to the endoplasmatic reticulum binding site for 
ryanodine [Sawyonok and Yaksh, 1993]) have only been observed at concentrations 
in the millimolar range. Similarly, an inhibition of phosphodiesterase by DPCPX 
(similar to that which has been postulated for caffeine and related compounds) is 
unlikely, since the maximal inhibition of human platelet cAMP phosphodiesterase at 
a concentration of 100 pM (which represents the limit of solubility for DPCPX) was 
only 31% (Lohse et a l, 1987). In addition, rolipram (a selective phosphodiesterase 
inhibitor) did not affect evoked field potentials in the hippocampal slice (Alzheimer 
et al., 1993), and enprofylline (a phosphodiesterase inhibitor with low affinity for 
adenosine receptors) is far less epileptogenic than theophylline (Czuczwar et al., 
1987). Phosphodiesterase inhibitors are usually central depressants (Beer et al., 
1972), although recent reports (see for instance Chaviez-Noriega and Stevens, 1994) 
have described an excitatory response to bath-applied forskolin (an activator of 
adenylate cyclase) in rat hippocampal slices maintained in vitro (and see below). A 
further argument in favour of A l receptors as the main site of action of the 
alkylxanthines used in this study comes from receptor distribution profiles of the 
main adenosine receptor subtypes: A l receptors are highly enriched in the 
hippocampus (particularly in the CA1 subfield - Onodera and Kogure, 1988), while 
the corresponding A l mRNA is particularly enriched in the stratum pyramidale 
(Johansson et a l, 1993), indicating that A l receptors are predominantly located on 
intrinsic pyramidal cell terminals and dendrites. High-affinity A2a receptors are 
sparse in the hippocampus (Fink et a l, 1992), although Sebastiao and Ribeiro (1992) 
have reported marked and specific excitatory effects of a selective A2 agonist (CGS 
21680, 3-10 nM) on field potentials in the rat hippocampal slice. The largely parallel 
timecourse of the decrease in spiking frequency and the recovery of the inhibitory 
effect of adenosine after the application of CPT or DPCPX (Fig. 39) also suggests 
that the effects of these alkylxanthines are due to the inhibition of endogenous 
adenosine, although the inhibition of adenosine's effects was slightly less marked 
than expected from previously published values (eg., Grover and Tyler (1993) 
reported that adenosine 100 pM depressed EPSP's by 51% in hippocampal slices, but 
only by 9% in the presence of DPCPX 200 nM). Finally, the effects of adenosine
deaminase and DPCPX were shown to be non-additive in several in vitro studies, 
excluding a novel, non-Al mechanism of DPCPX, and substantiating the view that 
A l receptor blockade by DPCPX is necessary for its proconvulsant effect. Adenosine 
deaminase is the enzyme which converts adenosine to inosine; it has convulsant 
effects when applied in vitro, which have been linked to the removal of the 
adenosinergic inhibitory tone; Alzheimer et al. (1993) failed to observe additive 
effects of adenosine deaminase and DPCPX which could have suggested an 
excitatory effects of DPCPX not attributable to interference with an inhibitory 
adenosinergic tone. Similarly, Feuerstein et al. (1988) reported that the effects of 
micromolar DPCPX and adenosine deaminase on 5-HT release were in the same 
order of magnitude. Adenosine deaminase and DPCPX displayed a trend towards an 
additive effect on spontaneous epileptiform activity in the present study (Fig. 40). 
The concentration of adenosine deaminase may have been submaximal, despite the 
fact that 3 units/ml of adenosine deaminase (one unit is defined as the amount needed 
to deaminate 1 pM of adenosine to inosine per minute at 25°C) have been shown to 
result in maximal effects on electrically evoked overflow of tritiated compounds in 
rabbit brain cortex slices (von Kiigelen et al., 1992). An alternative explanation will 
be presented in Section 8.2.4.
In summary, most of the evidence suggests that the proconvulsant effects of DPCPX 
cannot be attributed to a mechanism not linked to an antagonism of endogenous 
adenosine at central A 1-type receptors. However, some aspects of DPCPX-induced 
epileptiform activity appear to be incompatible with the expected response 
extrapolated from results obtained with the less selective A l antagonists theophylline 
and CPT. The main inconsistencies regard the inability of DPCPX to induce seizures 
in vivo (see below), and the remarkably prolonged proconvulsant effect of this 
compound in vitro, which appeared to be independent of a persistent blockade of 
adenosine receptors (Alzheimer et al., 1989): "the spontaneous burst discharges in 
guinea pig hippocampal slices, once induced [by DPCPX], were apparently 
irreversible within the observation period, even after prolonged washout (2-3 hours) 
in normal solution; in contrast, the hyperpolarising action of exogenous adenosine,
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which was substantially reduced by DPCPX, recovered within 30-60 min of drug 
washout, indicating that DPCPX was not irreversibly bound to the A1 receptor".
8.2.2 Onset o f DPCPX-induced spiking
When the ability of adenosine antagonists to induce seizures in vivo is compared to 
their affinity at the A1 receptor, an interesting discrepancy is noted. Despite its 
exceptionally high affinity for the A1 receptor (Kd: 0.42 nM in rat brain membranes - 
Bruns et al., 1987), there have so far been no descriptions in the literature of seizures 
triggered by the administration of DPCPX to animals in vivo: the intravenous 
infusion of DPCPX 100 pg/kg/min over several hours was well tolerated in a 
displacement study in anaesthetised rats (Kuan et al., 1992); bolus intravenous 
injections of DPCPX 0.03 mg/kg (Knight et al., 1991) or 0.1 mg/kg (Knight et al., 
1993) had no discernible effects on mean arterial blood pressure or heart rate in 
anaesthetised rats in studies on the effects of Al blockade on renal function, while 
persistently preventing the bradycardia induced by exogenous adenosine. In a 
behavioural study by Griebel et al. (1991) in freely moving mice, the intraperitoneal 
administration of DPCPX did not produce a caffeine-like motor stimulation in the 
way a non-xanthine, mildly selective triazolo-quinazoline A2 antagonist did. At the 
highest dose (6 mg/kg), slightly decreased locomotion and rearing responses, ataxia 
and lack of co-ordination were noted. Similarly, Dawid-Milner et al. (1994) did not 
record any adverse effects when they analysed the responses to hypothalamic 
electrical stimulation in anaesthetised cats after the administration of DPCPX 
(dissolved in ethanol) at a dose of 3 mg/kg intravenously. This lack of effect is not 
due to a poor blood-brain-barrier penetration; after the intravenous administration of 
DPCPX 50 to 80 nmol to rats, Bisserbe et al. (1992) found a blood/brain 
concentration ratio below one, which is in line with current concepts of blood-brain- 
barrier permeability: Hansch et al. (1968) have suggested that a log P value of about 
2 represents the ideal hydrophobic character for penetration into the CNS.
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The results are mirrored by some studies performed in in vitro preparations. In 
organotypic rat hippocampal slice cultures, Thompson et al. (1992) reported that bath 
application of DPCPX at a concentration of 200 nM did not affect either the resting 
membrane potential or the amplitude of synaptic responses, and Wu and Saggau 
(1994) noted that DPCPX 200 nM did not affect resting calcium levels in 
hippocampal slices. DPCPX was also found to have no effects of its own in a variety 
of experimental paradigms, including calcitonin gene-related peptide-like 
immunoreactivity release in rat spinal cord in vitro (Santicioli et al., 1993), and the 
orthodromically evoked population spike amplitude in rat hippocampal slices 
(Sebastiao et al., 1990). These findings were confirmed in the present study: DPCPX 
at concentrations between 5 nM and 10 pM failed to induce epileptiform spiking in 
rat hippocampal slices. However, spiking was readily induced by DPCPX in slices 
which had been exposed to either brief tetanic stimulation or (in most cases) a 
transient superfusion with magnesium-free ACSF. Conversely, if the stimulus 
preceded the application of DPCPX (by up to 30 minutes), spiking was observed 
within fifteen minutes of the start of superfusion with DPCPX. Interestingly, the 
onset of DPCPX-induced spiking appeared to be qualitatively similar both when 
stimulation preceded the application of DPCPX, or when the inducing stimulus was 
given some time after the application of DPCPX. In particular, a characteristic gap 
was observed before the onset of spiking in both cases (Figs. 37 and 38). This may be 
due to either one of two (mutually exclusive) mechanisms: either the drug is 
prevented from accessing the Al receptor under resting conditions and only binds to 
it after an increase in excitability, or else Al receptors are fully blocked by DPCPX 
without affecting the excitability in the absence of increased synaptic activity; the 
latter would suggest a predominantly presynaptic site of action for the inhibitory 
effects of endogenous adenosine. The two alternatives are denoted by curves (A) and 
(B) in the illustration below (Fig. 51).
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Figure 51: The gap observed before the onset of DPCPX-induced spiking suggests one of two 
mutually exclusive mechanisms for the onset of receptor occupancy: either the proconvulsant effect is 
directly related to A l occupancy, or else adenosine A l receptors can be blocked without affecting the 
excitability of the slice until spiking is induced by the superfusion with magnesium-free ACSF. The 
alternatives are illustrated by the curves shown in B.
An inability to access the receptor could either be due to an unfavourable 
conformational state (implying negative efficacy), or to the presence of tightly bound 
endogenous adenosine. The former has been suggested for many antagonists at 
calcium and sodium channels: lipid-soluble toxin binding to a strongly hydrophobic 
region such as at the boundary between membrane lipids and the membrane-crossing 
segments of the channel is known to be greatly enhanced by all treatments that 
promote or prolong opening of sodium channels, including modification with 
scorpion toxins and repetitive depolarisation. "Evidently the toxins are free to 
approach and leave their binding site from the lipid membrane only while the channel 
is open" (Hille, 1992).
Alternatively, the receptor may be occupied by endogenous adenosine. Adenosine 
binds with nanomolar affinity to the high-affinity state of the A l receptor, and very 
tightly bound endogenous adenosine can prevent DPCPX binding to the receptor, as 
early as 1980, Bruns et al. described that satisfactory binding of radioactively
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labelled cyclohexyladenosine (CHA) to guinea pig brain membranes could only be 
obtained in the presence of adenosine deaminase, and that the irreversible adenosine 
deaminase inhibitor deoxycoformicin reduced CHA binding even further, suggesting 
that endogenous adenosine was generated in sufficient quantity to inhibit agonist 
binding even in washed membranes. Similarly, DPCPX (0.8 nM at room temperature 
for two hours) binding to rat brain slices was markedly increased after pretreatment 
with adenosine deaminase and a,p-methylene adenosine diphosphate (AOPCP), 
which inhibits 5-nucleotidase (Fastbom and Fredholm, 1990); and finally, 
Schiemann et al. (1990) found that DPCPX 20 nM did not access receptors to a 
significant extent in the presence of endogenous adenosine (400 nM) trapped inside 
membrane vesicles. Therefore, an inability of DPCPX to access the receptor (due 
either to the conformational state of the receptor, or to the presence of tightly bound 
endogenous adenosine) could have offered an explanation for the observation that the 
superfusion with magnesium-free ACSF resulted in the appearance of epileptiform 
activity, as the absence of magnesium ions has been shown to affect both the affinity 
of the A l receptor for adenosine, and its conformational state (see above). However, 
GTP binding to the alpha subunit of the G protein, which is necessary for any G 
protein-mediated effects of adenosine, is known to lead to a decrease in the affinity of 
adenosine for the A l receptor. As the functional effects of adenosine agonists are 
mediated by the low-affinity state of the receptor (Tawfik-Schlieper et a l, 1989), 
persistent high-affinity bound adenosine would imply the absence of a basal 
inhibitory purinergic activity; if one accepts the unlikely model of a constitutively 
active A l receptor which is inaccessible to DPCPX, this fails to explain the marked 
effects of exogenous adenosine in all studies listed above, which furthermore could 
reliably be antagonised by DPCPX. Therefore, an inaccessible adenosine receptor can 
not be the sole reason for the lack of effect of adenosine antagonists in vivo and under 
certain circumstances (present study) in vitro.
Finally, the lag period observed before the appearance of DPCPX-induced spiking is 
probably not due to a slow association of the antagonist to the receptors, although the 
time scale was comparable to values reported in the literature (Gerwins et al., 1990), 
the mechanism may even be independent of the alkylxanthine used. This is suggested
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by the fact that a prolonged "rebound secondary afterdischarge" similar to that 
observed in slices preincubated with DPCPX has been observed in vivo after 
electrically induced seizures in rats pretreated with CPT (Dragunow and Robertson 
1987; and see Fig. 52) or with caffeine (Burdette and Dyer, 1987). Also, Peters et a l 
(1984) describe a case of status epilepticus incurred in an elderly patient on 
theophylline medication after the administration of electroconvulsive therapy (ECT): 
the latency between the end of the induced seizure and the appearance of spontaneous 
convulsions was reported to be about 20 seconds. The serum level of theophylline 
was 15.6 mg/ml, suggesting that - because theophylline is approximately 60% protein 
bound - the free concentration was around 9.4 mg/ml, or 70 pM. Status epilepticus 
induced by ECT is exceedingly rare; the causal link to the serum theophylline 
concentration is therefore rather strong. Therefore, although the slow appearance of 
spiking under circumstances of A l receptor blockade is clearly a reproducible effect 
previously described for seizures induced in vivo - and described for the first time for 
an in vitro paradigm in the present study -, it is not likely to be related to the slow 
association kinetics of the Al antagonist DPCPX. Rather, it appears that this may be 
a general feature of alkylxanthine-induced seizures.
10 SGC
Stimulus Primary 
artifact afterdischarge
Motor seizure 
activity
Figure 52: EEG records of vehicle(A)- and 8-cyclopentyl-l,3-dimethylxanthine(B)-treated rats in vivo 
(adapted from Dragunow and Robertson, 1987): after several tens of seconds, a secondary 
afterdischarge develops in methylxanthine-treated animals which converts from partial to generalised.
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The most parsimonious explanation of the data reported both here and in the 
literature is that the postulated "basal purinergic tone" appears to be of minor 
functional importance. The concept of a purinergic tone was based in part on 
estimates of interstitial adenosine levels in the micromolar range. However, the basal 
concentration of adenosine may have been overestimated due to the invasive methods 
(such as microdialysis) used for its assessment. Thompson et al. (1992) have 
suggested that the large amount of tissue damage inherent in the preparation of slices, 
as well as the low rate of exchange between the bathing saline and the extracellular 
space in the centre of the slice, may lead to an aberrant increase in the extracellular 
adenosine concentration. Further evidence for the assumption that adenosine is only 
present at physiologically effective levels under pathophysiological conditions comes 
from the observation that the binding enhancer PD 81,723, which reduced abnormal 
hippocampal activity evoked in low-magnesium ACSF, had no effect on 
hippocampal field potentials under normal conditions (Janusz and Berman, 1993).
Since the antagonism of adenosine receptors has only marginal effects under resting 
conditions, the proconvulsant effect of Al blockade clearly represents a pathological 
correlate of an activity-dependent inhibition mediated by adenosine in response to 
excessive neuronal excitation. Which of adenosine's inhibitory effects is most likely 
to play a cardinal role in this activity-dependent inhibition? Adenosine receptor 
blockade may result in an enhancement of transmitter release, somewhat similar to 
the effects of 4-aminopyridine (4-AP), a blocker of potassium currents, mainly of the 
early transient K+ current or A-current. In fact, adenosine fails to reduce the action 
potential duration in the presence of 4-AP 500 pM, suggesting that it acts on the 
same voltage-dependent 4-AP-sensitive potassium current (Ia ) by shifting the steady- 
state inactivation curve in the depolarising direction (Pan et al., 1994), and like the 
alkylxanthines, 4-AP is a potent convulsant: seizures have been reported after the 
oral administration of 60 mg 4-AP in man (Spyker et al., 1980). In both cases, the 
prolongation of Ca2+ influx through voltage-activated calcium channels results in an 
increased evoked transmitter release, while resting release remains relatively 
unaffected (Thesleff, 1980); the net effect would consist of an increase in excitability,
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rather than an increase in excitation, although the physiologial relevance of these 
findings has been questioned (Hu, 1993). However, while a nonselective 
enhancement of transmitter release may be a powerful proconvulsant mechanism, it 
fails to explain the fact that spiking induced by magnesium-free solution permitted 
the induction of spiking by DPCPX up to 20 minutes later (although presumably not 
hours later, since the dissection procedure, which is also known to result in a 
transient hyperexcitable state of the tissue, did not affect the response to DPCPX). 
The superfusion with magnesium-free ACSF was in most cases discontinued as soon 
as epileptiform spiking occurred, resulting in a total of less than ten interictal-type 
spikes. Such a weak activation is unlikely to result in an increase in excitation strong 
enough to be influenced by a facilitation of synaptic release one quarter of an hour 
later. In fact, the superfusion of slices with magnesium-free ACSF for periods of up 
to one hour did not result in persistent spiking or other signs of persistently increased 
neuronal activity, although spiking was observed to be induced more rapidly during 
subsequent perfusions with magnesium-free ACSF, indicating that some subtle 
change had taken place. A possible mechanism is suggested by the differential effects 
of conventional (high potassium) and excitatory amino acid-induced depolariations 
on intracellular calcium levels: a persistent activation of postsynaptic voltage- 
dependent calcium channels has been described to occur in isolated CA1 neurones 
after the application of excitatory amino acids (Wadman and Connor, 1992) which 
led to a sustained calcium influx into the cell. The spread of a region of elevated 
intracellular calcium towards the soma could be arrested by application of a kinase 
inhibitor, and was dependent on the presence of extracellular calcium. Interestingly, 
the transient elevation of intracellular calcium observed after high potassium-evoked 
depolarisations, which could be repeated many times without apparent potentiation, 
was significantly enhanced after challenge with glutamate: "Applying a same K+ 
challenge to the cell as was given before the EAA [excitatory amino acid] stimulation 
now caused a much larger Ca2+ change. [...] This high K+-protocol could be repeated 
several times without further change to the response. We consistently observed a 
significant augmentation of the responses to K+ depolarisation by EAA stimulus even 
when the persisting effects of the EAA stimulus itself, observed in normal saline, 
were vanishingly small. Repeated K+ depolarisations, on the other hand, did not lead 
to a persistent response, ie. the Ca2+ levels returned to predepolarisation levels or
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below. [...] The application of GABA facilitated the return to low calcium levels." 
(Wadman and Connor, 1992). These observations are remarkably similar to the 
effects described in the present study. If the main physiological effect of adenosine is 
to exert a negative feedback on the persistent activation of voltage-gated calcium 
channels by glutamate acting at NMDA receptors, these findings may allow to 
explain both the failure of DPCPX to induce seizures during physiological brain 
activity, and the observation that this became possible after the activation of NMDA 
receptors by superfusion with magnesium-free ACSF.
The alkylxanthine-induced seizures may therefore represent an activity-dependent 
disinhibition of an adenosine-mediated presynaptic inhibition of excitatory amino 
acid release. The low convulsant (i.e. seizure-inducing) activity of the selective Al 
antagonist DPCPX, which contrasts markedly with the effects of less specific 
compounds such as caffeine and theophylline may be due to the fact that seizures 
induced by the latter may involve mechanisms other than A l receptor blockade, i.e. 
phosphodiesterase (PDE) inhibition, intracellular calcium release or even an 
elevation of the interstitial pH. In that case, theophylline-induced seizures would 
represent a two-stage process - the induction of paroxysmal activity, e.g. through an 
inhibition of cAMP metabolism, and a prolongation of the seizure caused by the 
antagonism of adenosine-mediated inhibition. There is some evidence to support 
such an assumption: in an article on the EEG effects of theophylline medication, 
Shucard et al. (1985), while stating that "the relationship between theophylline 
dosage, serum levels and measures of CNS activity is not a simple one", presented 
data which suggest that the incidence of EEG abnormalities observed in patients 
treated with theophylline is markedly increased (25% vs. 13%) by the concomitant 
use of ephedrine, a non-selective beta-adrenergic compound.
The failure to induce seizures by Al blockade may also offer an explanation for the 
surprisingly high alkylxanthine doses used in some previously published studies: 
after some reports (eg. Dodd et al., 1986) had indicated that drugs such as 
carbamazepine may work by binding to adenosine receptors, Hornfeld and Larson
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(1994) published a study in which they claimed that neither carbamazepine, nor 
cyclohexyladenosine or dipyridamole influenced theophylline-induced seizures at 
clinically relevant doses. However, theophylline was used at doses of up to 6.5 g/kg. 
Hoffman et al. (1993) assessed the effect of pretreating rats with various clinically 
used antiepileptic drugs prior to a constant rate infusion of theophylline base, and 
found that the theophylline concentration at the onset of the first major seizure was 
increased from 285 mg/kg in control animals to 368 and 359 mg/kg after 
pretreatment with diazepam and clonazepam, respectively, whereas phenytoin (8 
mg/kg i.v.) and magnesium sulphate (300 mg/kg i.v.) were without effect. In the light 
of the present study, these theophylline doses would appear to have induced seizures 
by a non-specific mechanism, as the concentration used in the present study (50 pM) 
corresponds to an approximate dose of 20 mg/kg. Similarly, the DPCPX 
concentration (100 nM) used by Alzheimer et al. (1989) may have been sufficient for 
the induction of spiking and the antagonism of the hyperpolarising effects of 
adenosine 50 pM, but supramaximal with respect to the maintenance of epileptiform 
spiking (for which a minimal concentration of 1 to 5 nM was found to be sufficient in 
the present study - Fig. 43).
8.2.3 Duration o f action o f DPCPX: Role o f the lipid bilayer compartment
As discussed in the previous section, the available evidence suggests that the spiking 
observed after the application of DPCPX is directly related to its blockade of 
adenosine A l receptors, at least during the early phase of DPCPX-induced spiking: 
the main mode of action is likely to be an inhibition of the negative feedback exerted 
by endogenously released adenosine on increased calcium entry caused by glutamate 
receptor activation. Several studies have shown that endogenous extracellular 
adenosine levels rise in response to increased neuronal activity. For example, 
glutamate released at excitatory synapses can increase extracellular adenosine by 
acting at both NMDA- and non-NMDA receptors: NMDA-receptor activation results 
mainly in the release of nucleotides which are then hydrolysed to adenosine, while 
AMPA-receptor activation results mainly in the release of adenosine itself (Craig and 
White, 1993). Hoehn and White (1990) have suggested that low level NMDA
158
activation may already lead to full release. In the present study, a
substantial amount of adenosine (estimated at 7 pmol/slice/minute) could be shown 
to be produced by hippocampal slices during a 2 hour incubation period (Fig. 42). 
Similarly, experimental ischemia, or the induction of experimental seizures in 
animals, can cause an increase in extracellular adenosine levels (Schrader et al., 
1980) which is potentiated by adenosine derived from the hydrolysis of activity- 
dependent ATP release. The time scale of the rise in extracellular adenosine 
concentrations is in the range of several tens of seconds, and may be explained by the 
feed-forward inhibition of 5'-ectonucleotidase by both ATP and ADP: this leads to a 
delayed production of adenosine from released ATP, which only reaches significant 
levels once the concentrations of ATP and ADP have fallen substantially (Meghji, 
1993).
A transient block of the control mechanism which limits the extent of excitatory 
responses occurring after NMDA receptor activation should result in an equally 
transient increase in excitation. However, as noted by Alzheimer et al. (1989), the 
spiking induced by DPCPX (which was reported to persist for "the entire observation 
period", i.e. for several hours) appears to be irreversible, despite the fact that a rapid 
recovery of the inhibitory effects of exogenously applied adenosine (Fig. 53, below) 
suggested that the persistent effects of DPCPX were not due to a continuing blockade 
of postsynaptic A l receptors.
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Figure 53: The hyperpolarizing response evoked by the application of adenosine 50 pM, which is 
transiently suppressed after the brief superfusion of guinea pig hippocampal slices with DPCPX 100 
nM, recovers within 60 minutes of washout; the epileptiform activity persists for several hours (data 
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A prolonged drug washout is not an unusual feature when highly lipophilic 
compounds are used; these may wash out slowly due to several reasons. Firstly, the 
dmg may be absorbed to plastic and rubber components used in the experimental 
setup. For the experiments described in the present study, silicone tubing was used; 
and Starke et al. (1978) have conclusively shown in a study on the contrasting reports 
on the effects of dopamine autoreceptor stimulation that silicone tubing can absorb a 
substantial amount of lipophilic drugs, which are then slowly eluted upon washout: 
"After perfusion of silicone tubings with 3H-haloperidol [10 pM] and subsequent 
washing for 18 hours, the radioactivity in the effluent corresponded to a haloperidol 
concentration of 28 nM, showing that [...] in spite of careful and copious washing 
enough haloperidol was retained by, and eluted from, the tubings to interfere 
seriously with [...] the next experiment.". Indeed, a colleague (H. Hosseinzadeh) 
working in our laboratory reported a prolonged (> 2 weeks) effect of a single 
application of DPCPX on extracellular field recordings obtained in rat brain slices.
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This clearly implies that non-absorbent tubing made from materials such a teflon or 
Viton should be used whenever lipophilic compounds are used in order to avoid 
misinterpretations of the results due to a contamination of the setup; this is 
particularly relevant for antagonists, which generally tend to be larger and more 
hydrophobic molecules than agonists. Apart from the absorption to the perfusion 
system, lipid soluble drugs may also accumulate at hydrophobic sites in the slice 
tissue such as proteins and the lipid bilayer of the plasma membrane, as shown in the 
following compartment model:
DPCPX aqueous
tubing, 
plasma membrane
receptor
compartment
If access to the receptor is via the aqueous phase, then non-specifically bound drug in 
the lipid membrane can act as a depot from which leaching into the aqueous phase 
may occur. As absorption at non-specific binding sites is usually relatively rapid, the 
sequestration of drug molecules into the lipid phase should decrease the maximal 
receptor occupancy if the amount of drug delivered to the tissue is limited.
The offset rate is compounded by an additional first-order process, although washout 
takes place eventually. The introduction of a second compartment (the lipid bilayer) 
may also explain the delayed onset of action of DPCPX, which in some cases peaked 
well after the superfusion of the drug was discontinued, although both a 
contamination of the setup and the accumulation at nonspecific binding sites in the 
slice cannot result in drug concentrations at the receptor which are higher than the 
concentration originally found in the perfusing solution if the access to the receptor is 
via the aqueous phase. However, this model would imply features which are 
incompatible with the observed results: in particular, the prolonged washout from the
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receptor compartment would still reflect the degree of A l blockade, suggesting that 
the sensitivity to the inhibitory effects of adenosine should recover in parallel to the 
decay of the frequency of DPCPX-induced spiking; this was not found to be the case 
in the original publication by Alzheimer et al. (1989), although the results could not 
be conclusively reproduced in the present study (Fig. 39; see below for a discussion 
of this discrepancy).
A solution to these and some related questions is suggested by the close correlation 
between the affinities at Al receptors of the three alkylxanthines used and their oil- 
water partition coefficients as reported in the literature: when log Kd was plotted 
against logP, a linear relationship was found (correlation coefficent: r2 = 0.99).
Affinity at A 1 Reference Lipophilicity Solvent Reference
[log Ki [nM]]_______________________ [log P]_________________________________
Alkylxanthine
Theophylline 3.85 Gerwins etal., 1990 -0.126 olive oil Donoso et al., 1994
CPT 1.04 Bruns etal., 1987 2 octanol Bruns et al., 1985
DPCPX -0.25 Bruns et al., 1987 3.6 octanol Bruns etal., 1987
Table 3: A comparison of the affinities of the three alkylxanthines used in this study and their 
lipophilicity (expressed as the logarithm of the partitioning coefficient P) reported in the literature 
revealed a significant correlation, suggesting that their apparent affinity for the A l receptor may to a 
large extent be a function of their accumulation in the plasma membrane.
Despite the fact that the rate of washout depends on the amphiphilicity of the 
molecule rather than its partitioning coefficient, this suggested the possibility that the 
duration of action was governed mainly by the concentration in the lipid phase, and 
prompted the development of a model based on an access to the antagonist binding 
site via the lipid bilayer. Evidence to suggest that some drugs approach the receptor 
in two-dimensional space by first partitioning into the neuronal lipid membrane was 
first described by Kokubun and Reuter (1984) for nimodipine, a 1,4-dihydropyridine 
which blocks L-type voltage-sensitive calcium channels. This route of access is also 
highly likely with other lipophilic compounds such as DPCPX (L. Herbette, personal 
communication), as well as applying to adenosine itself, which is uncharged at 
physiological pH. Adenosine and its synthetic analogues probably cross the cell 
membrane to a similar extent as alkylxanthines; however, adenosine agonists and
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antagonists may bind to different domains of the receptor. This is suggested by the 
observation that preincubation with adenosine agonists offered relatively little cross­
protection against the loss of antagonist binding induced by diethyl pyrocarbonate (a 
histidine-specific reagent), and vice versa (Klotz et al., 1988). Site-specific mutation 
of one of the histidine residues at the binding site decreased antagonist but not 
agonist binding (Olah et al., 1992), and a threonine (Thr-277) residue was shown to 
be important for agonist, but not for antagonist binding (Townsend-Nicholson and 
Schofield, 1994). Modelling studies on drug-receptor interaction (Allende et al.,
1993) also indicate that alkylxanthines bind to a domain which is different from the 
agonist binding domain. This may turn out to be a general feature of 
agonist/antagonist binding; some authors claim that it may not even be valid to 
assume a single pharmacopore for agonist binding (Neve and Wiens, 1995).
The postulated route of access for alkylxanthine adenosine antagonists is summarised 
by the following model:
DPCPX
aqueous
phase
plasma receptor
membrane compartment
An approach to the receptor via the lipid bilayer has two major implications: firstly, 
the biologically active concentration at the antagonist binding site is likely to be in 
equilibrium with the plasma membrane concentration and therefore (depending on 
the partitioning coefficient of the drug) far higher than suggested by the concentration 
in the aqueous phase. The octanol:water partitioning coefficient (a commonly used 
measure of lipophilicity) may even represent an underestimate of the degree of drug 
concentration, as the chemical differences between biological lipid membranes and 
bulk solvent systems can make the latter unreliable predictors of drug concentration 
in the membrane: Herbette et al. (1989) observed a 7-fold higher partition coefficient
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for nimodipine in biological membranes than would be expected from its 
octanol/water partition coefficient
Additionally, the assumption that the affinity constants based on the concentration in 
the aqueous phase are hybrid constants, consisting of the lipid partitioning coefficient 
P and an affinity constant at the antagonist binding site (denoted by Kgff) suggests 
that when the potentiating effect on receptor binding conveyed by the access via the 
lipid phase is taken into account, these 'true' affinity constants may be of comparable 
magnitude for a range of alkylxanthines as different as theophylline, CPT and 
DPCPX (Fig. 54, below).
Theophylline CPT DPCPX
50 pM 100 nM 5 nM
Figure 54: Aqueous concentrations of lipophilic drugs may not reflect their true affinity at the 
receptor if access to the binding site is via the lipid membrane; in that case, the biologically relevant 
concentration is the concentration in the lipid membrane, which can be deduced from the lipid 
partitioning coefficient P. In theory, DPCPX, CPT and theophylline may have broadly similar 
affinities at the adenosine A l receptor.
The exact value of Keff will be rather difficult to assess, as the true partitioning 
coefficient for biological membranes may be different from that obtained in solvents 
such as octanol or olive oil; furthermore, the collision probability for a drug molecule
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in a two-dimensional plane is higher than in a three-dimensional (aqueous) space. 
However, it may offer an explanation for the finding that the affinity of 
alkylxanthines at adenosine Al receptors is to some extent inversely correlated with 
their degree of phosphodiesterase inhibition. For example, enprofylline (3- 
propylxanthine), a potent phosphodiesterase inhibitor, has virtually no adenosine 
antagonist activity, whereas DPCPX has a relatively low affinity for PDE (maximal 
inhibition: 31% - Lohse et al., 1987); caffeine and theophylline display intermediate 
values. An inverse correlation becomes plausible if access to the binding site for 
inhibitors of PDE is assumed to be via the aqueous phase: indeed, PDE are mainly 
found in the cytosolic fraction (Xiong et al., 1995); and the membrane-anchoring N- 
terminal domain of cAMP PDE, which targets this PDE to membranes, can be 
removed without affecting its enzymatic activity (Lobban et al., 1994).
What are the implications of such a model? Firstly, the access route can offer an 
explanation for the way in which adenosine sensitivity appears to recover more 
rapidly than the washout of the convulsant effect. Under circumstances where the 
washout kinetics of a competitive antagonist are governed by the offset rate from the 
receptor into the aqueous phase, addition of an agonist results in a parallel downward 
shift of the dose-response curve, that is, the overall duration of the washout is 
decreased, but the rate of washout remains unchanged. If, however, access to the 
receptor occurs via the plasma membrane, then the degree of receptor occupancy will 
be dictated by the drug concentration in the lipid bilayer. At or below the half- 
maximal effective concentration, the decrease in receptor occupancy will parallel the 
washout of drug from the plasma membrane (with the physicochemical properties of 
the drug molecule determining which of the two is the rate-limiting process); under 
these circumstances, the recovery of sensitivity of the tissue to the agonist will occur 
at a similar rate to the washout of the antagonist. In the presence of a large excess of 
antagonist molecules in the membrane (as is likely to occur with aqueous DPCPX 
concentrations above 50 nM; see Fig. 43), on the other hand, the same agonist 
concentration will have a proportionally smaller effect on the degree of receptor 
binding by the antagonist (and vice versa). The ability to recognise this non-linear 
agonist response hinges on the accuracy with which agonist-mediated changes can be
165
detected. Clearly, the lower the agonist concentration used, the more the timecourse 
of the recovery of agonist-mediated effects will parallel the decline in antagonist- 
induced effects, ie. the washout. Conversely, relatively high adenosine concentrations 
such as those used in Fig. 53 (50 pM) will result in an apparently biphasic recovery 
of agonist-mediated inhibition (Fig. 55, inset; and cf. the return of adenosine-induced 
S-H interval prolongation to 90% of its control value 35 minutes after the application 
of DPCPX to guinea pig atrioventricular nodes, as reported by Dennis et a l , 1992).
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Figure 55: Theoretical calculations show that if drug access to the receptor is via the cell membrane, 
then the solubility of the drug in the aqueous phase can determine the apparent rate of offset at the 
receptor. If the fall in concentration in the lipid phase is monoexponential, then the receptor occupancy 
curves will be sigmoidal; addition of an agonist results in an apparent leftward shift of this curve. The 
curves are based on hypothetical values (ka and k5 at the lipid compartment: 0.6 and 0.02; Kd of 
DPCPX: 5 nM; adenosine concentration: EC95) and are used to illustrate how the sensitivity to the 
inhibitory effects of adenosine and the receptor occupancy may appear to follow different timecourses 
at antagonist concentrations above Kd.
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Thus, to assume the presence of an excess drug concentration in the membrane 
during the initial phase of the washout of lipophilic drugs such as DPCPX allows to 
account for the unusual time course of the recovery of agonist-mediated effects 
reported previously (Alzheimer et a l ,  1989).
Secondly, addition of high concentrations of agonist will displace the antagonist into 
the lipid phase, from where it is free to re-associate with the receptor without 
noticeable loss (this assumes that the concentration of A l binding sites is 
substantially lower than the concentration of non-specific „binding sites“) after the 
washout of the agonist. This could be shown for adenosine (Figs. 39 and 56) in the 
present study: repeated applications of adenosine at a concentration of 100 pM, 
which resulted in a substantial suppression of spiking frequency, did not affect the 
timecourse of DPCPX-induced spiking. A similar mechanism has been suggested to 
occur with salmeterol, a highly selective (32 adrenoceptor agonist which was 
developed in an effort to produce a longer lasting antiasthmatic drug for once daily 
administration (Fitzpatrick et a l, 1990). The selectivity of this compound for p2 over 
Pj adrenoceptors was such that it led to speculation that it may act via a membrane 
perturbation, rather than a direct receptor interaction. Ball et a l  (1991) observed that 
application of 10 nM to guinea pig tracheal rings for 30 minutes resulted in a slowly 
developing relaxation of electrically-induced contractions; upon washout of the drug, 
this relaxant effect persisted for 7 hours without apparent washout. The competitive 
nature of the agonist could be demonstrated by the reversal of effects by a 
competitive antagonist such as sotalol; however, the relaxation was re-established 
upon washout of the antagonist.
Similarly, a transient displacement of DPCPX molecules from Al receptors into the 
surrounding lipid phase by adenosine would account for the observation that the rate 
of washout of DPCPX (taken to parallel the decrease in spiking frequency) was not 
increased by repeated brief applications of adenosine (Fig. 56, below). This could 
have been due to the avid uptake mechanisms which exist for the purine, which mean 
that sufficiently high concentrations may not be achieved at the receptor. The
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removal of the agonist by uptake or hydrolysis could have been avoided by the use of 
synthetic analogues of adenosine such as 2-chloroadenosine or cyclopentyladenosine 
(CPA). Preliminary findings suggest that CPA does not result in a displacement of 
DPCPX in the present paradigm; however, the use of long-acting adenosine 
analogues does not allow to discriminate between a factual displacement of DPCPX 
and a persistent physiological antagonism. Alternatively, the fact that adenosine, 
while being able to prevent the binding of DPCPX in various experimental 
paradigms (see above), was unable to achieve a similar displacement may indicate 
that a large proportion of adenosine Al receptors were converted to the low-affinity 
state by the antagonist.
control adenosine theophylline
[100 pM] [50 pM]
Figure 56: The decrease in DPCPX (10 nM)-induced spontaneous spiking over a 20 minute period 
was not significantly different in either untreated slices or after transient superfusion of adenosine (100 
pM), but was markedly enhanced by transient superfusion of theophylline (50 pM). ***: p < 0.001
Intriguingly, however, a marked reduction in spiking frequency was observed after 
the transient application of theophylline (Figs. 44 and 56). It was known from 
previously published studies that even weak Al antagonists like caffeine are able to 
displace DPCPX to a large extent from its receptor (Deckert et a l , 1993). If the 
hypothesis of a two-stage process of antagonist binding to the A 1 receptor proposed 
in the previous section is accepted, then the finding that adenosine agonists and 
antagonists differentially affect the displacement of DPCPX from the tissue may 
imply that alkylxanthine antagonists compete for DPCPX binding at both specific
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(receptor) and non-specific (membrane) binding sites. Traditionally, non-specific 
binding sites have been defined as the non-saturable compartment in receptor binding 
studies (see e.g. Fig. 57, below).
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Figure 57: Binding of [3H]-DPCPX to rat brain membranes (data from Bruns et al., 1987): at 50 nM, 
nonspecific binding accounts for over 50% of bound radioactivity.
However, the idea that DPCPX is displaced by a nonspecific site interaction 
mechanism receives support from a study by Young et al. (1992) which describe a 
non-specific inhibition of nimodipine binding to its receptor by clofilium (a class IE 
antiarrhythmic) in cardiac sarcolemrn<i membranes. Their results suggest that by virtue 
of their membrane localisation, some amphiphilic drugs can inhibit dihydropyridine 
binding to their receptor site by drug-drug interactions within the membrane.
8.2.4 Persistent effects o f alkylxanthines
The previous sections have described the extent to which the apparent high affinity of 
DPCPX for both the plasma membrane and the adenosine Al receptor may affect its 
actions in nervous tissue. Following the observation that a transient application of an 
antagonist, but not of an agonist, results in a permanent displacement of DPCPX 
from its receptor, a model based on the accumulation of DPCPX in the lipid bilayer
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and its subsequent association with the receptor was developed in which washout is 
determined by the lipophilicity of the compound as well as its affinity for Al 
receptors. The model could be shown to explain the apparent rapid recovery of 
adenosine sensitivity during a prolonged washout described by Alzheimer et al. 
(1989). This section will deal with the implications of the high selectivity of DPCPX 
for A l receptors in an attempt to clarify some observations which are not compatible 
with a purely inhibitory effect of adenosine.
Excitatory effects o f adenosine
There have been occasional reports in the literature of an excitatory effect of low 
doses of adenosine: for example, Garaschuk et al. (1992) described an excitatory 
effect at very low doses of adenosine (between 50 nM and 5 pM) in the absence of an 
A l block. In the present study, a slight excitatory effect was noted at 10 pM 
adenosine, albeit in ACSF containing no magnesium; therefore, the agonist 
concentrations are not directly comparable: adenosine binding to the A l receptor may 
be preferentially impaired by a low concentration of magnesium ions. Snyder et al. 
(1981) reported that low doses of adenosine agonists enhanced locomotor activity, 
and Morgan et al. (1989) described a proconvulsant effect of intraperitoneal 2- 
chloroadenosine, N6-cyclohexyladenosine and NECA on subsequent xanthine amine 
congener-(XAC)-induced convulsions in mice. This fits in with the findings in the 
present study of a trend towards an enhanced spiking, frequency with low doses (10 
pM, Fig. 30) of adenosine, and the rebound phenomenon observed during the wash­
out of adenosine 100 pM (Fig. 31; under control conditions, the interval between 
spike/afterdischarge complexes was characterised by a silent period followed by the 
gradual build-up of excitatory potentials (Fig. 17), whereas the period immediately 
following the application of high concentrations of adenosine was characterised by a 
markedly reduced interval between spike/afterdischarges). Both phenomena have 
also been described by others while this work was in progress: Nishimura et al. 
(1992) described that the population spike recorded in the granule cell layer of guinea 
pig hippocampal slices was depressed immediately after the application of adenosine 
(50 pM), but that after the removal of adenosine from the medium a rebound
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phenomenon appeared which they termed 'post-inhibitory excitation'. As with other 
potentiation-type effects, a vast number of potential mechanisms have been discussed 
for this effect. Nishimura et al. (1992) suggested the involvement of a protein kinase 
C (PKC)-mediated effect, since the excitatory effects of adenosine were blocked in 
the presence of PKC inhibitors such as melittin and polymyxin B. The protein 
kinases C, a group of calcium-dependent protein phosphorylating enzymes of which 
at least seven isoforms have been identified (Nelsestuen and Bazzi, 1991), are 
activated either through Ca2+ ions entering for example through NMDA receptor- 
linked channels, or through the activation of receptors coupled to phosphatidyl 
inositol turnover, such as the metabotropic glutamate receptors. Phosphatidyl inositol 
hydrolysis by phospholipase A results in the production of inositol-1,4,5- 
trisphosphate (IP3) and diacylglycerol (DAG); the former causes a release of Ca2+ 
ions from internal stores (Miyazaki et al., 1992) and the latter is an endogenous PKC 
activator (Nishizuka, 1992). PKC activity rises gradually after transient ischemia 
(Onodera et a l, 1989), and may be associated with LTP. Phorbol esters, which 
stimulate PKC, have been shown to potentiate synaptic transmission in the 
hippocampus (Malenka et al., 1986). Increases in membrane-associated PKC have 
also been observed in hippocampus- (Daigen et al., 1991) and amygdala-kindled rats 
(Beldhuis et al., 1993). PKC activation results in the formation of two membrane- 
associated states (Nelsestuen and Bazzi, 1991); one form needs co-factors, while the 
other forms an irreversible complex with the membrane and its activity does not 
depend on co-factors. Increased PKC activation caused by receptor activation, 
increased Ca[i], decreased protein phosphatase activity (Cohen et al., 1990), or 
formation of PKC activators such as DAG or cis-fatty acids results in 
hyperexcitability of the brain (Kishimoto et al., 1989; Murakami and Routtenberg, 
1986). The PKC-induced hyperexcitability may be mediated through phosphorylation 
of the NMDA receptor. This has been shown to induce a change in the kinetics of 
Mg2+ binding to the NMDA receptor, enabling an activation of NMDA receptor 
channels at more negative membrane potential levels (Chen and Huang, 1992). 
Under these circumstances, Mg2+ is released from the receptor site at about resting 
membrane potential, and PKC activation reduces the indirect inhibitory effects of 
adenosine by reducing the voltage-dependent block of NMDA channels, resulting in 
a lower frequency being required for calcium influx (Ben-Ari et al., 1992). The loss
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of the voltage-dependent magnesium-block means that membrane-stabilising 
modulators like adenosine are less effective in preventing NMDA channel-mediated 
calcium influx. Finally, adenosine and Al agonists, but not A2 agonists, attenuated 
the vasoconstrictor and negative inotropic effects of the phorbol ester PMA (a protein 
kinase C activator) (Lasley et al., 1994).
Also, the fact that stable adenosine analogues (NECA, 2-CA, CHA) were able to 
evoke similar excitatory effects (Morgan et al., 1989) indicates that the excitatory 
effects are indeed mediated by adenosine acting at adenosine receptors, and not an 
effect due to metabolic sequelae of adenosine release (adenosine receptor-dependent 
inhibition of metabolic pathways such as cGMP formation, or an effect of an 
adenosine metabolite), although the reported excitatory effects of both adenosine 
agonists (CHA, R-PIA, CGS-21680, NECA) and antagonists (8-CPT, DMPX, CGS- 
15943, theophylline) in guinea pig superior collicular slices (Ishikawa et al., 1994) 
awaits independent confirmation. The excitatory actions of adenosine at the cellular 
level have been suggested to be due to its differential activity on calcium currents. 
After the observation by Kuroda (1990) of increased presynaptic calcium influx 
following the selective adenosine receptor activation in neuroblastoma cells, Sakurai 
and Okada (1992) described an excitatory response to adenosine in hippocampal 
synapses which resulted in an increased release of glutamate. Subsequently, Mogul et 
al. (1993) found that in acutely dissociated guinea pig hippocampal CA3 cells, 
blocking the A l receptors with high concentrations ofcyclopentyltheophylline (CPT, 
500 pM) unmasked a potentiation of a calcium current by adenosine 50 pM which 
was insensitive to co-conotoxin, but sensitive to co-agatoxin-IVA, suggesting that 
adenosine activates a P-type calcium current. A similar calcium current potentiation 
was observed with N6-[2-(3,5-dimethyloxyphenyl)-2-(2-methylphenyl)ethyl)- 
adenosine (DPMA; 100 nM), a selective A2 agonist, but not with CGS 21680 1 pM, 
a selective A2a agonist. The results suggest that the excitatory effects of adenosine 
may be mediated via A2b receptors. This receptor subtype has a markedly lower 
affinity for adenosine compared to A l, and may therefore have been overlooked in 
functional studies on adenosinergic modulation. A mechanism involving P-type 
calcium channels could also help to explain the observation that pure adenosine
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transport inhibitors like nitrobenzylthioinosine are markedly less potent 
anticonvulsants than dilazep (Murray et al., 1993), which has a similar affinity for the 
adenosine transporter, but additional calcium channel antagonist activities 
(Nakagawa et al., 1986).
DPCPX: a functional A2 agonist?
Conceivably, the excitatory effects of endogenously released adenosine acting at A2 
receptors may be unmasked or enhanced by the selective blockade of A l receptors by 
DPCPX, resulting in an action of DPCPX indistinguishable from that of an A2 
agonist. This hypothesis assumes that the adenosine receptor block exerted by low 
DPCPX concentrations is selective for the Al receptor. Whereas theophylline (Ki at 
A2b: 4800 nM) and caffeine (Ki at A2b: 48100 nM) (Bruns et al., 1980) are 
relatively nonspecific, DPCPX is highly A l specific, allowing endogenously released 
adenosine (see below) to act either at A2a receptors (both the expression of 
adenosine A2a receptor mRNA, and the presence of specific binding sites have 
recently been demonstrated in the hippocampus (CA1, CA3 and dentate gyrus) and 
cerebral cortex (Cunha et al., 1994)) or at the ubiquitous low-affinity A2b receptor, 
whose main pharmacodynamic responses include cAMP generation (Bruns et al. 
(1986) give Ki values for adenosine of 12.8 nM, 37.0 nM and 750 pM at A l, A2a 
and A2b receptors, respectively).
On the basis of previously published results on excitatory effects of adenosine and 
adenosine agonists such as the observation by Garaschuk et al. (1992) of an 
adenosine-dependent enhancement of alkylxanthine-induced excitation in the rat 
hippocampus, theoretical considerations, and the results from the present study, a 
model for the mechanism by which DPCPX may cause persistent proconvulsant 
effects was developed. It incorporates the two characteristic features of the action of 
DPCPX (the prolonged persistence in the tissue due to its lipophilicity, and its 
selectivity), and is based on the following assumptions (see also Fig. 58).
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(i) - the initial proconvulsant effect of DPCPX is an enhancement of excitatory activity 
via a block of A 1-mediated inhibition of (presynaptic) transmitter release triggered 
by other means, and of (postsynaptic) NMDA receptor-mediated calcium currents
(ii) - this proconvulsant effect results in both a prolonged increase in extracellular 
adenosine levels (cf. Fig 42, and a large, protracted calcium influx into the cells
(iii) - the decreased DPCPX-induced spiking upon application of theophylline during the 
early phase is due to a displacement of DPCPX from A l receptors and the cell 
membrane, resulting in an overall decrease in spiking frequency. (The failure of 
theophylline to achieve this effect during the late phase (Fig. 45) in some cases may 
therefore suggest that the spiking is mediated by an effect other than A l blockade)
(iv) - when DPCPX is applied at low concentrations, the concentration of DPCPX at the 
receptors present during the prolonged washout is in the range of selective Al 
blockade, i.e. A2 receptors are still accessible; this would not be the case with less 
selective adenosine antagonists
(vi) - under these circumstances (i.e. blocked Al receptors, accessible A2 receptors, and 
elevated extracellular adenosine levels), DPCPX acts as a functional A2 agonist, 
resulting in increased cAMP levels which lead to further adenosine release
In this model, adenosine released during ictal activity may have excitatory effects at 
A2 receptors which are normally counterbalanced by its activity at A l receptors 
(upper left inset). In the presence of low concentrations of DPCPX (Fig. 58, main 
panel), this excitatory effect may be unmasked due to the Al selectivity, whereas 
theophylline and related alkylxanthines, which are relatively nonspecific adenosine 
receptor antagonists, block both effects (upper right inset).
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From the above, it would be expected that the application of adenosine A2 agonists 
should result in a similarly persistent increase in excitation. Somewhat unexpectedly 
however, direct application of an A2 agonist does not result in prolonged increases in 
excitability: CGS 21680, a highly selective A2a receptor agonist (Hutchison et a l, 
1989), had no proconvulsant effect on status epilepticus induced by electrical 
stimulation in the rat (Young and Dragunow, 1994). In rat hippocampal slices, direct 
bath application of CGS 21680 has been reported to increase the amplitude of 
orthodromically evoked population spikes in a vaguely concentration-dependent way 
(Sebastiao and Ribeiro, 1992); interestingly, however, this potentiation was fully 
reversible upon washout. Similar effects to those observed with the use of A2 
adenosine agonists have been reported for other Gs-coupled systems: although both 
NMDA receptor activation and the intracellular processes initiated by metabotropic 
glutamate receptor activation are clearly involved in the induction of LTP, an 
additional factor is required, as the combination of NMDA and t-ACPD application 
(without synaptic input) were insufficient for LTP induction (Otani et a l, 1993). By 
contrast, co-delivered 1 Hz test pulses allowed the induction of LTP after NMDA 
and t-ACPD application (Radpour and Thomson, 1992).
Adenylyl cyclase activation
A  possible mechanism for these observations is offered by the way adenylyl cyclases 
are activated. Adenylyl cyclases can respond to a wide number of stimuli including 
hormones, neurotransmitters and calcium (Tang and Gilman, 1992), and may play 
important roles for long term adaptive responses in neurones and at synapses. 
Calcium/calmodulin-sensitive adenylyl cyclases such as the type I adenylyl cyclase 
(which is regulated by calcium, G protein-coupled receptors, and protein kinase C) 
could be the main type involved in this kind of plasticity, as it is neurospecific (Xia et 
al., 1993) and expressed in those areas of the brain most commonly associated with 
neuroplasticity, such as the CA3 region of the hippocampus, and the dentate gyrus 
(Xia et a l, 1991). The involvement in LTP and memory is suggested by observations 
with type I adenylyl cyclase-deficient mice (Wu et a l, 1995) which showed markedly 
decreased LTP in response to tetanic stimulation, and an impaired performance in the
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Morris water task. Interestingly, type I adenylyl cyclase (I-AC), which can be 
stimulated by activated Gs proteins in purified enzyme preparations, failed to be 
stimulated by the activation of either beta-adrenergic receptors or glucagon receptors 
in a study by Wayman et al. (1994). However, when intracellular calcium was 
elevated by adding the calcium ionophore A23187 or carbachol, I-AC became 
sensitive to isoprenaline or glucagon, suggesting the need for a synergistic 
stimulation of the enzyme by calcium and G protein-coupled receptors to achieve 
maximum cAMP signals. The effects were quite marked, with A23187 stimulating I- 
AC activity 3-fold, while the combination of A23187 and glucagon resulted in a 90- 
fold increase in cAMP levels. This property has led Bourne and Nicoll (1993) to 
suggest that adenylyl cyclases can function as 'coincidence detectors'.
Similar effects have also been described for other systems: Radpour and Thomson 
(1992) reported that the activation of metabotropic glutamate receptors following 
NMDA activation results in a potentiation which develops slowly over a period of 
tens of minutes, as compared to the few minutes that are required to fully establish 
stable LTP. Direct activation of NMDA receptors through treatment of slices with 
NMDA alone (either by bath application or by iontophoresis) does not produce a 
long-lasting potentiation of synaptic responses (Manabe et al., 1992). Similarly, co­
activation of metabotropic glutamate receptors and beta-adrenergic receptors causes a 
synergistic increase in cAMP formation in the rat hippocampus, which could not be 
achieved by isoproterenol or trans-ACPD alone (Gereau and Conn, 1994). The 
coactivation resulted in a long-lasting (>30 min) increase in cell excitability which 
appears to be due to the activation of cAMP-dependent protein kinase, since it was 
completely blocked by protein kinase inhibitors. The physiological effects of second 
messenger-activated kinases include depolarization and blockade of the Ca++ 
dependent K+ current I a h p  responsible for the slow afterhyperpolarization (Madison 
and Nicoll, 1988), and the decrease of GABAA-mediated chloride influx (Sigel and 
Baur, 1988); at the same time, the target G proteins of both Al and GABAb receptors 
are inactivated by PKC and other second messenger-activated kinases (Houslay, 
1991), possibly by disrupting the coupling of G proteins to calcium channels (Swartz, 
1993).
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As shown in Fig. 58, DPCPX may act in a similar fashion by causing both an 
activation of Gs proteins coupled to A2 receptors (via the activity-dependent increase 
in extracellular adenosine), and an increase in intracellular calcium (via the 
enhancement of synaptic activity through the inhibition of adenosine's inhibitory 
effects at A l receptors); during interictal spiking, large and very rapid decreases in 
extracellular calcium have been observed, which clearly suggest a concomitant 
increase in the intracellular calcium concentration (e.g. Pumain and Heinemann,
1991). The particular significance for the present study lies in the fact that in the case 
of selective Al blockade and subsequent A2 activation, this A2 activation is further 
enhanced by the release of adenosine resulting from the intracellular metabolic 
degradation of cAMP: low concentrations of DPCPX in the presence of increased 
synaptic activity may therefore represent a uniquely powerful stimulus for adenylyl 
cyclase activation. It is conceivable that this mechanism may account for an effect of 
DPCPX observed in the present study, which could not be explained by either an 
artefact (i.e., contamination of the setup) or by persistent A l blockade due to 
accumulation in the lipid phase. As shown in Fig. 44, the application of theophylline 
during the early phase of DPCPX-induced spiking led to a transient suppression, and 
a subsequent significant reduction, of the epileptiform activity, indicating that the 
proconvulsant effect was related to the blockade of A l receptors. However, in some 
slices, no such effect was observed (Fig. 45) when theophylline was applied several 
hours after the induction of spiking by DPCPX, indicating that the spiking during the 
late phase was independent of DPCPX blockade of the A l receptor (the effect was 
apparently specific for DPCPX, as the application of theophylline or magnesium-free 
ACSF for over an hour did not result in persistent activity upon washout (data not 
shown)). If the development of a form of interictal spiking which could not be 
terminated by displacement with theophylline was indeed time-dependent, this may 
be an indication for the proposed second-messenger-dependent mechanism. Indeed, 
although cAMP levels have been shown to rise rapidly in response to receptor 
stimulation, the development of long-term changes in cellular activity is often a 
relatively slow process, requiring a prolonged or repeated stimulation of adenylyl 
cyclase. Nishimura et al. (1992) found that adenosine 100 nM evoked a lasting 
response when applied for 30 minutes, but not when applied for 10 minutes, 
Garaschuk et a l  (1992) obtained a massive (4-fold) increase in excitatory
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postsynaptic currents after the application of adenosine 10 pM in the presence of 
CPT 5 pM for 10 minutes which decreased only slowly over the next 40 minutes. 
The slow onset of cAMP-dependent responses has been suggested to be due to the 
fact that cAMP generated at synapses and the tips of neurites must diffuse back to the 
cell body of the neurone (Bacskai et al., 1993). Alternatively, this slow onset may be 
due to the kinetics of cAMP-activated PKA translocation into the nucleus, as 
Hagiwara et al. (1993) have shown in cultured PC 12 cells that the entry of the PKA 
C subunit into the nucleus occurs over a 30 minute period. C subunit entry into the 
nucleus is then followed by the activtion of transcriptional factors, as reviewed by 
Hunter (1995), pp. 229-230 (and see Fig. 58): "binding of cAMP to the inactive PKA 
holoenzyme, much of which is anchored in the perinuclear region of the cytoplasm 
through membrane-associated anchoring proteins, releases the active C subunit, 
which is then competent to phosphorylate its substrates [...]. A fraction of the C 
subunit population translocates into the nucleus, apparently through passive 
diffusion, where it phosphorylates its nuclear targets. PKA helps its own cause by 
activating an inhibitor of protein phosphatase 1, which is the main phosphatase acting 
on PKA substrates. [...] One of the major nuclear PKA substrates is the transcription 
factor CREB (= cAMP response element-binding protein), which binds to a 
palindromic sequence known as the cAMP-regulated enhancer in cAMP-inducible 
genes. A cAMP-induced gene expression is important in many cellular responses, 
including the establishment of long-term memory. The PKA C subunit 
phosphorylates a single serine residue of CREB, resulting in increased transactivating 
activity."
Protein synthesis has long been suspected to be involved in LTP-type effects: for 
example, Sargent Jones et al. (1992) have shown that the application of the protein 
synthesis inhibitors cycloheximide, anisomycin or puromycin block the maintenance 
(but not the induction) of epileptogenesis induced by electrical stimulation in rat 
hippocampal slices. The involvement of gene transcription in LTP-like mechanisms 
evoked by cAMP-dependent mechanisms was demonstrated by Nguyen et al. (1994) 
who showed that the long-term potentiation produced in hippocampal slices either by 
tetanic stimulation or by application of a synthetic cAMP analogue could be
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prevented by the simultaneous application of the transcriptional inhibitors 
actinomycin D and dichloro-D-ribofuranosyl-benzimidazole. The finding of a critical 
time window in their study (application during the first 120 min following tetanic 
stimulation prevented the induction of LTP, whereas delayed application starting two 
hours after the first tetanus was without effect) is consistent with the recruitment of 
immediate response genes, many of which are expressed between 0.5 and 3 hours 
after LTP induction in the hippocampus (Abraham et a l, 1991). The implication that 
CREB is involved in LTP-type effects is greatly strengthened by results obtained 
with experiments on hippocampal slices from CREB deficient mutant mice, where 
LTP induced by tetanic stimulation decayed to baseline within 90 minutes 
(Bourtchuladze et a l, 1994), even though two other forms of synaptic plasticity 
(paired-pulse facilitation and post-tetanic potentiation) were normal. Remarkably, the 
same cAMP signal transduction pathway, including its nuclear components, seems to 
be required for memory-related functions in a wide variety of species, as long-term 
memory in the fruitfly Drosophila could also be blocked by disrupting CREB 
function (Yin et a l, 1994). Finally, it is of interest to note that in the work by 
Nishimura et a l  (1992) describing a 'post-inhibitory excitation' after the application 
of adenosine which was mentioned earlier, reference is made to the fact that "when 
the periods of application of adenosine were more than 30 minutes, the 
population spike maintained a higher plateau level even after washing the slice for 
two hours. The rebound and facilitating 'post-inhibitory excitation' could be induced 
at all [adenosine] concentrations greater than 10 pM"; they conclude that "whether or 
not the post-inhibitory excitation and excitatory effect of adenosine at low doses are 
mediated by Al or A2 receptors should be further investigated by using specific 
agonists and antagonists".
In summary, it is suggested that DPCPX may act to maximally stimulate neuronal 
adenylyl cyclase by virtue of its selective blockade of Al receptors. Upon an increase 
in excitation, either through electrical stimulation or the removal of extracellular 
magnesium ions, this Al blockade results in both a massive increase in excitation 
and a concomitant elevation of adenosine levels in the tissue. At low DPCPX 
concentrations, this endogenous neuromodulator may then be able to stimulate
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adenylyl cyclase via A2 receptors. The synergistic effects of elevated calcium 
concentrations and Gs activation lead to maximal adenylyl cyclase activity (not noted 
after the direct application of A2a agonists, as shown by Phillis [1990] for 
CGS21680), which is further potentiated by the elevated extracellular adenosine 
levels resulting from cAMP hydrolysis. Elevated intracellular cAMP results in short 
term changes such as increased synapsin I phosphorylation at synaptic terminals, and 
in the transcription of genes involved in long-term changes in cellular excitability via 
a PKA-mediated activation of transcription factors at the level of the soma. The time- 
course of PKA activation, and the finding of a critical time window for the induction 
of persistent LTP (Nguyen et a l, 1994) suggest a possible mechanism by which 
DPCPX (a long-acting, selective A l blocker) may activate a persistent increase in 
excitability.
Epilepsy models and increased cAMP levels
Cyclic AMP-mediated effects have previously been implied in excitability changes 
(e.g. the down-regulation of the fast desensitizing glycine current in hypothalamic 
neurons of the rat - Agopyan et al., 1993), behavioural arousal, and synaptic 
plasticity underlying learning and memory. The fact that Gs-stimulated adenylyl 
cyclase needs additional factors (increased intracellular calcium) for maximal 
activation, and that the effects are in part mediated by a slow process involving 
protein transcription, may explain the difficulty in establishing unambiguously that 
modulation of neuronal excitability is mediated by protein phosphorylation. In fact, 
while phosphorylation-dependent modulation of ion channels from the brain have 
been demonstrated in lipid bilayers and expression systems (Reinhart et a l, 1991), it 
has been difficult to show that protein phosphorylation actually mediates transmitter 
effects on neuronal excitability in the central nervous system (Pedarzani and Storm,
1993), or even to unambiguously establish the role of cAMP in long-term increases 
in excitability: LTP-inducing tetanic stimulation does not result in a measurable 
increase in cAMP in hippocampal slices (Frey et a l, 1993), suggesting that any 
increases may be highly localized. However, recent advances in the development of 
specific protein kinase and phosphatase inhibitors, and the use of more physiological
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models to include several aspects of neuronal activity involved in the generation of 
long-term changes in excitability, should provide detailed insights into the way these 
changes are mediated. The fact that these pathways exist in adult brain tissue also 
suggests an involvement in physiological brain function; this is further indication for 
the similarity between physiological changes in synaptic plasticity {ie. learning and 
memory; the underlying assumption being that memories are stored in nerve 
networks through changes in the strength of synapses) and abnormal changes leading 
to excessive activity and the ability to generate seizures.
Strong evidence for a role of G protein-mediated effects on cellular excitability stems 
from the animal models of epilepsy developed by JG Jefferys and his co-workers 
using the application of minute quantities of cholera or pertussis toxins to the brain. 
These models differ from commonly used models in that their main action is on G 
proteins and second messenger systems, rather than directly on synaptic transmission, 
as is the case with the acute application of penicillin to block synaptic inhibition (Part 
One of this study, in vivo), or the lowering of extracellular magnesium concentration 
to increase excitatory synaptic transmission (Part One, in vitro). However, they are 
functionally similar to the potent adenylyl cyclase activation postulated to be induced 
by DPCPX, as both cholera toxin (which permanently activates Gs proteins) and 
pertussis toxin (which acts by inhibiting Gi proteins) shift the balance towards an 
activation of second messenger-mediated pathways. Cholera toxin injections into 
various brain regions (Watts et al., 1993; Williams, et al., 1993) cause long-lived 
epileptic foci which generate interictal discharges and brief epileptic seizures 
intermittently over many days; the A subunit of the toxin which, when introduced 
into the cell, stimulates adenylyl cyclase, is probably responsible for this effect. 
Cyclic AMP accumulation has been observed to occur; the prolonged duration of the 
epileptic syndrome most likely reflects the sustained elevation of cAMP due to the 
permanent ADP ribosylation of stimulatory G proteins (Gs). The permanent 
activation is terminated only by the turnover of the G proteins in the membrane. 
When analysed in vitro, the focus is found to extend around 2 mm around the 
injection track. The main difference found intracellularly is an impairment of 
potassium current-mediated accommodation of action potential discharges (Watts et
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al., 1993): cAMP has been demonstrated to depress the slow afterhyperpolarisation 
in hippocampal neurones (Madison and Nicoll, 1986).
Similarly, an electrical stimulus given to rats pre-treated three days prior to 
stimulation with pertussis toxin (a compound which inactivates Gi proteins) resulted 
in status epilepticus, suggesting that impairment of G protein-linked receptors could 
be involved in the development of status epilepticus. The blockade of A l receptor- 
activated potassium channels appeared not to be involved in this effect, as phaclofen 
(an antagonist at GABAb receptors coupled to the same subset of K+ channels as Al 
receptors) failed to induce status in this model (Young and Dragunow, 1994). This 
increase in excitability, or susceptibility to seizures, may be related to other 
frequently used epilepsy models: for example, elevated cAMP levels have been 
reported in some experimental models of epilepsy such as seizures induced by FeCl2 
injections into the sensorimotor cortex (Hattori, 1990).
Persistent effects o f theophylline
As mentioned earlier, the response of hippocampal slices to brief superfusions with 
theophylline (50 pM) was used routinely to assess the state of the slice. It could be 
shown that slices judged to be electrophysiologically 'healthy' by other means 
invariably showed a rapid decline in spontaneous spiking during the washout of 
theophylline; spiking usually stopped completely within ten to 15 minutes. This did 
not change after repeated applications of theophylline (Fig. 47), even if slices had 
been mechanically injured or exposed to brief episodes of low oxygen. 'Damaged' 
slices on the other hand were characterised by persistent spiking. This long-lasting 
effect, which was similar to that described for DPCPX in hippocampal slices, and to 
the clinical observations of theophylline-induced seizures refractory to standard 
antiepileptic treatment (see below), was also noted by Ault et al. (1986, 1987), who 
reported persistent spontaneous bursting after the application of theophylline (30 
pM), but assumed this to be a general property of theophylline: "this effect did not 
reverse during 15-20 min of washing the slices with theophylline-free medium,
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suggesting that the slices were 'kindled' ", in analogy to the long-lasting or even 
permanent increases in CNS excitability which can be experimentally produced in 
previously healthy animals by repeated electrical stimulation (Goddard et a l, 1969). 
This results in progressive development of electro-encephalographic and behavioural 
epileptiform manifestations, such that, for example, a behavioural seizure is readily 
evoked by stimulation of previously kindled rats after a period of three months 
without stimulation; kindled brains retain a state of excitability to stimulation which 
may last for the entire life of the rat. The cellular and/or molecular mechanisms 
underlying establishment and particularly maintenance of the kindled state are still 
unclear (Beldhuis et a l, 1993), although some indication comes from the observation 
that protein synthesis inhibition with cycloheximide, anisomycin or puromycin 
blocks the maintenance, but not the induction of epileptogenesis in rat hippocampal 
slices by electrical stimulation (Sargent Jones et a l, 1992).
It is difficult to assess the reasons for the prolonged epileptiform spiking observed in 
response to theophylline, as it was found to be impossible to mimick the damage by 
experimental procedures. Cyclic AMP-mediated effects may be involved, since the 
application of a low concentration of adenosine (5 pM) for 60 minutes during the 
washout of DPCPX (10 nM) resulted in a massively prolonged duration of action of 
theophylline, suggesting that the combined administration of DPCPX and adenosine 
caused an increase in excitability similar to that observed in 'damaged' slices. 
However, this is rather tentative, since the persistent spiking observed after the 
administration of theophylline in damaged slices (Fig. 46) may be due to any of a 
number of possible mechanisms which increase the excitability of the slice. Several 
recent reports have focused on the role of NMDA channels in anoxia-dependent LTP. 
A second mechanism for increased excitability after damage is an alteration in the 
response of ATP-sensitive potassium channels. Ocana and Baeyens (1994) reported 
that antinociception produced by R-PIA in mice was inhibited by the KATP channel 
blockers gliquidone > glipizide > glibenclamide, increased by the KATP opener 
cromakalim, and not affected by the potassium channel blockers 4-aminopyridine and 
tetraethylammonium.
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Independently of the exact mechanism resulting in this exaggerated response to 
theophylline, these experiments may be regarded as a useful test for uncovering a 
state of abnormal excitability: in this view, the persistent spiking reported by Ault et 
al. (1987) would not represent a 'kindling', i.e. causative, effect of theophylline, but 
the unmasking of a 'kindled' state of the brain tissue by theophylline. Similarly, the 
uncovering of an increased excitability by theophylline may be the reason for the 
idiosyncratic nature of theophylline-induced seizures in the clinical setting. 
Theophylline is widely used as bronchodilator despite its relatively narrow range of 
therapeutic plasma concentrations. One of the most serious manifestations of chronic 
theophylline toxicity is the occurrence of generalised seizures. These have frequently 
been reported to be refractory to standard treatment with anticonvulsant drugs 
(Yamell and Chu, 1975; Zwillich et al., 1975; Nakada et al., 1983; Peters et al., 
1984), and often result in either permanent neurological damage or death. Although 
early reports suggested that these convulsive episodes only occurred in the high 
(toxic) dose range, recent reports indicate that seizures may occur within the 
therapeutic range or even below (Bahls et al., 1991). The fact that theophylline- 
induced seizures are associated with a wide range of plasma theophylline 
concentrations indicates that the pharmacodynamics of theophylline neurotoxicity 
may depend on variables such as pathophysiological conditions and concomitant 
drug therapy, and many other variables that are as yet unrecognised: no causative 
lesions and no prior history of epilepsy were found in five out of 14 elderly patients 
who died after status epilepticus which occurred during theophylline therapy (Mori et 
a l, 1992; status epilepticus is a life-threatening condition characterized by 
unremitting seizure activity, which usually does not begin as an unlimited seizure, 
but rather builds up gradually from initially discrete seizures, suggesting a failure of 
endogenous seizure-terminating systems). Further evidence for the idiosyncratic 
nature of these seizures is the fact that the convulsions observed in the presence of 
methylxanthines do not invariably lead to an entry into status epilepticus, but instead 
may be self-limiting. This is observed both with ECS treatment (studies reporting the 
use of caffeine to prolong electroconvulsive shock treatment include Coffey et al.9 
1990; Cantu and Korek, 1991; Francis and Fochtmann, 1994; Lurie and Coffey, 
1990; and Rasmussen and Zorumski, 1993), and in accidental poisoning: in a recently 
reported case, Wiirl (1994) described an extremely brief, spontaneously subsiding
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tonic-clonic seizure in a patient who had ingested 500 g of ground coffee beans, 
resulting in caffeine plasma levels of 29 pg/ml.
These clinical reports of a highly variable response to theophylline (ranging from a 
prolongation of induced seizures to life-threatening status epilepticus) and the results 
from the present study (see Fig. 46) suggest that alkylxanthines may contribute to 
paroxysmal activity in one of two (not mutually exclusive) ways: either by enhancing 
neuronal activity through the inhibition of adenosine-mediated effects on transmitter 
release and the postsynaptic membrane potential, or by unmasking an underlying 
brain dysfunction. Whether the latter is related to the postulated second messenger- 
induced changes triggered by the activation of A2 receptors as discussed in the 
previous section remains to be clarified.
Conclusion
The present study has attempted to elucidate some of the physical (connectivity of 
neurones) and biochemical (cellular excitability) requirements for the generation of 
epileptiform seizures and ultimately, for epilepsy. It could be shown that the cortical 
tissue dimensions required for epileptiform activity can be surprisingly small, and do 
not require the inclusion of either a specific cortical layer or of a presumptive 'basic 
cortical module' such as the barrels found in rodent primary somatosensory cortex. 
Also, the continuing debate on the role of third-messenger mediated effects in LTP- 
type mechanisms, and in particular of methylxanthine-mediated seizures ("caffeine 
lengthens the duration of convulsions [but] the mechanism of caffeine's effect is 
unknown" - McCall et al., 1993), may be due to a combination of factors. Firstly, 
pharmacological blockade of the adenosine Al receptor in intact brain tissue does not 
necessarily induce epileptiform activity. While the present studies do not allow to 
discriminate between an inaccessible Al receptor and the lack of a physiologically 
relevant adenosinergic inhibitory tone as the reason for the inability of DPCPX to 
induce epileptiform spiking both in vitro (Chapter 7) and in vivo (see Chapter 5), they 
do suggest that the marked increase in interstitial adenosine levels under pathological 
circumstances plays an important role in counteracting glutamatergic/cholinergic
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excitation. The concept of a basal 'purinergic tone' may have been based on 
overestimates of extracellular adenosine concentrations obtained by biochemical ex 
vivo techniques or invasive sampling procedures; this has recently been supported by 
an electrophysiological study (Dunwiddie and Diao, 1994). Alternatively (and based 
in part on the observation that the focal application of AOPCP results in severe 
seizure activity in the rat - Zhang et al., 1993), the A l receptor may be occupied by 
tightly bound endogenous adenosine, which displays nanomolar affinity towards the 
high-affinity state of the Al receptor. This, however, leaves open the question as to 
which configuration of the agonist/receptor/G protein complex is involved in the 
effects mediated by adenosine. Secondly, while it is feasible that long-term blockade 
of A l receptors may cause persistent changes in excitability by a mechanism outlined 
in the previous section, the main reason for the persistence of seizure-like activity 
following A l receptor blockade (such as, for instance, status epilepticus during 
theophylline therapy; or the persistent spiking in hippocampal slices described by 
Ault et al., 1987; or the 'late1 component of DPCPX-induced spiking shown in Fig. 
45) is probably the unmasking of an underlying neuronal dysfunction. Thirdly, it 
could be shown that the timecourse of DPCPX-induced epileptiform activity can be 
adequately explained by assuming that methylxanthines access their binding site via 
the plasma membrane. The resulting 'depot action' of the drug could be shown to 
account for both the prolonged effects of DPCPX, and for the apparent rapid 
recovery of agonist-mediated inhibition. Intriguingly, the differential effects of 
adenosine receptor agonists and antagonists on the washout of DPCPX may indicate 
that binding of alkylxanthines to the A l receptor, involves a two-stage process: 
anchoring of the molecule within the plasma membrane, and occupation of the 
binding site on the receptor. The involvement of both non-specific (membrane) and 
specific (receptor protein) binding components has recently been suggested for 
dihydropyridines (Young et a l, 1992); the present study may furnish the functional 
evidence for the proposed mechanism of binding.
The final chapter represents a brief discussion of the potential of purinergic 
compounds as antiepileptic drugs, and suggestions for further studies on the 
observations discussed in the previous sections.
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9 Th erapeutic  use  o f  pur in er g ic  co m po u nd s
As changes in adenosinergic systems have been implied in the pathophysiology and 
biochemistry of conditions as diverse as anxiety and sleep disorders, psychosis, 
neurodegenerative pathology, cerebral ischemia and convulsions (Bisserbe et a l,
1992), adenosine or related compounds could potentially have a wide therapeutic 
scope. Furthermore, several adenosinergic drugs are approved for human use; 
adenosine for example has already been licensed for clinical use in several European 
countries: it is currently one of the most effective drugs for the treatment of 
supraventricular cardiac arrhythmias in juvenile patients (Clarke et al., 1987).
As far as epilepsy is concerned, the depressant action exerted by adenosine upon 
central neurones may enable endogenous adenosine or a related compound to act as 
an antiepileptic agent. Several lines of evidence support this: first, brain levels of 
adenosine increase within seconds following the onset of experimental seizures 
(Schrader et a l, 1980). Second, adenosine, its analogues and adenosine uptake 
inhibitors are effective in decreasing epileptiform activity in both in vivo and in vitro 
models of epilepsy (Barraco et a l, 1984, Ault and Wang, 1986; but cf. the lack of 
effect of R-PIA on strychnine- and pentylenetetrazole-induced convulsions at doses 
which exhibited marked locomotor depressant effects (Snyder et a l, 1981)), while 
adenosine antagonists possess potent convulsant activity, as discussed in this study. 
Third, theophylline-induced increases in cyclohexyladenosine binding in the brain 
were found to parallel an increase in seizure threshold in rats (Szot et a l, 1987). 
Finally, while adenosine inhibits synaptic transmission at virtually all excitatory 
synapses in the hippocampus, it does not inhibit transmission at GABAergic synapses 
(Yoon and Rothman, 1991; Lambert and Teyler, 1991; but cf. O'Regan et a l, 1992). 
How likely is the development of novel antiepileptic drugs based on purinergic 
mechanisms?
Owing to the high density of peripheral receptor sites, it may not be feasible to use 
either adenosine (which shows poor blood-brain-barrier permeability [Berne et a l,
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1974] and has an extremely short half-life) or adenosine agonists for chronic 
administration. Besides their peripheral side-effects such as hypotension, adenosine 
agonists also have severe effects on psychomotor performance and produce marked 
sedation (Ahlijanian and Takemori, 1986) and myasthenic effects; this makes them 
unsuitable for chronic (prophylactic) administration. Also, maintaining epileptic 
patients continuously on a prophylactic dose of an A l agonist could only work if 
tolerance did not develop to the agent. However, there is evidence that 
desensitisation to the effects of Al agonists occurs with prolonged exposure: chronic 
adenosine agonist administration was found to lead to relatively rapid desensitisation 
of the A l receptor-adenylate cyclase system (Parsons and Stiles, 1987). The 
desensitisation may occur at either the A l receptor itself or at the level of the G 
proteins. A l receptor density has been found to be reduced after prolonged R-PIA 
exposure as revealed by receptor binding assays (Green et a l, 1990), and the 
percentage of Al receptors in the high-affinity state was also reduced after the 
desensitisation with PIA (Ramkumar et a l, 1991). Because the high-affinity state is 
thought to occur when the receptor is attached to its G-protein, desensitisation could 
be the result of depletion of the G proteins or failure of the G proteins to couple 
properly to the receptor. Indeed, reduced levels of the three alpha subunits of Gi 
protein have been reported by Longabaugh et a l  (1989) in the A l receptors of rat 
adipocytes desensitised by R-PIA.
For these reasons, antiepileptic drug development has recently begun to focus on 
agents which potentiate the action of endogenously released adenosine and therefore 
may be a way of limiting seizure duration. These include substances such as 
soluflazine (Boissard and Gribkoff, 1993) and other adenosine uptake inhibitors, or 
blockers of enzymatic degradation: while phosphorylation of adenosine by the kinase 
appears to predominate under normal physiological conditions, adenosine deaminase 
contributes significantly to adenosine degradation under pathophysiological 
conditions such as ischemia or hypoxia (Zhang et a l, 1993); therefore, adenosine 
deaminase inhibitors may be one possible way of enhancing the protective effect of 
adenosine, particularly since re-uptake of adenosine generated from the activity- 
dependent co-release of ATP with glutamate is quantitatively more important than
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the block of release via the bi-directional carrier. Recently, the adenosine binding 
enhancer PD 81,723, which is thought to allosterically modify the Al receptor (Bruns 
and Fergus, 1990), has been reported to enhance adenosine's physiological activity in 
isolated guinea pig hearts (Kollias-Baker et a l, 1994). This has been suggested to be 
due to a stabilization of the receptor-G protein interaction in the presence of agonists, 
thus providing a site- and event-specific potentiation of the effects of endogenously 
released adenosine. Protective effects in the CNS remain to be demonstrated; as PD 
81,723 may act by stabilizing the high-affinity (G-protein bound) state of the Al 
receptor, the effects on adenosine binding may be more pronounced than the 
enhancement of its G protein-mediated effects.
Alternatively, upregulation of adenosine Al receptors in response to chronic 
treatment with low-dosed Al antagonists may exert a protective effect, as suggested 
by Rudolphi et a l  (1989) and by Pagonopoulou (1993). Long-term administration of 
caffeine results in significant habituation to its behavioural effects, and plasma levels 
of caffeine 98 pM and theophylline 56 pM have been observed to be well tolerated in 
rats after long-term treatment (Johansson et al., 1993). The exact mechanism is 
unknown, but has been proposed to be independent of mRNA upregulation and 
possibly involves a redistribution of adenosine receptors from the outer membrane 
into cytosolic vesicles. Whereas a desensitization of the A 1-adenylate cyclase system 
is observed upon chronic exposure to R-PIA (Parsons and Stiles, 1987), Ramkumar 
et a l  (1988) have reported a Gi upregulation in rat. cerebral cortex (determined by 
pertussis toxin-mediated labelling) after chronic caffeine treatment. A variation in Al 
receptor/G-protein coupling, reflected in a decreased potency of GTP in shifting 
high-affinity sites to low-affinity, has been observed after chronic treatment with 
theophylline (Fastbom and Fredholm, 1990). Intriguingly however, patients who 
chronically receive theophylline generally will have greater manifestations of toxicity 
at comparable toxic levels than those patients who have achieved that same level due 
to an acute exposure (Olson et a l ,  1985); this may represent further evidence for the 
differential effects of methylxanthines on seizure initiation (by an adenosine Al 
receptor-independent mechanism) and augmentation (through the blockade of Al 
receptors).
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Independently of the mechanisms involved, an assessment of the value of 
prophylactic treatment with agents which enhance the actions of endogenous 
adenosine by one of the mechanisms discussed above (adenosinergics, binding 
enhancers/uptake inhibitors, or A l receptor upregulation) depends on whether 
adenosine is a tonically acting 'endogenous anticonvulsant', or whether its effects are 
confined to ongoing seizures, i.e. if adenosine was brought into play as an 
anticonvulsant only by the seizure itself (as suggested by During and Spencer, 1992). 
The results from the present study suggest that the latter may be the case. In line with 
these considerations is the fact that an inhibition of the 'purinergic tone' often results 
in significant increases in seizure duration without affecting the seizure threshold: 
McCall et al. (1993) found that caffeine (242 mg intravenously) did not change the 
convulsive threshold in 12 patients undergoing electroconvulsive therapy for major 
depression, while reliably lengthening seizure duration (and see Shapira et al., 1987). 
Similar observations have been observed by a number of other groups: for example, 
Krahl et al. (1995) reported that afterdischarge threshold and behavioural seizure 
stage in amygdala-kindled rats were not affected by an adenosine agonist (metrifudil) 
which significantly reduced afterdischarge duration, and Albertson et al. (1983) 
noted that "despite large increases in afterdischarge durations seen with both 
threshold and suprathreshold amygdaloid stimulation [in kindled rats], no change in 
seizure threshold was noted after aminophylline [100 mg/kg i.p.]". The main 
implication from the present study would appear to be that an adenosinergic basal 
tone is indeed of minor importance under resting conditions, but that adenosine may 
be able to limit the sequelae of NMDA receptor activation. Clinically therefore, 
purinergic drugs would be expected to contribute mainly to the limitation of 
epileptiform activity, although there is evidence to suggest that adenosinergic 
mechanisms may only play a relatively minor role in this respect: White et al. (1993) 
have claimed that NMDA activation leads to a loss of adenosine efficiency because 
the requirements to overcome the magnesium-block decrease, leading to a decreased 
effect of hyperpolarising agents. Secondly, the fact that seizures occurring in the 
presence of high methylxanthine levels are self-limiting in most cases {e.g., Wiirl,
1994) suggests that adenosine-mediated inhibition is not the main mechanism 
involved in the termination of epileptic convulsions. Also, the potential involvement 
of second-messenger evoked effects implied by recent reports of excitatory effects of
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adenosine and the activation of adenylyl cyclases would suggest that while the A l- 
mediated inhibition of these mechanisms may be important for the normal 
functioning of the brain, a failure of this inhibition may induce irreversible changes, 
implying that adenosinergic compounds may only be of use within a narrow time 
window during the onset of paroxysmal activity. Indeed, epilepsy itself may be 
caused by mechanisms similar to those involved in the second-messenger mediated 
excitation described in this study. Therefore, a study of these mechanisms, rather than 
of the balance between inhibitory and excitatory synaptic transmission, may be of 
particular relevance to the understanding of human idiopathic epilepsy.
An entirely different approach to the therapeutic use of purinergic mechanisms may 
involve the potentially anticonvulsant effects of A l blockade in absence seizures. 
One of the most disabling aspects of epilepsy is the unpredictability of individual 
seizures, despite the fact that numerous studies now show that seizure occurrence is 
not a random process. An examination of the behavioural and environmental settings 
in which seizures occur and of the associated cerebral physiology indicate that, at 
least for certain common types of epilepsy, clinical seizures occur at periods related 
to the sleep-wake cycle. In petit mal epilepsy, a remarkable suppression of seizure 
discharges during rapid-eye-movement (REM) sleep, and an augmentation of spike 
activity in these patients during non-REM sleep was reported
Rodin (l984). Adenosine acting at A l receptors, and GAB A 
acting at GABAb receptors converge in part on identical effector pathways 
(Thompson et a l, 1992). GABAB-mediated de-inactivation of low-threshold calcium 
currents through late inhibitory postsynaptic potentials from reticular thalamic 
neurones has a marked effect on rhythmical spindle activity (Destexhe and 
Babloyantz, 1993) in thalamocortical neurones. A l receptor-mediated decreases in 
the hyperpolarization-activated cation current I h  (Pape, 1992) via a decrease in 
intracellular cAMP increase the amplitude and duration of strong membrane 
hyperpolarisations, thereby also promoting spindle oscillations in the thalamus. A 
similar oscillation in thalamocortical afferents has been suggested to be the 
mechanism underlying absence seizures (Steriade, 1990). The involvement of 
adenosine in sleep and EEG arousal (Rainnie et al., 1994) and the convergence of
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GABAergic and adenosinergic mechanisms in those pathways involved in 
thalamocortical spindle generation would therefore suggest that in these patients an 
intriguing effect of Al blockade, as well as the use of orally available GABAb 
antagonists (Olpe et a l, 1993), might be the suppression of petit mal-type fits, 
although a recent report (Ulrich and Huguenard, 1995) suggests that adenosine may 
negatively affect the amplitude rather than the frequency of thalamic oscillations. It 
may therefore be of interest to study the effects of adenosine A l antagonists such as 
theophylline on the EEG of patients suffering from absence (petit mal) epilepsy, 
using methods similar to those described by Shucard et al. (1985).
Further studies 
The following points are suggested for further studies:
(a) the involvement of Al receptor blockade in the initiation of seizures was assumed 
to be minimal in the present study. Experimentally, this may be shown by assessing 
the seizure threshold to electrical stimulation in the presence of a high level of 
DPCPX in vivo. It is predicted that the seizure threshold should be unchanged in 
either the presence or absence of DPCPX, whereas the time to onset, and the 
duration, of the seizures would be markedly affected. In vitro, the use of a broad 
range of adenosine agonists and antagonists on hippocampal slices pre-incubated in 
defined amounts of DPCXP may be instrumental, in corroborating the proposed 
model of a two-stage binding of DPCPX to the Al receptor. Ideally, one would also 
like to assess the molecular location of various alkylxanthines within the lipid 
bilayer.
(b) the time course and extent of adenylyl cyclase activation by convergent stimuli 
such as the 'functional A2 activation' proposed for DPCPX may be studied 
biochemically, using for example the method described by Salomon (1991), whereby 
the adenine nucleotide pool of the cell is labelled with [3H]-adenine prior to 
stimulation. A2 activation could be stimulated by the concomitant application of an
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A 1-selective concentration of DPCPX (5 nM) and low concentrations of adenosine (5 
pM), similar to the experiment shown in Fig. 48. The recent development of CREB- 
deficient mutants (Bourtchuladze et a l, 1994) may greatly facilitate the 
demonstration of a role for cAMP-induced changes in protein synthesis in the long­
term effects of a synergistic activation of adenylyl cyclase by the functional A2 
agonism of DPCPX during epileptiform activity. It may be of interest to study 
whether the proposed mechanism for the long-term excitatory effects of DPCPX 
described in this study also applies to other antagonistic transmitter systems, such as 
the D1/D2 dopamine receptor system: dopaminergic D1/D5 receptors have been 
reported to induce a protein synthesis-dependent late potentiation in the CA1 region 
of the hippocampus while this work was in progress (Huang and Kandel, 1995).
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